[
    {
        "realidx": "10173769",
        "question": "To consider whether the Barthel Index alone provides sufficient information about the long term outcome of stroke.\nCross sectional follow up study with a structured interview questionnaire and measures of impairment, disability, handicap, and general health. The scales used were the hospital anxiety and depression scale, mini mental state examination, Barthel index, modified Rankin scale, London handicap scale, Frenchay activities index, SF36, Nottingham health profile, life satisfaction index, and the caregiver strain index.\nSouth east London.\nPeople, and their identified carers, resident in south east London in 1989-90 when they had their first in a life-time stroke aged under 75 years.\nObservational study.\nComparison and correlation of the individual Barthel index scores with the scores on other outcome measures.\nOne hundred and twenty three (42%) people were known to be alive, of whom 106 (86%) were interviewed. The median age was 71 years (range 34-79). The mean interval between the stroke and follow up was 4.9 years. The rank correlation coefficients between the Barthel and the different dimensions of the SF36 ranged from r = 0.217 (with the role emotional dimension) to r = 0.810 (with the physical functioning dimension); with the Nottingham health profile the range was r = -0.189 (with the sleep dimension, NS) to r = -0.840 (with the physical mobility dimension); with the hospital and anxiety scale depression component the coefficient was r = -0.563, with the life satisfaction index r = 0.361, with the London handicap scale r = 0.726 and with the Frenchay activities index r = 0.826.\nLonger term quality of life and outcome in stroke patients: is the Barthel index alone an adequate measure of outcome?",
        "answer": "yes",
        "answer_rationale": "The place of the Barthel index as the standard outcome measure for populations of stroke patients is still justified for long term follow up, and may be a proxy for different outcome measures intended for the assessment of other domains.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the Barthel Index alone is sufficient for assessing the long-term outcome of stroke patients. The study provided compares the Barthel Index with several other outcome measures.\n\nFirst, I need to recall what the Barthel Index measures. It's primarily about activities of daily living (ADLs), like mobility and self-care. But the question is about long-term outcome, which might involve more aspects like emotional health, social functioning, etc.\n\nLooking at the study results: The correlations between Barthel and other scales vary. For example, it had a high correlation with physical functioning (SF36's 0.810) and physical mobility (Nottingham's -0.840). But with the role emotional dimension of SF36, it was only 0.217, which is low. Also, the hospital anxiety scale had a -0.563 correlation, which is moderate. The life satisfaction index was 0.361, another moderate correlation. \n\nSince the correlations are strong for physical aspects but weaker for emotional, social, or psychological factors, the Barthel Index might not capture the full picture. The study's conclusion would likely suggest that other measures are needed alongside Barthel for a comprehensive long-term outcome assessment. Therefore, the answer should be \"no\" because the Barthel alone isn't sufficient.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 489,
            "completion_tokens": 291
        },
        "time_elapsed": 4.0601418018341064
    },
    {
        "realidx": "10223070",
        "question": "To critically assess the evidence that appendiceal perforation is a risk factor for subsequent tubal infertility or ectopic pregnancy.\nEpidemiologic studies investigating the relationship between appendectomy and infertility or ectopic pregnancy were identified by searching the MEDLINE database from 1966 to 1997. Appropriate citations were also extracted from a manual search of the bibliographies of selected papers.\nTwenty-three articles were retrieved. Only 4 presented original data including comparisons to a nonexposed control group and they form the basis for this study.\nBecause the raw data or specific techniques of data analysis were not always explicitly described, indices of risk for exposure were extracted from the data as presented and were analysed without attempting to convert them to a common measure.\nArticles were assessed according to the criteria of the Evidence-Based Medicine Working Group for evaluating articles on harm. Review of the literature yielded estimates of the risk of adverse fertility outcomes ranging from 1.6 (95% confidence interval [CI] 1.1 to 2.5) for ectopic pregnancy after an appendectomy to 4.8 (95% CI 1.5 to 14.9) for tubal infertility from perforation of the appendix. Recall bias, and poor adjustment for confounding variables in some reports, weakened the validity of the studies.\nIs perforation of the appendix a risk factor for tubal infertility and ectopic pregnancy?",
        "answer": "maybe",
        "answer_rationale": "The methodologic weaknesses of the studies do not permit acceptance of increased risk of tubal pregnancy or infertility as a consequence of perforation of the appendix, so a causal relationship cannot be supported by the data currently available. Only a well-designed case-control study with unbiased ascertainment of exposure and adjustment for confounding variables will provide a definitive answer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether appendiceal perforation is a risk factor for tubal infertility and ectopic pregnancy. The provided information is from a study that looked into this by reviewing existing literature up to 1997.\n\nFirst, I need to parse the key points from the study summary. They found 23 articles, but only 4 had original data with control groups. The main results mentioned are risk estimates: 1.6 (CI 1.1-2.5) for ectopic pregnancy after appendectomy and 4.8 (CI 1.5-14.9) for tubal infertility from perforation. The confidence intervals for both don't include 1, which means the risks are statistically significant. However, the study also points out weaknesses like recall bias and poor adjustment for confounders, which might affect the validity.\n\nThe question specifically asks about perforation, not just appendectomy. The higher risk for tubal infertility is linked directly to perforation (4.8), while the ectopic pregnancy risk is after appendectomy in general. Since the options are yes, no, or maybe, the data shows increased risk, but with some study limitations. However, since the confidence intervals exclude 1, the association is still there. The answer should be \"yes\" because the evidence, despite its flaws, indicates an increased risk. The \"maybe\" might be tempting due to study weaknesses, but the question is about being a risk factor, which the data supports.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 321
        },
        "time_elapsed": 4.250558853149414
    },
    {
        "realidx": "11146778",
        "question": "The APACHE II (Acute Physiology and Chronic Health Evaluation II) score used as an intensive care unit (ICU) admission score in emergency surgical patients is not independent of the effects of treatment and might lead to considerable bias in the comparability of defined groups of patients and in the evaluation of treatment policies. Postoperative monitoring with the APACHE II score is clinically irrelevant.\nInception cohort study.\nSecondary referral center.\nEighty-five consecutive emergency surgical patients admitted to the surgical ICU in 1999. The APACHE II score was calculated before surgery; after admission to the ICU; and on postoperative days 3, 7, and 10.\nAPACHE II scores and predicted and observed mortality rates.\nThe mean +/- SD APACHE II score of 24.2 +/- 8.3 at admission to the ICU was approximately 36% greater than the initial APACHE II score of 17.8 +/- 7.7, a difference that was highly statistically significant (P<.001). The overall mortality of 32% favorably corresponds with the predicted mortality of 34% according to the initial APACHE II score. However, the predicted mortality of 50% according to the APACHE II score at admission to the ICU was significantly different from the observed mortality rate (P =.02). In 40 long-term patients (>/=10 days in the ICU), the difference between the APACHE II scores of survivors and patients who died was statistically significant on day 10 (P =.04).\nRisk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment?",
        "answer": "yes",
        "answer_rationale": "For risk stratification in emergency surgical patients, it is essential to measure the APACHE II score before surgical treatment. Longitudinal APACHE II scoring reveals continuous improvement of the score in surviving patients but has no therapeutic relevance in the individual patient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the APACHE II score is a reliable marker of physiological impairment in emergency surgical patients based on the provided study.\n\nFirst, I need to recall what the APACHE II score is generally used for. It's a scoring system to assess the severity of illness in critically ill patients, often used in ICUs to predict mortality and guide resource allocation. The question here is about its reliability in this specific context of emergency surgical patients and postoperative monitoring.\n\nLooking at the study details: They followed 85 patients. The APACHE II was calculated before surgery, on ICU admission, and on postoperative days 3,7,10. The key findings were that the ICU admission score was 36% higher than the pre-surgery score, which was significant. The overall mortality (32%) matched the predicted 34% from the initial score. However, the ICU admission score's predicted mortality was 50% vs actual 32%, which was significantly different (p=0.02). Also, in long-term patients, the day 10 scores showed a significant difference between survivors and non-survivors.\n\nThe question is about whether APACHE II is a reliable marker here. The study's results show that the score increases after ICU admission, which might be due to treatment effects. The initial score (before surgery) predicted mortality accurately, but the ICU admission score overestimated it. Also, the later scores (like day 10) did show a difference between survivors and non-survivors, but the main issue is whether it's independent of treatment effects. The study's conclusion seems to suggest that using the APACHE II after admission isn't independent of treatment, leading to bias. The statement in the question also mentions that postoperative monitoring with APACHE II is clinically irrelevant, which aligns with the study's findings that the later scores aren't as reliable because they're influenced by treatment. \n\nSo the answer would be that the APACHE II isn't a reliable marker here because the scores after treatment (ICU admission) are higher and not independent, leading to biased predictions. The correct answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 435,
            "completion_tokens": 454
        },
        "time_elapsed": 5.657436847686768
    },
    {
        "realidx": "11411430",
        "question": "The purpose of this study is to determine if baseline antral follicle assessment may serve as additional information in predicting in vitro fertilization outcome.\nProspective, descriptive preliminary study of in vitro fertilization outcome. From July 1998 to July 1999, 224 patients underwent antral follicle assessment (follicle 2-6 mm in diameter) on baseline of the planned, stimulated in vitro fertilization cycle. The outcomes were analyzed with respect to antral follicle assessment (<or = 6 or>6), basal cycle day 3 follicle stimulated hormone (<or = 10 or>10 IU/L) and maternal age (<or = 35 or>35 years).\nThe clinical pregnancy rate was significantly higher in the group with baseline antral follicle>6 compared to that in the group with antral follicle<or = 6 (51% vs. 19%, respectively). Controlling for patient age, and basal follicle stimulated hormone, the pregnancy rate was significantly higher in the group with antral follicle>6 compared to that in the group with antral follicle<or = 6. The cancellation rate was significantly increased with advancing maternal age, elevated basal follicle stimulated hormone levels, and baseline antral follicle<or = 6. The cancellation rate was significantly higher in the group with antral follicle<or = 6 compared to that in the group with antral follicle>or = 6 (33% vs. 1%, respectively).\nAntral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?",
        "answer": "maybe",
        "answer_rationale": "In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether antral follicle count can predict IVF outcomes better than age and FSH. The options are yes, no, maybe.\n\nFirst, I need to look at the results given. The study says that the clinical pregnancy rate was significantly higher when the antral follicle count was over 6 compared to 6 or under (51% vs 19%). Even when controlling for age and FSH, the pregnancy rate was still higher in the higher antral follicle group. That suggests antral follicle count is a good predictor. \n\nThen, the cancellation rate was much higher in the group with \u22646 antral follicles (33% vs 1%). So, the antral follicle count seems to be a strong indicator here. The question is whether it's a better predictor than age and FSH. The study mentions that even when adjusting for age and FSH, the antral follicle count still showed significance. That implies that antral follicle count adds independent predictive value beyond age and FSH. \n\nBut wait, the question is if it's a \"better\" predictor than those factors. The study doesn't directly compare which factor is stronger, just that antral follicle count is significant even when considering the others. So maybe it's an additional predictor but not necessarily better. However, the results show that the pregnancy rates and cancellation rates varied a lot based on antral count, which might indicate it's more predictive. \n\nAlternatively, since the cancellation rate was highly associated with antral count, age, and FSH, but the question is about being a better predictor. The answer options are yes, no, maybe. The study's results support that antral follicle assessment is a better predictor because even when controlling for the others, it still had a significant effect. So the answer might be A) yes. But I need to be careful. The study says \"controlling for age and FSH, the pregnancy rate was significantly higher in the group with antral>6\". That means that antral count adds predictive value beyond age and FSH. So it's a better or at least as good predictor. The question is whether it's a better predictor than those factors. Since it's still significant after controlling for them, it suggests that it's an independent predictor, possibly better. So the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 447,
            "completion_tokens": 512
        },
        "time_elapsed": 6.133861064910889
    },
    {
        "realidx": "11458136",
        "question": "By requiring or encouraging enrollees to obtain a usual source of care, managed care programs hope to improve access to care without incurring higher costs.\n(1) To examine the effects of managed care on the likelihood of low-income persons having a usual source of care and a usual physician, and; (2) To examine the association between usual source of care and access.\nCross-sectional survey of households conducted during 1996 and 1997.\nA nationally representative sample of 14,271 low-income persons.\nUsual source of care, usual physician, managed care enrollment, managed care penetration.\nHigh managed care penetration in the community is associated with a lower likelihood of having a usual source of care for uninsured persons (54.8% vs. 62.2% in low penetration areas) as well as a lower likelihood of having a usual physician (60% vs. 72.8%). Managed care has only marginal effects on the likelihood of having a usual source of care for privately insured and Medicaid beneficiaries. Having a usual physician substantially reduces unmet medical needs for the insured but less so for the uninsured.\nDoes managed care enable more low income persons to identify a usual source of care?",
        "answer": "maybe",
        "answer_rationale": "Having a usual physician can be an effective tool in improving access to care for low-income populations, although it is most effective when combined with insurance coverage. However, the effectiveness of managed care in linking more low-income persons to a medical home is uncertain, and may have unintended consequences for uninsured persons.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether managed care enables more low-income persons to identify a usual source of care. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study had two parts: examining the effect of managed care on having a usual source of care and a usual physician, and the association between usual source of care and access. The data is from a cross-sectional survey in 1996-1997 with a national sample of 14,271 low-income individuals.\n\nThe key findings mentioned are that high managed care penetration in the community is linked to a lower likelihood of having a usual source of care for the uninsured. Specifically, 54.8% vs. 62.2% in low penetration areas. Similarly, the likelihood of having a usual physician is lower in high penetration areas (60% vs. 72.8%). For the privately insured and Medicaid beneficiaries, managed care only had marginal effects. Also, having a usual physician reduces unmet needs more for the insured than the uninsured.\n\nThe question is whether managed care helps more low-income people have a usual source. The answer seems to be no, especially for the uninsured. Since the uninsured are part of the low-income group, and their rates are lower where managed care is prevalent, that suggests managed care isn't enabling more people. The insured (like Medicaid) only had marginal effects, so overall, the answer would be B) no. The study's results show a negative association for the uninsured and minimal effect for others, so the answer is no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 342,
            "completion_tokens": 341
        },
        "time_elapsed": 4.296390056610107
    },
    {
        "realidx": "11570976",
        "question": "Sulfasalazine is a widely used anti-inflammatory agent in the treatment of inflammatory bowel disease and several rheumatological disorders. Although as many as 20% of treated patients may experience reversible, dose-dependent side effects, less frequent but potentially severe, systemic reactions have also been reported.\nA severe systemic reaction to sulfasalazine developed in a 21-year old female with rheumatoid arthritis characterized by eosinophilia, granulomatous enteritis and myelotoxicity, cholestatic hepatitis, and seizures. The clinical course and management of this patient are presented as well as a review of the incidence and outcome of severe systemic reactions to sulfasalazine.\nIs it Crohn's disease?",
        "answer": "maybe",
        "answer_rationale": "Granulomatous myelotoxicity and enteritis developed in a 21 year old female within 3 weeks of initiating sulfasalazine for rheumatoid arthritis. Following a short course of corticosteroids, the patient had resolution of her cholestatic hepatitis, rash, eosinophilia, and gastrointestinal symptoms with no residual manifestations at 7 months follow-up. Although severe reactions to sulfasalazine are rare and unpredictable, practicing physicians should be aware of unusual clinical presentations of toxicity when prescribing sulfasalazine.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the described case is Crohn's disease. The patient is a 21-year-old female with rheumatoid arthritis who developed a severe systemic reaction to sulfasalazine. The symptoms mentioned include eosinophilia, granulomatous enteritis, myelotoxicity, cholestatic hepatitis, and seizures.\n\nFirst, I need to recall what Crohn's disease typically presents with. Crohn's is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, often causing symptoms like abdominal pain, diarrhea, weight loss, and sometimes extraintestinal manifestations. However, the key here is the reaction to the medication, not the underlying condition.\n\nThe question states that the patient has rheumatoid arthritis, which is a rheumatological disorder. Sulfasalazine is used for both IBD and rheumatoid arthritis. The severe reaction described\u2014eosinophilia, granulomatous enteritis, etc.\u2014sounds like a drug-induced reaction rather than the natural progression of Crohn's or rheumatoid arthritis. The article mentions that these are severe systemic reactions to the drug, not the disease itself. \n\nCrohn's disease wouldn't present with myelotoxicity or seizures as primary symptoms. The combination of eosinophilia and granulomatous enteritis could be part of a hypersensitivity reaction. The question is whether the scenario is describing Crohn's. Since the patient has rheumatoid arthritis and the symptoms are due to a drug reaction, the answer should be no. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 236,
            "completion_tokens": 335
        },
        "time_elapsed": 4.166651964187622
    },
    {
        "realidx": "11926574",
        "question": "Hepatitis G virus can cause chronic infection in man but the role of this agent in chronic liver disease is poorly understood. Little is known about the relation of another newly discovered agent, the TT virus, with chronic liver disease.AIM: To investigate the rate of infection with hepatitis G virus and TT virus in patients with cryptogenic chronic liver disease.\nA total of 23 subjects with chronically raised alanine transaminase and a liver biopsy in whom all known causes of liver disease had been excluded, and 40 subjects with hepatitis C virus-related chronic liver disease.\nEvaluation of anti-hepatitis G virus by enzyme immunoassay. Hepatitis G virus-RNA by polymerase chain reaction with primers from the 5' NC and NS5a regions. TT virus-DNA by nested polymerase chain reaction with primers from the ORF1 region. Results. Hepatitis G virus-RNA was detected in 4 out of 23 patients with cryptogenic chronic hepatitis and in 6 out of 40 with hepatitis C virus chronic hepatitis (17.4% vs 15% p=ns). At least one marker of hepatitis G virus infection (hepatitis G virus-RNA and/or anti-hepatitis G virus, mostly mutually exclusive) was present in 6 out of 23 patients with cryptogenic hepatitis and 16 out of 40 with hepatitis C virus liver disease (26. 1% vs 40% p=ns). T virus-DNA was present in serum in 3 subjects, 1 with cryptogenic and 2 with hepatitis C virus-related chronic liver disease. Demographic and clinical features, including stage and grade of liver histology, were comparable between hepatitis G virus-infected and uninfected subjects. Severe liver damage [chronic hepatitis with fibrosis or cirrhosis) were significantly more frequent in subjects with hepatitis C virus liver disease.\nAre hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?",
        "answer": "no",
        "answer_rationale": "In Southern Italy, hepatitis G virus infection is widespread among patients with chronic hepatitis, independently of parenteral risk factors. Its frequency in subjects with cryptogenic liver disease parallels that observed in hepatitis C virus chronic liver disease, thus ruling out an aetiologic role of hepatitis G virus. TT virus infection is uncommon in patients with cryptogenic or hepatitis C virus-related liver disease who do not have a history of parenteral exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Hepatitis G virus (HGV) and TT virus are involved in cryptogenic chronic liver disease based on the provided study.\n\nFirst, I need to recall what cryptogenic means here. It refers to cases where all known causes of liver disease have been excluded. The study looked at 23 patients with cryptogenic chronic liver disease and 40 with HCV-related disease. They tested for HGV RNA, anti-HGV, and TT virus DNA.\n\nThe results showed that HGV RNA was found in 4 out of 23 (17.4%) cryptogenic patients and 6 out of 40 (15%) HCV patients. The p-value was not significant (p=ns), meaning no statistical difference between the groups. When considering any HGV marker (RNA or antibodies), 26.1% of cryptogenic vs 40% HCV had it, but again, not significant. TT virus was present in 1 cryptogenic and 2 HCV patients. \n\nThe study also mentions that demographic and clinical features, including liver damage severity, didn't differ between HGV-infected and uninfected in their groups. However, severe liver damage was more in HCV, which makes sense since HCV is a known cause.\n\nThe key point is whether HGV or TT are implicated in cryptogenic cases. Since the infection rates in cryptogenic weren't higher than in HCV patients (and even lower for HGV RNA), and the p-values were not significant, it suggests no strong association. The study's aim was to see if these viruses are involved, but the results don't show a significant link. The answer would lean towards \"no\" because there's no evidence here supporting their involvement. The \"maybe\" might be if there was a trend, but since the rates are comparable and not significant, \"no\" is more accurate.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 501,
            "completion_tokens": 402
        },
        "time_elapsed": 5.159851789474487
    },
    {
        "realidx": "12094116",
        "question": "The purpose of this study was to identify the relationships between leg muscle power and sprinting speed with changes of direction.\nthe study was designed to describe relationships between physical qualities and a component of sports performance.\ntesting was conducted in an indoor sports hall and a biomechanics laboratory.\n15 male participants were required to be free of injury and have recent experience competing in sports involving sprints with changes of direction.\nsubjects were timed in 8 m sprints in a straight line and with various changes of direction. They were also tested for bilateral and unilateral leg extensor muscle concentric power output by an isokinetic squat and reactive strength by a drop jump.\nThe correlations between concentric power and straight sprinting speed were non-significant whereas the relationships between reactive strength and straight speed were statistically significant. Correlations between muscle power and speed while changing direction were generally low and non-significant for concentric leg power with some moderate and significant (p<0.05) coefficients found for reactive strength. The participants who turned faster to one side tended to have a reactive strength dominance in the leg responsible for the push-off action.\nIs muscle power related to running speed with changes of direction?",
        "answer": "yes",
        "answer_rationale": "The relationships between leg muscle power and change-of-direction speed were not consistent. Reactive strength as measured by the drop jump appears to have some importance for lateral change-of-direction speed, possibly because of similar push-off actions. It was concluded that reactive strength of the leg extensor muscles has some importance in change-of-direction performance but the other technical and perceptual factors than influence agility performance should also be considered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether muscle power is related to running speed with changes of direction based on the study described.\n\nFirst, I need to recall the details from the study provided. The study looked at leg muscle power (both concentric and reactive strength) and how they relate to sprinting speed, especially during changes of direction. \n\nThe key results mentioned are that the correlations between concentric power (which is the type of muscle contraction where the muscle shortens, like in a squat) and straight sprinting speed were non-significant. That means there wasn't a strong statistical link there for straight sprints. \n\nHowever, when it came to changing direction, the correlations between muscle power and speed were different. The text says that correlations for concentric leg power were generally low and non-significant. But for reactive strength (which is the ability to quickly produce force after a rapid eccentric load, like in a drop jump), there were some moderate and significant correlations (p<0.05). Also, participants who turned faster on one side had better reactive strength in the leg they used to push off.\n\nThe question specifically asks about muscle power's relation to speed during changes of direction. The options are yes, no, maybe. \n\nNow, the term \"muscle power\" here could be a bit ambiguous. The study differentiates between concentric power and reactive strength. The answer hinges on whether \"muscle power\" in the question refers to both types or just one. Since the options are general, I need to see if any form of muscle power showed a significant relationship. \n\nThe study found that concentric power didn't have a significant correlation (non-significant), but reactive strength did have some significant moderate correlations. Since reactive strength is a component of muscle power (as it involves power output in a different context), the answer would lean towards \"yes\" because reactive strength (a type of muscle power) is related. However, if the question is specifically about concentric power, then it's no. But the question just says \"muscle power\" generally. \n\nThe options are (A) yes, (B) no, (C) maybe. The study shows that at least one aspect of muscle power (reactive strength) is related, so the answer should be yes. The non-significant results for concentric power don't negate the presence of a relationship in another form of power. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 328,
            "completion_tokens": 507
        },
        "time_elapsed": 6.122002124786377
    },
    {
        "realidx": "12407608",
        "question": "To investigate whether prepuncture ultrasound evaluation of vascular anatomy facilitates internal jugular vein cannulation compared with landmark-guided puncture.\nProspective randomized study.\nSingle community hospital.\nAdult patients undergoing general anesthesia (n = 240).\nThe right internal jugular vein was cannulated using either anatomic landmarks or prepuncture ultrasound (3.75/7.5 MHz) guidance. In the landmark group, respiratory jugular venodilation was used as the primary landmark for locating the vein. Results of cannulation and the incidence of complications were compared.\nPatients were randomly assigned to the ultrasound or landmark group. Respiratory jugular venodilation was identified in 188 patients (78.3%), in whom results of cannulation did not differ between the 2 techniques with respect to the venous access rate (cannulated at the first attempt: 83.5% in the landmark v 85.7% in the ultrasound group), the success rate (cannulated within 3 attempts: 96.9% v 95.6%), and the incidence of arterial puncture (1.0% v 3.3%). In the remaining 52 respiratory jugular venodilation-unidentified patients, the access rate (30.4% v 86.2%, p<0.001) and the success rate (78.3 v 100%, p<0.05) were significantly better in the ultrasound group, and no arterial puncture was recorded in the ultrasound group, whereas the incidence was 13.0% in the landmark group. The results were similar regardless of the ultrasound frequency used.\nDoes ultrasound imaging before puncture facilitate internal jugular vein cannulation?",
        "answer": "maybe",
        "answer_rationale": "Prepuncture ultrasound evaluation did not improve the result of right internal jugular vein cannulation compared with the respiratory jugular venodilation-guided approach. When the landmark was not observed, however, the prepuncture ultrasound guidance was helpful in facilitating the cannulation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing ultrasound guidance versus landmark-guided cannulation of the internal jugular vein. The key here is to see under what conditions ultrasound helps.\n\nFirst, the study split 240 patients into two groups. In the group where respiratory jugular venodilation was identified (188 patients), there wasn't a big difference between the two methods. The first-attempt success rates were similar (83.5% vs 85.7%), and overall success within three attempts was almost the same too. Arterial puncture rates were a bit higher in the landmark group but not statistically significant maybe? The p-values aren't given for those, except for the access rate and success in the other group.\n\nNow, the crucial part is the 52 patients where they couldn't identify the venodilation. Here, ultrasound really shone. The access rate at first attempt was way better (30.4% vs 86.2%), and success rates within three attempts were 78.3% vs 100%. Also, no arterial punctures in the ultrasound group versus 13% in landmark. That's a big difference. \n\nThe question is asking if ultrasound facilitates cannulation. Well, in cases where the landmark method is tricky (when venodilation isn't visible), ultrasound is clearly better. Since the study shows that in those harder cases ultrasound is better, the overall answer would be yes. The fact that in the majority where landmarks worked okay, ultrasound didn't hurt but wasn't better, but in the subset where landmarks failed, ultrasound was superior. So overall, ultrasound does help, especially when landmarks aren't clear. Therefore, the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 452,
            "completion_tokens": 366
        },
        "time_elapsed": 4.876432657241821
    },
    {
        "realidx": "12630042",
        "question": "The long-term survival of patients with gastric cancer is governed by various factors, such as the clinical stage of the cancer, the patient's nutritional state, and the treatment and may be governed by the volume of intraperitoneal adipose tissue. The aim of this study is to clarify the relationship between the degree of the patients' body mass index and their long-term survival.\nGastric cancer patients who had undergone a gastrectomy with D2-lymphadenectomy and with resection A and B according to the criteria of the Japanese Research Society for Gastric Cancer Rules were subgrouped into those patients with a body mass index<0.185 (the lower body mass index group) and those patients with a body mass index>0.210 (the higher body mass index group). The patient's morbidity and long-term survival rate was retrospectively compared between the 2 groups.\nA significantly longer mean survival rate was observed for the lower body mass index group in stage 2 (1667 vs. 1322 days, P = 0.0240). Also, a significantly longer mean survival rate was observed for the higher BMI group in stage 3a (1431 vs. 943, P = 0.0071).\nDoes body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?",
        "answer": "maybe",
        "answer_rationale": "The body mass index is one of the prognostic factors of stage 2 and stage 3a gastric cancer. However, it does not appear to be useful for determining the prognosis of stage 1a, 1b, 3b, and 4a gastric cancers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether BMI influences morbidity and long-term survival in gastric cancer patients after gastrectomy. The study mentioned subgrouped patients into lower and higher BMI groups.\n\nLooking at the results: in stage 2, the lower BMI group had longer survival (1667 vs 1322 days, p=0.0240). In stage 3a, the higher BMI group had better survival (1431 vs 943, p=0.0071). So the effect of BMI depends on the cancer stage. The question is if BMI has an influence. Since there are significant differences in survival based on BMI in different stages, that means BMI does play a role. The answer should be yes (A). The options are A, B, C. The study shows BMI affects survival depending on stage, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 383,
            "completion_tokens": 196
        },
        "time_elapsed": 2.780601739883423
    },
    {
        "realidx": "12790890",
        "question": "Mesial temporal sclerosis (MTS) is characterized by neuronal loss in the hippocampus. Studies on experimental models and patients with intractable epilepsy suggest that apoptosis may be involved in neuronal death induced by recurrent seizures.\nWe searched evidence for apoptotic cell death in temporal lobes resected from drug-resistant epilepsy patients with MTS by using the terminal deoxynucleotidyl transferase (TdT) and digoxigenin-11-dUTP (TUNEL) method and immunohistochemistry for Bcl-2, Bax, and caspase-cleaved actin fragment, fractin. The temporal lobe specimens were obtained from 15 patients (six women and nine men; mean age, 29 +/- 8 years).\nUnlike that in normal adult brain, we observed Bcl-2 immunoreactivity in some of the remaining neurons dispersed throughout the hippocampus proper as well as in most of the reactive astroglia. Bax immunopositivity was increased in almost all neurons. Fractin immunostaining, an indicator of caspase activity, was detected in approximately 10% of these neurons. Despite increased Bax expression and activation of caspases, we could not find evidence for DNA fragmentation by TUNEL staining. We also could not detect typical apoptotic changes in nuclear morphology by Hoechst-33258 or hematoxylin counterstaining.\nIs the cell death in mesial temporal sclerosis apoptotic?",
        "answer": "maybe",
        "answer_rationale": "These data suggest that either apoptosis is not involved in cell loss in MTS, or a very slow rate of cell demise may have precluded detecting TUNEL-positive neurons dying through apoptosis. Increased Bax expression and activation of caspases support the latter possibility.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the cell death in mesial temporal sclerosis (MTS) is apoptotic based on the provided study.\n\nFirst, I need to recall what the study found. The key points are:\n\n- They used TUNEL staining to look for DNA fragmentation, which is a hallmark of apoptosis. But they didn't find evidence of DNA fragmentation with TUNEL.\n- They also checked for apoptotic nuclear changes using Hoechst and hematoxylin, and those didn't show typical apoptosis either.\n- However, there were some markers that might suggest apoptosis: Bax (pro-apoptotic) was increased in almost all neurons, and fractin (a caspase-cleaved protein) was present in about 10% of neurons. Bcl-2 (anti-apoptotic) was present in some neurons and astroglia.\n\nWait, so Bax is up, which usually promotes apoptosis, and fractin indicates caspase activation, which is part of the apoptotic pathway. But the absence of TUNEL positivity and morphological changes like condensed nuclei would argue against apoptosis. \n\nHmm, the question is whether the cell death is apoptotic. Apoptosis typically involves DNA fragmentation (detected by TUNEL) and specific nuclear changes. Since those weren't found, even though some apoptotic markers are present, the study's main findings don't support apoptosis. The authors might be suggesting that while some elements of apoptosis are present (like caspase activation), the classic signs of apoptosis (DNA fragmentation, nuclear changes) aren't there. So maybe the cell death isn't apoptotic here. \n\nThe options are yes, no, maybe. The study's conclusion seems to say they couldn't find evidence of apoptosis because TUNEL and morphological signs were absent. So the answer would be B) no. But wait, sometimes in some contexts, even if TUNEL isn't positive, other markers might indicate apoptosis. But according to the study's results, since the key markers for apoptosis (DNA fragmentation and nuclear changes) are missing, the answer should be no. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 450
        },
        "time_elapsed": 5.30761456489563
    },
    {
        "realidx": "12970636",
        "question": "To examine the impact of early discharge on newborn metabolic screening.\nMetabolic screening results were obtained from the Alabama State Lab for all infants born at our hospital between 8/1/97, and 1/31/99, and were matched with an existing database of early discharge infants. An early newborn discharge was defined as a discharge between 24 and 47 hours of age. Metabolic screening tests included phenylketonuria (PKU), hypothyroidism, and congenital adrenal hyperplasia (CAH). Early discharge and traditional stay infants were compared to determine the percentage of newborns screened and the timing of the first adequate specimen.\nThe state laboratory received specimens from 3860 infants; 1324 were on early discharge newborns and 2536 infants in the traditional stay group. At least one filter paper test (PKU, hypothyroidism, and CAH) was collected on 99.2% of early discharge infants and 96.0% of traditional stay infants (P<.0001). Early discharge infants had a higher rate of initial filter paper specimens being inadequate (22.9%) compared with traditional stay infants (14.3%, P<.0001) but had a higher rate of repeat specimens when the initial specimen was inadequate (85.0% early discharge vs 75.3% traditional stay, P=.002). The early discharge group was more likely to have an adequate specimen within the first 9 days of life (1001, 98.8% early discharge vs 2016, 96.7% traditional stay, P=.0005).\nDoes early discharge with nurse home visits affect adequacy of newborn metabolic screening?",
        "answer": "no",
        "answer_rationale": "In this well established early discharge program with nurse home visits, newborn metabolic screening is not compromised by early discharge.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether early discharge with nurse home visits affects the adequacy of newborn metabolic screening. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided in the study. The study compared early discharge infants (24-47 hours) with traditional stay infants. The key points are:\n\n1. Screening rates: 99.2% of early discharge vs 96.0% traditional. So higher in early discharge.\n2. Initial inadequate specimens: 22.9% early vs 14.3% traditional. So more initial issues here.\n3. But when the first was inadequate, early discharge had a higher rate of getting a repeat (85% vs 75.3%). \n4. Ultimately, the early group had a higher percentage with adequate specimen within first 9 days (98.8% vs 96.7%, p=0.0005).\n\nThe question is about the effect of early discharge with nurse home visits. The study's results show that despite more initial inadequate samples, the early discharge group ended up with a higher rate of adequate specimens in the first 9 days. The higher repeat rate might be due to the nurse home visits ensuring that even if the first sample was bad, they followed up. \n\nThe answer would be \"yes\" because the adequacy (having an adequate specimen within 9 days) was better in early discharge. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 318
        },
        "time_elapsed": 4.3021080493927
    },
    {
        "realidx": "14599616",
        "question": "Lymphedema may be identified by simpler circumference changes as compared with changes in limb volume.\nNinety breast cancer patients were prospectively enrolled in an academic trial, and seven upper extremity circumferences were measured quarterly for 3 years. A 10% volume increase or greater than 1 cm increase in arm circumference identified lymphedema with verification by a lymphedema specialist. Sensitivity and specificity of several different criteria for detecting lymphedema were compared using the academic trial as the standard.\nThirty-nine cases of lymphedema were identified by the academic trial. Using a 10% increase in circumference at two sites as the criterion, half the lymphedema cases were detected (sensitivity 37%). When using a 10% increase in circumference at any site, 74.4% of cases were detected (sensitivity 49%). Detection by a 5% increase in circumference at any site was 91% sensitive.\nCan a practicing surgeon detect early lymphedema reliably?",
        "answer": "maybe",
        "answer_rationale": "An increase of 5% in circumference measurements identified the most potential lymphedema cases compared with an academic trial.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a practicing surgeon can reliably detect early lymphedema based on the study described.\n\nFirst, I need to understand the study's findings. The study enrolled 99 breast cancer patients and measured their arm circumferences quarterly for three years. They used two main criteria to identify lymphedema: a 10% volume increase or a 1 cm or more increase in arm circumference. The gold standard here is the academic trial's identification of 39 cases.\n\nThe key data points are the sensitivity values for different criteria. Sensitivity refers to the test's ability to correctly identify those with the condition. \n\nWhen using a 10% increase in circumference at two sites, the sensitivity was 37%, meaning only 37% of actual cases were detected. That's pretty low. Then, using a 10% increase at any site, sensitivity went up to 74.4%, which is better but still leaves about a quarter of cases undetected. The best sensitivity was 91% when using a 5% increase at any site. \n\nThe question is whether a surgeon can reliably detect early lymphedema. The options are yes, no, maybe. \n\nNow, considering the criteria: if the surgeon is using the 10% at two sites, that's not reliable because of low sensitivity. But if they use the 5% at any site, the sensitivity is high. However, the problem is that the question doesn't specify which criteria the surgeon is using. The study shows that the higher the threshold (like 10% at two sites), the lower the sensitivity. Early detection would require a lower threshold, like 5%, which has higher sensitivity. \n\nBut the options given don't mention the criteria. The question is general. The study's results suggest that using the 10% at two sites isn't reliable (only 37% detection), but maybe if they use a lower threshold, it's better. However, in practice, maybe surgeons aren't using the 5% cutoff. The question is whether they can do it \"reliably.\" Since the study shows that even with the 5% cutoff, there's still 9% of cases missed, but that's the highest sensitivity. However, the options are yes/no/maybe. \n\nThe answer might be \"no\" because the standard criteria (maybe the 10% at two sites) aren't reliable.",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 299,
            "completion_tokens": 512
        },
        "time_elapsed": 6.093919277191162
    },
    {
        "realidx": "14627582",
        "question": "The purpose of our study was to determine the effectiveness, clinical impact, and feasibility of double reading barium enemas.\nIndependent double readings of 1,003 consecutive barium enemas (822 double- and 181 single-contrast examinations) were prospectively performed. From this pool of 1,003 examinations, 994 were included in our study. Examinations showing at least one polyp or carcinoma 5 mm or larger were considered to have positive results. For combined readings, results were considered positive if either of the two interpreters reported finding a polyp or carcinoma. A McNemar test was used to compare the first reader's results with the combined results of the first and second readers. Results were retrospectively correlated with endoscopic or surgical results in 360 patients, and agreement between first and combined readings and endoscopic results was determined.\nAdding a second reader increased the number of positive results on examinations from 249 to 315 (p<0.0001) and resulted in potential alteration of clinical treatment in 98 patients (9.9%). Sensitivity of the first and combined readings for detection of all lesions was identical, 76.3% (95% CI, 65.4-87.1%). Specificity decreased from 91.0% (95% CI, 87.9-94.3%) for the first reading to 86.4% (95% CI, 82.2-90.0%) for the combined reading. The overall measurement of agreement decreased from a kappa value of 61.8 (95% CI, 51.2-72.4%) for the first reading to 52.9 (95% CI, 42.2-63.6%) for the combined reading. The second reading required an average of 3.3 min. Sensitivity for the detection of adenocarcinomas was 100%.\nDouble reading of barium enemas: is it necessary?",
        "answer": "no",
        "answer_rationale": "Although feasible, double reading of barium enemas does not improve sensitivity for detection of polyps and produces a higher false-positive rate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether double reading barium enemas is necessary. The options are yes, no, or maybe. \n\nFirst, I need to look at the results provided. The key points are:\n\n- Adding a second reader increased positive results from 249 to 315, which is a significant increase (p<0.0001). That means more lesions were detected when two readers were used. \n\n- The clinical impact was that 98 patients (9.9%) might have had their treatment altered. That's a notable number, suggesting that double reading can lead to better patient outcomes by catching more issues.\n\n- Sensitivity for the first reader and combined readings was the same at 76.3%. Wait, that's interesting. Sensitivity is the ability to detect true positives. So even though adding a second reader found more positives, the sensitivity didn't go up? Hmm, maybe because the combined reading's true positives were already accounted for in the first reader's sensitivity? Or perhaps the way they calculated it considered all lesions, and the second reader found some that the first missed, but the overall sensitivity remained the same? Not sure, but the key point here is that the sensitivity for adenocarcinomas was 100%, which is important because those are cancers, so catching all of them is crucial.\n\n- Specificity decreased from 91% to 86.4%. Specificity is the ability to correctly identify negatives. Lower specificity means more false positives. So with two readers, there might be more cases where they thought there was a lesion when there wasn't. But the trade-off here is between sensitivity and specificity. Since they're looking at clinical impact, maybe the increase in sensitivity (even if the number stayed the same overall) for critical cases like adenocarcinoma is worth the slight drop in specificity.\n\n- The agreement (kappa) between first and combined readings decreased. Kappa measures inter-rater reliability. Lower kappa here might mean that the two readers didn't always agree, but since combining them found more true positives, that's a good thing even if they don't agree all the time.\n\n- The time taken was only 3.3 minutes extra per exam. That's not a huge time investment for the potential benefits.\n\nThe question is whether double reading is necessary. The study shows that it increases the number of detected positive cases, especially important ones like adenocarcinomas (1",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 533,
            "completion_tokens": 512
        },
        "time_elapsed": 6.369735479354858
    },
    {
        "realidx": "16392897",
        "question": "Quantitative real-time PCR has become the predominant molecular technique to monitor BCRABL levels in response to treatment in Ph(+) leukemia patients. However, without some form of standardized methodology between laboratories, the correlation of results is difficult.\nUsing TaqMan-based assays, parallel quantitative real-time PCR analysis was performed on 70 clinical specimens at Vanderbilt University Medical Center and Virginia Commonwealth University. While the same positive control cell line (K562) and quality control gene (BCR) were used, the RNA isolation technique, cDNA synthesis, BCR control cell line, and PCR primer and probe sequences were different.\nThe detection of BCRABL-positive results spanned a dynamic range from 10(0) to 10(5)/100,000 cells. Forty-three samples were negative at both facilities. A Spearman rank correlation analysis was performed for the 22 BCRABL-positive paired results. The correlation coefficient, r(s), was 0.9435 (p<0.00001), suggesting a strong correlation of the results. One discordant result was obtained for consecutive samples from one patient with a low BCRABL copy number as a result of a minimal RNA yield at one laboratory.\nBCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays?",
        "answer": "maybe",
        "answer_rationale": "These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for patients who are monitored at different facilities, but also for larger investigative studies in which hematologic, cytogenetic and molecular responses are to be compared.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether correlated results are possible from homebrew assays when detecting BCR-ABL transcripts using quantitative real-time PCR. The question is based on a study described where two labs used different methods but some common controls.\n\nFirst, I need to recall what the study found. The key points are that even though the labs had differences in RNA isolation, cDNA synthesis, and primers/probes, they still found a strong correlation (Spearman r_s of 0.9435, p <0.00001) in 22 positive samples. There was only one discordant result from a patient with low copy number due to low RNA yield in one lab. \n\nThe question is whether correlated results are possible. The high correlation coefficient (close to 1) indicates a strong monotonic relationship between the two labs' results. The p-value being very low suggests this correlation is statistically significant. The fact that only one discordant case occurred, especially in a low yield situation, might be an outlier. \n\nThe options are yes, no, maybe. The study's results support that despite methodological differences, the results are strongly correlated. So the answer should be yes (A). The presence of one discordant result might make someone think \"maybe,\" but the high correlation coefficient and the context of the question (are correlated results possible) suggests that yes, they are possible. The study's conclusion would likely say that even with different homebrew assays, correlation is achievable, except in edge cases. Therefore, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 367,
            "completion_tokens": 330
        },
        "time_elapsed": 4.0317840576171875
    },
    {
        "realidx": "16538201",
        "question": "To determine whether the use of hydrophilic guidewires has increased the technical success rate of peripheral percutaneous transluminal angioplasty (PTA).MATERIAL/\nWe performed 125 procedures and analyzed the technical success rates of PTA using the conventional guidewire first and then if needed, the hydrophilic guidewire for iliac and SFA stenoses or occlusions. Angioplasty was performed on 25 stenosed, 25 occluded iliac arteries and 25 stenosed, 50 occluded femoral arteries. The result was defined as technical success when the lesion was crossed by a guidewire and balloon, then it was dilated with restoration of vessel lumen and less than 30% residual stenosis and the rise in ABI values was at least 0.15 after 24 hours.\nThe technical success rate after PTA of stenosed iliac arteries was achieved in 96% (24/25) using conventional wires and 100% using hydrophilic guidewire; in iliac occlusions, the rates were 60% (15/25) and 96%, respectively; in femoral stenosis - 84% (21/25) and 100%; in occlusions in the first group: lesions<10 cm -64% (16/25) and 96%, in the second group: lesions>10 cm -48% (12/25) and 88%. In the iliac group, there was no significant difference in the success of iliac stenosis PTA. However, there were significant changes in the success rates of PTA performed for SFA stenosis and iliac and SFA occlusions.\nDoes use of hydrophilic guidewires significantly improve technical success rates of peripheral PTA?",
        "answer": "maybe",
        "answer_rationale": "In summary, we report an overall improvement and high technical success rate for peripherial PTA. The use of hydrophilic guidewires made significant difference to the technical success rate of PTA, especially in occlusion and more complicated lesions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hydrophilic guidewires significantly improve the technical success rates of peripheral PTA based on the provided study data.\n\nFirst, I need to understand the data given. The study compared conventional and hydrophilic guidewires in different types of lesions: stenosed vs. occluded in iliac and femoral arteries. The technical success is defined by crossing the lesion, restoring the lumen with less than 30% residual stenosis, and an ABI increase of at least 0.15 after 24 hours.\n\nLooking at the numbers:\n\nFor iliac stenosis:\n- Conventional: 96% (24/25)\n- Hydrophilic: 100%\nThe difference here is small (4%), and the text mentions there was no significant difference in iliac stenosis. So hydrophilic didn't make a significant improvement here.\n\nIliac occlusions:\n- Conventional: 60% (15/25)\n- Hydrophilic: 96%\nThat's a big jump. 60% to 96% is a 36% increase. The question is whether this is significant. The study states there were significant changes in success rates for iliac occlusions and SFA (superficial femoral artery) cases.\n\nFor femoral (SFA?) stenosis:\n- Conventional: 84% to 100% with hydrophilic. That's a 16% increase. The text says there were significant changes here too.\n\nIn femoral occlusions, they split into <10cm and >10cm:\n- <10cm occlusions: conventional 64% vs hydrophilic 96% (32% improvement)\n- >10cm occlusions: conventional 48% vs hydrophilic 88% (40% improvement)\nAgain, those are substantial increases. The study mentions significant changes in SFA occlusions as well.\n\nThe key point is that while in iliac stenosis there was no significant difference, the other categories (occlusions in iliac, SFA stenosis, and SFA occlusions) all showed significant improvements with hydrophilic wires. The question is whether overall, the use of hydrophilic guidewires \"significantly improve\" the technical success rates. Since the study states there were significant changes in",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 494,
            "completion_tokens": 512
        },
        "time_elapsed": 5.890178680419922
    },
    {
        "realidx": "16816043",
        "question": "To determine under what conditions lay people and health professionals find it acceptable for a physician to breach confidentiality to protect the wife of a patient with a sexually transmitted disease (STD).\nIn a study in France, breaching confidentiality in 48 scenarios were accepted by 144 lay people, 10 psychologists and 7 physicians. The scenarios were all possible combinations of five factors: severity of the disease (severe, lethal); time taken to discuss this with (little time, much time); intent to inform the spouse about the disease (none, one of these days, immediately); intent to adopt protective behaviours (no intent, intent); and decision to consult an expert in STDs (yes, no), 2 x 2 x 3 x 2 x 2. The importance and interactions of each factor were determined, at the group level, by performing analyses of variance and constructing graphs.\nThe concept of breaching confidentiality to protect a wife from her husband's STD was favoured much more by lay people and psychologists than by physicians (mean ratings 11.76, 9.28 and 2.90, respectively, on a scale of 0-22). The patient's stated intentions to protect his wife and to inform her of the disease had the greatest impact on acceptability. A cluster analysis showed groups of lay participants who found breaching confidentiality \"always acceptable\" (n = 14), \"depending on the many circumstances\" (n = 87), requiring \"consultation with an expert\" (n = 30) and \"never acceptable (n = 13)\".\nDo French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease?",
        "answer": "maybe",
        "answer_rationale": "Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from an STD. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study involved 144 lay people, 10 psychologists, and 7 physicians. The key results mentioned are the mean ratings: lay people had 11.76, psychologists 9.28, and physicians 2.90 on a 0-22 scale. The higher the score, the more acceptable they found breaching confidentiality. \n\nThe question is asking if they \"find it acceptable,\" so we need to see if the ratings are high enough to indicate acceptance. The scale goes up to 22, so 11.76 for lay people is over halfway, which suggests they do find it acceptable. Psychologists are a bit lower but still above half. Physicians are much lower at 2.90, which is less than a third. However, the question groups both lay people and health professionals (which include psychologists and physicians). \n\nWait, the options are yes, no, maybe. The study says that lay people and psychologists favored it more than physicians. Since the question is about both groups together, but the options are a single answer. The key point is that the lay people and the health professionals (psychologists and physicians) have different views. However, the first sentence of the question states that the study found that breaching was accepted more by lay and psychologists than physicians. The question is whether they (both groups) find it acceptable. Since the lay people and psychologists do, but physicians less so, but the options are yes/no/maybe. The answer probably is yes because the lay people and at least some health professionals (psychologists) do. The question is phrased as \"do French lay people and health professionals find it acceptable\"\u2014so the answer would be yes because at least some of them do. The options don't have a \"sometimes\" but maybe is an option. Wait, but the question is whether they find it acceptable, and the study shows that on average, lay people and psychologists do, so the answer is yes. The physicians are part of the health professionals, but the question is about both groups. The first sentence says \"favoured much more by lay people and psychologists than by physicians,\" so the answer is yes because the lay and psychologists do",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 448,
            "completion_tokens": 512
        },
        "time_elapsed": 6.614202499389648
    },
    {
        "realidx": "16962519",
        "question": "To estimate changes in uterine myoma volume during pregnancy.\nReview of departmental electronic perinatal database and medical records. Canadian Task Force Classification II-3.\nObstetrical ultrasound unit in an academic tertiary care center.\nOne hundred-seven patients diagnosed with uterine myomas during pregnancy and who had two or more obstetrical ultrasounds in different periods of pregnancy.\nWe analyzed the change in volume of uterine myomas between the first half of pregnancy (up until 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The volume of largest uterine myoma was calculated using the formula Volume (mm3)=Pi/6x(length mm)x(width mm)x(height mm).\nThe mean age of the population was 31+/-6 years. Between the first and the second study periods, the percentage of uterine myomas that decreased in size was 55.1% (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%.\nVolume change of uterine myomas during pregnancy: do myomas really grow?",
        "answer": "no",
        "answer_rationale": "Contrary to common belief, we found that uterine myomas commonly decrease in volume over the course of pregnancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether uterine myomas really grow during pregnancy based on the provided study. The options are yes, no, or maybe.\n\nFirst, I need to look at the data given. The study tracked changes in myoma volume in 107 pregnant patients with multiple ultrasounds. They divided the pregnancy into three periods: first half (up to 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). \n\nLooking at the first interval between the first and second periods (which I assume are the first half and then the third quarter?), the results show that 55.1% of myomas decreased in size with a mean decrease of 35%, while 44.9% increased by an average of 69%. So here, some grew significantly, but most shrank. \n\nThen between the second and third periods (third quarter to last quarter), 75% decreased by 30% on average, and 25% increased by 102%. Again, a portion grew a lot, but the majority shrank. \n\nThe question is whether myomas \"really grow\" during pregnancy. The answer hinges on whether there's any growth observed. Since in both intervals, a significant percentage (over 40% initially, then 25% later) did grow, even if the majority didn't, the answer would be yes, some do grow. However, the options are yes, no, maybe. The study shows that a subset of myomas do grow, so the answer should be yes. But wait, the question is phrased as \"do myomas really grow?\" which might be interpreted as whether they generally tend to grow. The majority actually shrink, but the fact that some do grow means the answer is yes. The options don't have a \"sometimes\" but \"maybe\" is an option. Wait, the options are (A) yes (B) no (C) maybe. The study clearly shows that some myomas do grow during pregnancy, so the answer is yes. The fact that the majority don't doesn't negate that some do. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 464,
            "completion_tokens": 468
        },
        "time_elapsed": 6.0123443603515625
    },
    {
        "realidx": "16968876",
        "question": "The aim of this prognostic factor analysis was to investigate if a patient's self-reported health-related quality of life (HRQOL) provided independent prognostic information for survival in non-small cell lung cancer (NSCLC) patients.\nPretreatment HRQOL was measured in 391 advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module (QLQ-LC13). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap validation technique was used to assess the stability of the outcomes.\nThe final multivariate Cox regression model retained four parameters as independent prognostic factors for survival: male gender with a hazard ratio (HR) = 1.32 (95% CI 1.03-1.69; P = 0.03); performance status (0 to 1 versus 2) with HR = 1.63 (95% CI 1.04-2.54; P = 0.032); patient's self-reported score of pain with HR= 1.11 (95% CI 1.07-1.16; P<0.001) and dysphagia with HR = 1.12 (95% CI 1.04-1.21; P = 0.003). A 10-point shift worse in the scale measuring pain and dysphagia translated into an 11% and 12% increased in the likelihood of death respectively. A risk group categorization was also developed.\nIs a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients?",
        "answer": "maybe",
        "answer_rationale": "The results suggest that patients' self-reported HRQOL provide independent prognostic information for survival. This finding supports the collection of such data in routine clinical practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a patient's self-reported health-related quality of life (HRQOL) is a prognostic factor for survival in non-small cell lung cancer (NSCLC) patients. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided in the question. The study mentioned used the EORTC QLQ-C30 and QLQ-LC13 to measure HRQOL. The key part here is the results from the multivariate Cox regression model. The final model included four independent prognostic factors: male gender, performance status, pain score, and dysphagia. \n\nThe question specifically asks about self-reported HRQOL. The pain and dysphagia scores are components of the HRQOL questionnaires used. The hazard ratios for pain and dysphagia are both significant (p < 0.05), with a 10-point worse score increasing the hazard by 11% and 12% respectively. Since these are part of the HRQOL assessments, their inclusion as independent factors in the model suggests that self-reported HRQOL does contribute to survival prognosis. \n\nThe options are straightforward. Since the analysis shows that pain and dysphagia (elements of HRQOL) are independent predictors, the answer should be yes. The study's conclusion supports that HRQOL provides independent prognostic information. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 472,
            "completion_tokens": 313
        },
        "time_elapsed": 3.7328953742980957
    },
    {
        "realidx": "17076091",
        "question": "We sought to determine whether patients with obstructive sleep apnea (OSA) had an objective change in aerobic fitness during cycle ergometry compared to a normal population. The most accurate test of aerobic fitness is measurement of maximum oxygen consumption (VO2max) with cycle ergometry.\nWe performed a retrospective cohort analysis (247 patients with OSA) of VO2max from annual cycle ergometry tests compared to a large control group (normative data from 1.4 million US Air Force tests) in a tertiary care setting.\nOverall, individuals with OSA had increased VO2max when compared to the normalized US Air Force data (p<.001). Patients with an apnea-hypopnea index of greater than 20 demonstrated a decreased VO2max as compared to normalized values (p<.001). No differences in VO2max were observed after either medical or surgical therapy for OSA.\nDoes obstructive sleep apnea affect aerobic fitness?",
        "answer": "maybe",
        "answer_rationale": "Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with OSA severity and treatment is needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether obstructive sleep apnea (OSA) affects aerobic fitness. The options are yes, no, or maybe. \n\nFirst, I need to look at the provided information. The study compared VO2max (the gold standard for aerobic fitness) in OSA patients versus a large control group. The results showed that overall, OSA patients had higher VO2max than the normative data (p<0.001). Wait, that's interesting because I would expect OSA to maybe lower aerobic capacity. But then there's a nuance here: when they looked at patients with an apnea-hypopnea index (AHI) over 20 (which is considered moderate to severe OSA), those patients had a decreased VO2max compared to the controls (also p<0.001). \n\nSo the answer might depend on the severity. The question is general, though: does OSA affect aerobic fitness? The study shows that in the overall OSA group, they had higher VO2max, but in the subgroup with more severe OSA (AHI>20), they had lower. The question is whether the answer is yes, no, or maybe. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's results are mixed. The overall group had higher, but the severe group had lower. So the presence of OSA alone might not be the only factor. The answer might be \"maybe\" because it depends on severity. But the question is phrased generally. The first part says \"Does OSA affect aerobic fitness?\" The study shows that in some cases (severe), it does lower it, but overall maybe not. However, the question is whether OSA affects it, not whether all patients are affected. Since in some cases (those with AHI>20) it does, then the answer would be yes. But the overall group had higher, which is conflicting. \n\nWait, why would the overall OSA group have higher VO2max? Maybe the study's population had other factors. The control was from the US Air Force, which might be more physically fit. The OSA patients in the study might be more active? Or perhaps the study's design has some confounders. But the key point is that in the subgroup with severe OSA (AHI>20), their VO2max was lower. So the",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 290,
            "completion_tokens": 512
        },
        "time_elapsed": 6.066256284713745
    },
    {
        "realidx": "17208539",
        "question": "The transanal endorectal pull-through (TERPT) is becoming the most popular procedure in the treatment of Hirschsprung disease (HD), but overstretching of the anal sphincters remains a critical issue that may impact the continence. This study examined the long-term outcome of TERPT versus conventional transabdominal (ABD) pull-through for HD.\nRecords of 41 patients more than 3 years old who underwent a pull-through for HD (TERPT, n = 20; ABD, n = 21) were reviewed, and their families were thoroughly interviewed and scored via a 15-item post-pull-through long-term outcome questionnaire. Patients were operated on between the years 1995 and 2003. During this time, our group transitioned from the ABD to the TERPT technique. Total scoring ranged from 0 to 40: 0 to 10, excellent; 11 to 20 good; 21 to 30 fair; 31 to 40 poor. A 2-tailed Student t test, analysis of covariance, as well as logistic and linear regression were used to analyze the collected data with confidence interval higher than 95%.\nOverall scores were similar. However, continence score was significantly better in the ABD group, and the stool pattern score was better in the TERPT group. A significant difference in age at interview between the 2 groups was noted; we therefore reanalyzed the data controlling for age, and this showed that age did not significantly affect the long-term scoring outcome between groups.\nAre the long-term results of the transanal pull-through equal to those of the transabdominal pull-through?",
        "answer": "no",
        "answer_rationale": "Our long-term study showed significantly better (2-fold) results regarding the continence score for the abdominal approach compared with the transanal pull-through. The stool pattern and enterocolitis scores were somewhat better for the TERPT group. These findings raise an important issue about the current surgical management of HD; however, more cases will need to be studied before a definitive conclusion can be drawn.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the long-term results of the transanal pull-through (TERPT) are equal to those of the transabdominal (ABD) pull-through for Hirschsprung disease based on the provided study.\n\nFirst, I need to look at the study's findings. The question states that the overall scores were similar between the two groups. However, there were differences in specific aspects: continence was better in the ABD group, and stool pattern was better in the TERPT group. The study also mentions that age at interview was different between groups, but after adjusting for age using statistical methods like analysis of covariance, age didn't significantly affect the outcomes. \n\nThe key point here is that while the total scores were similar, the components differed. The question is about whether the long-term results are \"equal.\" Since the overall scores were similar, one might think the answer is yes. But the problem is that the components (continence vs. stool pattern) were better in different groups. However, the question is about the overall results being equal. The study says \"overall scores were similar,\" so maybe the total scores don't show a significant difference. But the options are yes, no, maybe. \n\nWait, the options are (A) yes, (B) no, (C) maybe. The study's conclusion is that overall scores were similar, but there were differences in specific areas. The question is whether the long-term results are equal. Since the total scores are similar, maybe the answer is yes. But the problem is that the continence and stool pattern were different. However, the question is about the overall results. The study says \"overall scores were similar,\" so the answer would be yes. But the options might be tricky here. Wait, the question says \"Are the long-term results... equal?\" The study found that the total scores were similar, but there were differences in specific domains. However, the overall scores being similar would mean that the total outcomes are comparable. The answer would then be yes (A). But wait, the continence was better in ABD and stool pattern in TERPT. The total scores being similar might mean that the overall outcome is equal. The study's conclusion probably states that the overall results are similar, so the answer is yes. But the options are (A) yes. However, the question might be a trick because even though the total scores are similar, the components differ. But the question is about",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 450,
            "completion_tokens": 512
        },
        "time_elapsed": 5.866036891937256
    },
    {
        "realidx": "17445978",
        "question": "To evaluate renal damage and impairment of renal function 1 yr after laparoscopic partial nephrectomy (LPN) with warm ischemia>30 min.\nFrom July 2004 to June 2005, 18 patients underwent LPN with warm ischemia time>30 min. Kidney damage markers (daily proteinuria and tubular enzymes) and renal function (serum creatinine, cystatin C, and creatinine clearances) were assessed on postoperative days 1 and 5 and at 12 mo. Glomerular filtration rate (GFR) was evaluated before surgery and at 3 mo. Renal scintigraphy was performed before the procedure, at 5 d and at 3 and 12 mo postoperatively. Statistical analysis was performed using the Student t test and logistic regression analysis.\nIn terms of kidney damage and renal function markers, the statistical analysis demonstrated that at 1 yr there was complete return to the normal range and no statistical difference between the values at the various time points. The GFR was not significantly different before and 3 mo after surgery. In terms of scintigraphy of the operated kidney, the values were 48.35+/-3.82% (40-50%) before the procedure, 36.88+/-8.42 (16-50%) on postoperative day 5 (p=0.0001), 40.56+/-8.96 (20-50%) at 3 mo (p=0.003), and 42.8+/-7.2% (20-50%) 1 yr after surgery (p=0.001).\nIs renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible?",
        "answer": "no",
        "answer_rationale": "Our results demonstrate that kidney damage occurs during LPN when warm ischemia is>30 min. This damage is only partially reversible and efforts should be made to keep warm ischemia within 30 min.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy is possible, based on the provided study.\n\nFirst, I need to understand the context. The study followed 18 patients who had LPN with warm ischemia times exceeding 30 minutes. They measured various kidney function markers and GFR at different time points. The results showed that by 1 year, all the kidney damage markers and renal function tests returned to normal, with no statistical differences from baseline except in the scintigraphy. The scintigraphy values did decrease post-op but started to recover over time, though still lower than pre-op at 1 year. However, the key point here is whether having warm ischemia over 30 minutes is possible without causing permanent damage, as the question is about the possibility, not the outcome.\n\nThe options are yes, no, maybe. The study's results indicate that even with ischemia over 30 minutes, the patients' kidney function markers returned to normal at 1 year. The scintigraphy showed some reduction but maybe that's acceptable. The question isn't about whether it's safe, but whether it's possible. Since the study included patients who underwent the procedure with ischemia over 30 minutes and they survived with function\u6062\u590d, the answer would be yes, it's possible. The fact that the study was done on these patients shows that it can be done, even if there were temporary issues. The statistical analysis showed no difference in markers at 1 year, so the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 480,
            "completion_tokens": 336
        },
        "time_elapsed": 4.364004373550415
    },
    {
        "realidx": "17565137",
        "question": "To evaluate the effect of an antismoking advertisement on young people's perceptions of smoking in movies and their intention to smoke.SUBJECTS/\n3091 cinema patrons aged 12-24 years in three Australian states; 18.6% of the sample (n = 575) were current smokers.DESIGN/\nQuasi-experimental study of patrons, surveyed after having viewed a movie. The control group was surveyed in week 1, and the intervention group in weeks 2 and 3. Before seeing the movie in weeks 2 and 3, a 30 s antismoking advertisement was shown, shot in the style of a movie trailer that warned patrons not to be sucked in by the smoking in the movie they were about to see.\nAttitude of current smokers and non-smokers to smoking in the movies; intention of current smokers and non-smokers to smoke in 12 months.\nAmong non-smokers, 47.8% of the intervention subjects thought that the smoking in the viewed movie was not OK compared with 43.8% of the control subjects (p = 0.04). However, there was no significant difference among smokers in the intervention (16.5%) and control (14.5%) groups (p = 0.4). A higher percentage of smokers in the intervention group indicated that they were likely to be smoking in 12 months time (38.6%) than smokers in the control group (25.6%; p<0.001). For non-smokers, there was no significant difference in smoking intentions between groups, with 1.2% of intervention subjects and 1.6% of controls saying that they would probably be smoking in 12 months time (p = 0.54).\nOut of the smokescreen II: will an advertisement targeting the tobacco industry affect young people's perception of smoking in movies and their intention to smoke?",
        "answer": "yes",
        "answer_rationale": "This real-world study suggests that placing an antismoking advertisement before movies containing smoking scenes can help to immunise non-smokers against the influences of film stars' smoking. Caution must be exercised in the type of advertisement screened as some types of advertising may reinforce smokers' intentions to smoke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about evaluating the effect of an antismoking ad on young people's perceptions and intentions to smoke. The key points here are the results they found.\n\nFirst, looking at non-smokers: the intervention group had 47.8% thinking smoking in the movie wasn't OK versus 43.8% in the control. That's a statistically significant difference (p=0.04). So the ad did affect their perception positively. But for smokers, there was no significant difference in their perception (16.5% vs 14.5%, p=0.4). \n\nNow, the intention to smoke in the next year. For non-smokers, there was no significant difference between groups (1.2% vs 1.6%, p=0.54). But here's the kicker: among current smokers in the intervention group, 38.6% said they might smoke in a year, compared to 25.6% in the control. That's a big jump and statistically significant (p<0.001). Wait, that's the opposite of what you'd expect. The ad was supposed to deter smoking, but among smokers, their intention to continue smoking increased? That's a problem.\n\nThe question is asking if the advertisement targeting the tobacco industry (the ad warned not to be sucked in by movie smoking) affected their perception and intention. The answer depends on both outcomes. The ad did improve non-smokers' perceptions, but it had a negative effect on smokers' intentions. The question is whether the ad \"affected\" them, which it did, but the options are yes/no/maybe. The title mentions \"smokescreen II\" which might imply the ad was ineffective or backfired. The main point is whether the ad had the intended effect. Since it helped non-smokers' perceptions but made smokers more likely to smoke, the overall effect might be considered negative or mixed. The question is phrased as \"will an advertisement... affect...\" so technically, yes, it did affect, but maybe the answer is no because the intention to smoke increased in smokers. Wait, the options are (A) yes (B) no (C) maybe. The question is whether the ad had the intended effect. The intended effect would be to reduce intention to smoke. Since in smokers, the intention went up, which is bad, but non-smokers' perceptions improved. The question is",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 498,
            "completion_tokens": 512
        },
        "time_elapsed": 6.266191244125366
    },
    {
        "realidx": "17621202",
        "question": "A prospective randomized clinical study.\nTo determine whether shaving the incision site before spinal surgery causes postsurgical infection.\nSpine surgeons usually shave the skin of the incision site immediately before surgery is performed. However, evidence from some surgical series suggests that presurgical shaving may increase the postsurgical infection rate. To our knowledge, no previously published studies have addressed this issue.\nA total of 789 patients scheduled to undergo spinal surgery were randomly allocated into 2 groups: those in whom the site of operation was shaved immediately before surgery (shaved group; 371 patients) and the patients in whom presurgical shaving was not performed (unshaved group; 418 patients). The mean duration of anesthesia and the infection rates in both groups were recorded and compared.\nThe duration of anesthesia did not differ in the 2 groups (P>0.05). A postoperative infection developed in 4 patients in the shaved group and in 1 patient in the nonshaved group (P<0.01).\nDoes shaving the incision site increase the infection rate after spinal surgery?",
        "answer": "maybe",
        "answer_rationale": "The shaving of the incision site immediately before spinal surgery may increase the rate of postoperative infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether shaving before spinal surgery increases the infection rate. The options are yes, no, or maybe.\n\nFirst, the study design: it's a randomized controlled trial with 789 patients split into two groups. One group got shaved before surgery, the other didn't. The key results are the infection rates. The shaved group had 4 infections out of 371, and the unshaved had 1 out of 418. The p-value for the infection rate difference is less than 0.01, which is statistically significant. \n\nThe question is asking if shaving increases the infection rate. Since the shaved group had a higher infection rate and the result is statistically significant, the answer should be yes. The p-value for anesthesia duration was not significant, so that's a confounder they controlled for. The study's conclusion would support that shaving does increase the risk. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 314,
            "completion_tokens": 206
        },
        "time_elapsed": 2.937203884124756
    },
    {
        "realidx": "17691856",
        "question": "Rising health care costs and the need to consolidate expertise in tertiary services have led to the centralisation of services. In the UK, the result has been that many rural maternity units have become midwife-led. A key consideration is that midwives have the skills to competently and confidently provide maternity services in rural areas, which may be geographically isolated and where the midwife may only see a small number of pregnant women each year. Our objective was to compare the views of midwives in rural and urban settings, regarding their competence and confidence with respect to 'competencies' identified as being those which all professionals should have in order to provide effective and safe care for low-risk women.\nThis was a comparative questionnaire survey involving a stratified sample of remote and rural maternity units and an ad hoc comparison group of three urban maternity units in Scotland. Questionnaires were sent to 82 midwives working in remote and rural areas and 107 midwives working in urban hospitals with midwife-led units.\nThe response rate from midwives in rural settings was considerably higher (85%) than from midwives in the urban areas (60%). Although the proportion of midwives who reported that they were competent was broadly similar in the two groups, there were some significant differences regarding specific competencies. Midwives in the rural group were more likely to report competence for breech delivery (p = 0.001), while more urban midwives reported competence in skills such as intravenous fluid replacement (p<0.001) and initial and discharge examination of the newborn (p<0.001). Both groups reported facing barriers to continuing professional development; however, more of the rural group had attended an educational event within the last month (p<0.001). Lack of time was a greater barrier for urban midwives (p = 0.02), whereas distance to training was greater for rural midwives (p = 0.009). Lack of motivation or interest was significantly higher in urban units (p = 0.006).\nMidwives' competence: is it affected by working in a rural location?",
        "answer": "maybe",
        "answer_rationale": "It is often assumed that midwives in rural areas where there are fewer deliveries, will be less competent and confident in their practice. Our exploratory study suggests that the issue of competence is far more complex and deserves further attention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether midwives' competence is affected by working in a rural location based on the study described.\n\nFirst, I need to recall the details from the provided text. The study compared rural and urban midwives' competence and confidence. The key points are:\n\n- Both groups had similar overall competence proportions.\n- However, there were specific differences: rural midwives were more competent in breech delivery, while urban midwives were better in IV fluids and newborn exams.\n- Both faced barriers to continuing education, but rural ones attended more events recently. Barriers differed: time for urban, distance for rural, and motivation more in urban.\n\nThe question is whether location affects competence. The answer hinges on whether the differences in specific competencies count as an overall effect. Since the study found that competence varied by location for certain skills, that suggests that rural vs. urban does influence their competence in those areas. Even though overall competence was similar, the specific competencies differ. So the answer would be \"yes\" because competence in certain areas is affected by location. The options are (A) yes, (B) no, (C) maybe. The study shows differences, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 528,
            "completion_tokens": 256
        },
        "time_elapsed": 3.4701480865478516
    },
    {
        "realidx": "17894828",
        "question": "An association has been described between elevated serum angiotensin-converting enzyme (ACE) and an increased risk of severe hypoglycaemia (SH). To ascertain whether this reported association could be replicated in a different country, it was re-examined in 300 individuals with Type 1 diabetes.\nPeople with Type 1 diabetes, none of whom was taking renin-angiotensin system blocking drugs, were recruited. Participants recorded the frequency with which they had experienced SH. Glycated haemoglobin (HbA(1c)) and serum ACE were measured. The difference in the incidence of SH between different quartiles of ACE activity and the relationship between serum ACE and SH were examined using non-parametric statistical tests and a negative binomial model.\nData were obtained from 300 patients [158 male; HbA(1c) median (range) 8.2% (5.2-12.8%), median age 36 years (16-88); duration of diabetes 14.5 years (2-49)]. The incidence of SH was 0.93 episodes per patient year. The mean incidence of SH in the top and bottom quartiles of ACE activity was 0.5 and 1.7 episodes per patient year, respectively, but this difference was not statistically significant (P = 0.075). Spearman's test showed a very weak, although statistically significant, association between serum ACE level and SH incidence (r = 0.115, P = 0.047). The binomial model also showed a statistically significant (P = 0.002), but clinically weak, relationship between serum ACE and SH.\nSerum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist?",
        "answer": "yes",
        "answer_rationale": "The present survey showed a weak relationship between serum ACE and the frequency of SH, the clinical relevance of which is unclear. This limits the proposed role for serum ACE as an index of risk for SH.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a relationship between serum angiotensin-converting enzyme (ACE) and the frequency of severe hypoglycaemia (SH) in Type 1 diabetes based on the provided study.\n\nFirst, I need to parse the study details. The study involved 300 individuals with Type 1 diabetes not on renin-angiotensin system blockers. They measured ACE levels, HbA1c, and recorded SH episodes. The key results are:\n\n1. The difference in SH incidence between the top and bottom ACE quartiles (0.5 vs 1.7 episodes per patient year) had a p-value of 0.075, which is not statistically significant (since typically p <0.05 is considered significant).\n\n2. Spearman's test showed a weak but statistically significant correlation (r=0.115, p=0.047). Here, the p-value is just under 0.05, so technically significant, but the correlation is weak (r=0.115 is a small effect size).\n\n3. The negative binomial model also found a statistically significant relationship (p=0.002), but again described as clinically weak.\n\nThe question is whether a relationship exists. The options are yes, no, maybe. The study's results are conflicting in terms of statistical significance and clinical significance. The quartile comparison wasn't significant, but the other two tests were statistically significant but weak. However, the question is about whether a relationship exists. Since some tests showed statistical significance, even if weak, the answer might lean towards \"yes\" but the clinical relevance is questioned. However, the problem states that the original association was being re-examined in a different country to see if it could be replicated. The results here are mixed. The abstract mentions that the binomial model showed a statistically significant but clinically weak relationship. The Spearman's was weak but significant. The quartiles weren't significant. The conclusion here might be that there is a statistical association but it's weak. The options are yes/no/maybe. The question is phrased as \"does a relationship exist?\" The study's results suggest a statistically significant but weak relationship. So the answer would be yes, but maybe the answer expects \"no\" because the quartiles weren't significant and the effect is weak. Wait, but the question is whether the association exists. The study found some",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 481,
            "completion_tokens": 512
        },
        "time_elapsed": 5.998668432235718
    },
    {
        "realidx": "17940352",
        "question": "To evaluate the impact of HER2 immunoreactivity on clinical outcome in locally advanced urothelial carcinoma patients who received surgery alone, or methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) as adjuvant chemotherapy.\nWe studied 114 formalin-fixed paraffin-embedded specimens obtained from locally advanced urothelial carcinoma patients receiving surgery alone or adjuvant M-VEC. The authors evaluated HER2 immunoreactivity using immunohistochemical staining and explored the influence of pathological parameters and HER2 immunoreactivity on progression-free survival (PFS) and disease-specific overall survival (OS) using univariate and multivariate Cox's analyses.\nUrothelial carcinoma of the bladder had a significantly higher frequency of HER2 immunoreactivity than that of the upper urinary tract (60.7 vs. 20.7%, p<0.0001). Overall, nodal status was a strong and independent prognostic indicator for clinical outcome. The HER2 immunoreactivity was significantly associated with PFS (p = 0.02) and disease-specific OS (p = 0.005) in advanced urothelial carcinoma patients. As for patients with adjuvant M-VEC, HER2 immunoreactivity was a significant prognostic factor for PFS (p = 0.03) and disease-specific OS (p = 0.02) using univariate analysis, but not multivariate analysis, and not for patients receiving watchful waiting.\nDoes HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?",
        "answer": "maybe",
        "answer_rationale": "HER2 immunoreactivity might have a limited prognostic value for advanced urothelial carcinoma patients with adjuvant M-VEC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether HER2 immunoreactivity provides prognostic information in locally advanced urothelial carcinoma patients who received adjuvant M-VEC chemotherapy. The options are yes, no, or maybe.\n\nFirst, I need to look back at the provided information. The study included 114 patients who had surgery alone or adjuvant M-VEC. They used immunohistochemistry for HER2 and analyzed survival outcomes with Cox's models. \n\nThe key points from the study results: \n\n- Overall, HER2 was significantly associated with both PFS (p=0.02) and OS (p=0.005) in advanced patients. \n- For the subgroup that received M-VEC, HER2 was significant in univariate analysis for PFS (p=0.03) and OS (p=0.02), but not in multivariate analysis. \n- It wasn't significant for those who had watchful waiting instead of chemo.\n\nThe question specifically asks about patients receiving adjuvant M-VEC. The univariate analysis showed significance, but multivariate didn't. The problem is whether that's enough to say it provides prognostic info. \n\nIn medical studies, multivariate analysis adjusts for other variables, so if it's not significant there, maybe other factors are confounding. But the question is about whether HER2 provides any prognostic info. Since it was significant in univariate, even if not in multivariate, some might argue it still has some association. However, the standard is usually that multivariate is more reliable for independence. The answer options are yes/no/maybe. The study says \"HER2 immunoreactivity was a significant prognostic factor for PFS and OS in univariate but not multivariate.\" So the correct answer would be that it doesn't provide independent prognostic info in multivariate, but the question is phrased as \"provide prognostic information\"\u2014so maybe the answer is yes because it was significant in univariate, but the options might hinge on whether they consider multivariate necessary. The question is a bit ambiguous. Wait, the options are (A) yes (B) no (C) maybe. The study states that in the M-VEC group, HER2 was significant in univariate but not multivariate. So in the context of the question, which asks if it \"provides prognostic information,\" the answer might be yes",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 444,
            "completion_tokens": 512
        },
        "time_elapsed": 6.173948287963867
    },
    {
        "realidx": "18235194",
        "question": "In a prospective study 218 preschool children were enrolled (stratified in 2 training programs, one specialized for phonologic awareness in order to prevent dyslexia, the other consisting in training of general perception) during the last year of kindergarten. After finishing the first grade 131 children were compared in their reading and writing abilities.\nIn the whole group only a slight difference was found between both training modalities concerning their writing abilities. However, children with a history of hearing loss, actual hearing loss or pathologic middle ear findings profited most from the specialized training program compared to the control in their reading abilities.\nIs a specialised training of phonological awareness indicated in every preschool child?",
        "answer": "maybe",
        "answer_rationale": "A specialized training program to improve phonologic awareness as a basis for reading and writing in every kindergarten and preschool child seems to be unnecessary. However, children with temporary hearing deficits benefit from such a program. For all other children general perception training may be sufficient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study involved 218 preschool kids split into two training programs: one focused on phonological awareness to prevent dyslexia and the other on general perception. After first grade, they compared 131 kids' reading and writing. The overall group didn't show much difference in writing between the two trainings. But the key point is that children with a history of hearing loss, current hearing loss, or middle ear issues benefited more from the specialized phonological training in their reading abilities.\n\nThe question is whether specialized phonological training is indicated for EVERY preschool child. The options are yes, no, maybe. \n\nHmm, the study's results show that the general group didn't have a big difference, but a specific subgroup (those with hearing issues) did benefit. So the answer probably isn't \"yes\" for everyone. Since the benefit was only significant in that subgroup, the recommendation would be that it's not necessary for all kids, but maybe for those with hearing problems. The question is asking if it's indicated for EVERY child. Since the study found that only certain kids had better outcomes, the answer should be no. So the correct answer is B) no. Because it's only beneficial for those with hearing issues, not every child needs it.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 232,
            "completion_tokens": 269
        },
        "time_elapsed": 3.7283108234405518
    },
    {
        "realidx": "18243752",
        "question": "This study aims to evaluate local failure patterns in node negative breast cancer patients treated with post-mastectomy radiotherapy including internal mammary chain only.\nRetrospective analysis of 92 internal or central-breast node-negative tumours with mastectomy and external irradiation of the internal mammary chain at the dose of 50 Gy, from 1994 to 1998.\nLocal recurrence rate was 5 % (five cases). Recurrence sites were the operative scare and chest wall. Factors associated with increased risk of local failure were age<or = 40 years and tumour size greater than 20mm, without statistical significance.\nShould chest wall irradiation be included after mastectomy and negative node breast cancer?",
        "answer": "maybe",
        "answer_rationale": "Post-mastectomy radiotherapy should be discussed for a sub-group of node-negative patients with predictors factors of local failure such as age<or = 40 years and larger tumour size.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is about evaluating local failure patterns in node-negative breast cancer patients who had post-mastectomy radiotherapy that included the internal mammary chain. The key points here are that the patients had negative nodes, underwent mastectomy, and received radiation to the internal mammary area at 50 Gy. The local recurrence rate was 5%, and the recurrences were in the scar or chest wall. The factors like age \u226440 and tumor size >20mm were mentioned but not statistically significant.\n\nThe question is whether chest wall irradiation should be included after mastectomy in these cases. The options are yes, no, maybe.\n\nFirst, I need to recall standard practices. Typically, after mastectomy, if the nodes are negative, the standard radiation fields might not include the chest wall unless certain high-risk factors are present. But the study here included internal mammary chain radiation but not the chest wall? Wait, the question says the radiotherapy included the internal mammary chain only. The local recurrences were in the chest wall and scar. So even with IMN radiation, the failures were in the chest wall area. \n\nThe study's local recurrence rate was 5%, which is relatively low, but the question is whether adding chest wall irradiation would be necessary. Since the recurrences occurred in the chest wall, maybe the current treatment (IMN only) isn't covering that area. But the standard approach might be that for node-negative patients, chest wall irradiation isn't routinely done unless there are other risk factors. However, the study's results show that even with IMN radiation, there were chest wall recurrences. \n\nThe factors mentioned (age and tumor size) weren't statistically significant, so they can't be used to stratify risk here. The study's authors might be suggesting that since the local failures are in the chest wall, perhaps including chest wall irradiation would be better. But the question is asking based on the study's findings. The study's recurrence sites were in the chest wall, so maybe the current treatment (IMN only) isn't sufficient, implying that adding chest wall RT would help. But the options are yes, no, maybe. \n\nAlternatively, maybe the standard of care is that for node-negative, chest wall irradiation isn't needed, so the answer would be no. But the study's data shows that even with IMN RT, there were chest wall recurrences. However, the recurrence rate was 5%, which might",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 242,
            "completion_tokens": 512
        },
        "time_elapsed": 6.046233654022217
    },
    {
        "realidx": "18284441",
        "question": "Paraffin-embedded tissues in Cukurova University Faculty of Medicine Department of Pathology between January 2002 and February 2006 were searched restrospectively to investigate this issue. We performed immunohistochemistry on biopsies of 125 patients with HBV infection, grouped as: mild, moderate and severe hepatitis, cirrhosis and HCC, 25 patients in each of them, using anti c-kit monoclonal antibody. The severity of parenchymal inflammation and of interface hepatitis was semiquantitatively graded on a haematoxylin and eosin stained paraffin sections. Additionally, 50 more HCC, formed on HBV basis, were studied to determine the prevalence of c-kit overexpression.\nIn cirrhotic liver, lower intensity of staining and rarely c-kit positivity were present. The greatest number of the c-kit positivity and higher intensity of staining was found in the livers of patients with severe hepatitis and HCC. In chronic hepatitis B infection, the staining intensity was parallel with the grade and stage of the disease. In the areas where fibrosis was seen, c-kit positivity was rare or absent. In the HCC specimens, c-kit positivity appeared both inside and around the cancerous nodes. C-kit expression was observed in 62 of 75 HCC tissue specimens (82%) (p<0.001).\nExpression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?",
        "answer": "maybe",
        "answer_rationale": "C-kit positivity was observed in the mitotic, proliferating and also dysplastic hepatic cells. These results suggest that c-kit expression may be used as an early diagnostic indicator for HBV induced HCC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about c-kit expression in HBV-related liver diseases. The options are whether this expression has a diagnostic role, with yes, no, or maybe.\n\nFirst, I need to recall what the study found. The abstract says that in cirrhosis, c-kit positivity was lower and less intense. But in severe hepatitis and HCC, there was higher positivity and staining. Also, in HCC, 82% showed c-kit expression, which is statistically significant (p<0.001). The staining correlated with the severity of hepatitis and the stage of disease. In fibrotic areas, it was rare. So, in HCC, it's present both inside and around the cancer nodes.\n\nThe question is whether this has a diagnostic role. Well, if c-kit expression is significantly higher in HCC compared to cirrhosis and even more so in severe hepatitis, maybe it can help distinguish between these stages. Since it's overexpressed in HCC, which is a malignancy, and less so in earlier stages like cirrhosis, it might be a marker for HCC. The high prevalence (82%) in HCC suggests it could be useful. But does it have a diagnostic role? The study shows an association, but\u8bca\u65ad usually requires more than just association. However, the question is whether the study's findings suggest it has a role. Since the expression is higher in HCC and correlates with disease severity, it might aid in diagnosis or staging. The answer options are yes, no, maybe. The study's results support that it could have a diagnostic role, so the answer is probably A) yes. But wait, maybe there's a catch. The question is about \"diagnostic role\"\u2014like, can it be used to diagnose HCC or differentiate stages? Since it's overexpressed in HCC, maybe it's a biomarker. The study's conclusion seems to suggest that since it's so prevalent in HCC, it might be useful. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 417,
            "completion_tokens": 426
        },
        "time_elapsed": 5.530561685562134
    },
    {
        "realidx": "18359123",
        "question": "Swedish hospital mergers seem to stem from a conviction among policy makers that bigger hospitals lead to lower average costs and improved clinical outcomes. The effects of mergers in the form of multisited hospitals have not been systematically evaluated. The purpose of this article is to contribute to this area of knowledge by exploring responses to the merger of Blekinge Hospital.\nThe evaluation was guided by the philosophy of triangulation. A questionnaire was sent to 597 randomly selected employees, that is 24% of the health care staff. Four hundred ninety-eight employees answered the questionnaire, giving a response rate of 83%. Furthermore, interviews of different groups of stakeholders were conducted.\nA moderate increase of quality was assessed, which, a low proportion of the employees perceived had decisively or largely to do with the merger. The majority perceives economical incentives as the drivers of change, but, at the same time, only 10% of this group believes this target was reached completely or to a large extent.\nIs it better to be big?",
        "answer": "no",
        "answer_rationale": "The employees believe the merger has neither generated economy of scale advantages nor substantial quality improvement. Instead, it seems more rewarding to promote cross-functional collaboration together with clinical specialisation. Needs for both integration and differentiation could thereby be fulfilled.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether it's better to be big, based on the information provided about the Swedish hospital mergers.\n\nFirst, I need to recall the details from the passage. The article discusses the merger of Blekinge Hospital and evaluates its effects. The key points are:\n\n- Policy makers believed bigger hospitals would lead to lower costs and better outcomes.\n- The evaluation used triangulation, with a questionnaire and interviews.\n- The results showed a moderate increase in quality, but only a low proportion of employees thought the merger was the main reason.\n- Most employees saw economic incentives as the driver of change, but only 10% felt that goal was largely achieved.\n\nThe question is whether being big (i.e., merging into larger hospitals) is better. The options are yes, no, maybe.\n\nLooking at the results: the quality increase wasn't strongly linked to the merger, and the economic goals (lower costs) weren't met by most. So the study's findings suggest that the merger didn't achieve what was hoped. Therefore, the answer would lean towards \"no\" or \"maybe\". But the options are A, B, C. The study's results are somewhat mixed but mostly negative. The majority didn't see the merger as the cause of quality improvements, and the economic targets weren't met. So the conclusion would probably be that being big isn't better, hence answer B (no). But wait, the question is phrased as \"Is it better to be big?\" based on the study. Since the study's results don't support the policy makers' conviction, the answer would be \"no\". Alternatively, maybe the study didn't find strong evidence, so \"maybe\"? But the results do show that the merger didn't lead to the expected outcomes. The majority thought economic incentives were the driver but only 10% thought that target was achieved. So the answer is probably B) no. The article's findings suggest that the merger didn't lead to the expected benefits, so the answer is no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 300,
            "completion_tokens": 423
        },
        "time_elapsed": 5.157714128494263
    },
    {
        "realidx": "18496363",
        "question": "To characterize the gender dimorphism after injury with specific reference to the reproductive age of the women (young,<48 yrs of age, vs. old,>52 yrs of age) in a cohort of severely injured trauma patients for which significant variation in postinjury care is minimized.\nSecondary data analysis of an ongoing prospective multicenter cohort study.\nAcademic, level I trauma and intensive care unit centers.\nBlunt-injured adults with hemorrhagic shock.\nNone.\nSeparate Cox proportional hazard regression models were formulated based on all patients to evaluate the effects of gender on mortality, multiple organ failure, and nosocomial infection, after controlling for all important confounders. These models were then used to characterize the effect of gender in young and old age groups. Overall mortality, multiple organ failure, and nosocomial infection rates for the entire cohort (n = 1,036) were 20%, 40%, and 45%, respectively. Mean Injury Severity Score was 32 +/- 14 (mean +/- SD). Men (n = 680) and women (n = 356) were clinically similar except that men required higher crystalloid volumes, more often had a history of alcoholism and liver disease, and had greater ventilatory and intensive care unit requirements. Female gender was independently associated with a 43% and 23% lower risk of multiple organ failure and nosocomial infection, respectively. Gender remained an independent risk factor in young and old subgroup analysis, with the protection afforded by female gender remaining unchanged.\nCharacterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible?",
        "answer": "no",
        "answer_rationale": "The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hormonal differences are responsible for the observed gender dimorphism after injury and hemorrhagic shock based on the provided study.\n\nFirst, I need to recall the study's findings. The study compared men and women in a cohort of severely injured trauma patients. They found that female gender was associated with lower risks of multiple organ failure and nosocomial infections, even after adjusting for confounders. The effect persisted when they looked at younger and older women (under 48 vs over 52). \n\nThe key here is the question about hormonal differences. The study's analysis controlled for various factors but didn't explicitly mention hormonal levels or menopausal status. The age groups split at 48 and 52 years might be around menopause, which is typically around 51, so maybe they were considering hormonal changes. However, the study states that the protective effect of being female remained unchanged in both age groups. If hormonal differences (like estrogen levels) were the cause, you might expect a difference between premenopausal and postmenopausal women, since estrogen levels drop after menopause. But the study found the same protective effect in both younger and older women. That suggests that the hormonal differences (like estrogen) might not be the main factor here because the effect didn't vary with age. \n\nAlternatively, maybe other factors related to gender, such as genetic or anatomical differences, are at play. Since the study controlled for confounders and the effect remained, but the hormonal explanation would require that even postmenopausal women have the same protection, which might not align with hormonal changes. Therefore, the answer would be \"no\" because the study's results don't support hormonal differences as the cause since the effect is consistent across age groups where hormone levels would differ.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 430,
            "completion_tokens": 378
        },
        "time_elapsed": 4.782289981842041
    },
    {
        "realidx": "18565233",
        "question": "Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being involved in colon cancerogenesis. In animal studies the lipid-lowering PPAR ligand bezafibrate suppressed colonic tumors. However, the effect of bezafibrate on colon cancer development in humans is unknown. Therefore, we proposed to investigate a possible preventive effect of bezafibrate on the development of colon cancer in patients with coronary artery disease during a 6-year follow-up.\nOur population included 3011 patients without any cancer diagnosis who were enrolled in the randomized, double blind Bezafibrate Infarction Prevention (BIP) Study. The patients received either 400 mg of bezafibrate retard (1506 patients) or placebo (1505 patients) once a day. Cancer incidence data were obtained by matching a subject's identification numbers with the National Cancer Registry. Each matched record was checked for correct identification.\nDevelopment of new cancer (all types) was recorded in 177 patients: in 79 (5.25%) patients from the bezafibrate group vs. 98 (6.51%) from the placebo group. Development of colon cancer was recorded in 25 patients: in 8 (0.53%) patients from the bezafibrate group vs. 17 (1.13%) from the placebo group, (Fisher's exact test: one side p = 0.05; two side p = 0.07). A difference in the incidence of cancer was only detectable after a 4 year lag and progressively increased with continued follow-up. On multivariable analysis the colon cancer risk in patients who received bezafibrate tended to be lower with a hazard ratio of 0.47 and 95% confidence interval 0.2-1.1.\nDoes the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?",
        "answer": "yes",
        "answer_rationale": "Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether bezafibrate, a PPAR ligand used to lower lipids, can prevent colon cancer in patients with coronary artery disease. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided. The study had 3011 patients split into bezafibrate and placebo groups. After 6 years, colon cancer developed in 8 out of 1506 (0.53%) in the bezafibrate group versus 17 out of 1505 (1.13%) in the placebo group. The p-values from Fisher's exact test are one-sided 0.05 and two-sided 0.07. The hazard ratio from multivariable analysis was 0.47 with a 95% CI of 0.2 to 1.1.\n\nHmm, the key here is interpreting the statistical significance. The two-sided p-value is 0.07, which is above the common threshold of 0.05 for significance. That suggests the difference might not be statistically significant. The confidence interval for the hazard ratio includes 1 (since the upper limit is 1.1), which means the effect isn't statistically significant either. The hazard ratio of 0.47 indicates a trend towards reduced risk, but since the CI includes 1, it's not conclusive. \n\nThe question is whether bezafibrate \"prevents\" colon cancer. Since the results are not statistically significant (p>0.05 two-tailed, CI includes 1), the answer can't be a definitive yes. But the trend is there, so maybe the answer is \"maybe\" because the study suggests a possible benefit but isn't conclusive. Alternatively, if the question requires statistical significance for a \"yes,\" then the answer would be \"no\" or \"maybe.\" The options are A (yes), B (no), C (maybe). The study's results are borderline, with the one-sided p=0.05, but two-sided is 0.07. Depending on whether one-tailed or two-tailed is considered, but in most medical studies, two-tailed is standard. So the result isn't significant. Therefore, the answer is either B or C. The hazard ratio's CI includes 1, so the effect isn't statistically significant. So the correct answer would be \"maybe\" because the data show a trend",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 541,
            "completion_tokens": 512
        },
        "time_elapsed": 5.716196298599243
    },
    {
        "realidx": "18568290",
        "question": "The etiology of hemodialysis (HD)-induced hypotension and hypertension remains speculative. There is mounting evidence that endothelin-1 (ET-1) may play a vital role in these hemodynamic changes. We examined the possible role of intradialytic changes of ET-1 in the pathogenesis of hypotension and rebound hypertension during HD.\nThe present study included 45 patients with end-stage renal disease (ESRD) on regular HD. They were divided according to their hemodynamic status during HD into three groups (group I had stable intradialytic hemodynamics, group II had dialysis-induced hypotension, and group III had rebound hypertension during HD). In addition, 15 healthy volunteers were included as a control group. Pulse and blood pressure were monitored before, during (every half hour), and after HD session. ET-1 level was measured at the beginning, middle, and end of HD. ET-1 was measured in the control group for comparison.\nPre-dialysis levels of ET-1 were significantly higher in dialysis patients compared to the controls (P<0.001); however, they were comparable in the three HD groups. The post-dialysis ET-1 level was not changed significantly in group I compared with predialysis values (14.49 +/- 2.04 vs. 14.33 +/- 2.23 pg/ml; P = NS), while the ET-1 concentration decreased significantly in group II and increased in group III in comparison to predialysis values (8.56 +/- 1.44 vs. 11.75 +/- 2.51; 16.39 +/- 3.12 vs. 11.93 +/- 2.11 pg/ml, respectively; P<0.001).\nIs there a role for endothelin-1 in the hemodynamic changes during hemodialysis?",
        "answer": "maybe",
        "answer_rationale": "Altered ET-1 levels may be involved in the pathogenesis of rebound hypertension and hypotension during HD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether endothelin-1 (ET-1) plays a role in the hemodynamic changes during hemodialysis, specifically hypotension and rebound hypertension.\n\nFirst, the study divided 45 ESRD patients into three groups: those with stable hemodynamics (group I), those with dialysis-induced hypotension (group II), and those with rebound hypertension (group III). They also had a control group of healthy volunteers. They measured ET-1 levels before, during, and after dialysis.\n\nThe key findings were that pre-dialysis ET-1 levels in all dialysis patients were higher than controls, but similar among the three groups. Post-dialysis, group I's ET-1 didn't change much. But group II (hypotension) had a significant decrease in ET-1, while group III (rebound hypertension) had a significant increase. \n\nSo, the question is whether ET-1 has a role here. The data shows that in hypotension cases, ET-1 goes down, which might contribute to the drop in blood pressure. Conversely, in rebound hypertension, ET-1 increases, which could lead to higher BP post-dialysis. Since ET-1 is a potent vasoconstrictor, lower levels would relax blood vessels, possibly causing hypotension, and higher levels would constrict, causing hypertension. This suggests that ET-1 fluctuations are linked to these hemodynamic changes. Therefore, the answer should be yes (A).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 496,
            "completion_tokens": 321
        },
        "time_elapsed": 3.7627904415130615
    },
    {
        "realidx": "18714572",
        "question": "Vaginal intraepithelial neoplasia is a little known disease which could be related to risk factors different from simple HPV infections.\nTo ascertain wheter vaginal lesions have a natural history similar to cervical lesions.MATERIALS &\nA retrospective study to identify patients with vaginal lesions and synchronous cervical lesions through biopsy. The rate of mild cervical lesions (koilocytosis, warts, CIN I with and without koilocytosis) was compared with the rate of severe cervical lesions (CIN II and III, cervical carcinoma) in patients with mild vaginal lesions (warts and koilocytosis, and low-grade VAIN) and in patients with severe vaginal lesions (high-grade VAIN). Using koilocytosis as a marker, the rate of \"active\" cervical lesions was compared with the rate of \"non active\" cervical lesions in patients with \"active\" versus \"non active\" vaginal lesions. Finally, the rates of mild and severe cervical lesions were compared among each group of VAIN (low-grade, high-grade, with or without koilocytosis).\nIn patients with mild vaginal lesions, mild cervical lesions were significantly more frequent than severe cervical lesions. In patients with \"active\" vaginal lesions the rate of \"active\" cervical lesions was significantly higher than \"non active\" cervical lesions. The differences in rates of mild cervical lesions and severe cervical lesions among patients with high-grade VAIN and low-grade VAIN (with and without koilocytosis) were not significant.\nDoes vaginal intraepithelial neoplasia have the same evolution as cervical intraepithelial neoplasia?",
        "answer": "maybe",
        "answer_rationale": "These data suggest that CIN and VAIN may have some common features in certain cases, i.e., if an HPV infection is proved.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vaginal intraepithelial neoplasia (VAIN) has the same evolution as cervical intraepithelial neoplasia (CIN). The options are yes, no, or maybe.\n\nFirst, I need to recall what the study found. The question provided a summary of a retrospective study comparing vaginal and cervical lesions. The key points from the study's results are:\n\n1. In patients with mild vaginal lesions (like warts, koilocytosis, low-grade VAIN), mild cervical lesions (like CIN I) were more common than severe ones (CIN II/III or cancer).\n2. When looking at \"active\" vaginal lesions (those with koilocytosis), there was a higher rate of \"active\" cervical lesions compared to non-active ones. \n3. However, when comparing high-grade VAIN (severe) versus low-grade VAIN (with or without koilocytosis), the rates of mild vs severe cervical lesions weren't significantly different.\n\nNow, the question is about whether VAIN's evolution is the same as CIN's. In cervical lesions, typically, mild lesions (like CIN I) can progress to more severe ones (CIN II/III) over time. The study here shows that in vaginal cases, mild vaginal lesions are associated with more mild cervical lesions, which aligns with the idea that they might follow a similar progression. But the critical part is the third point: high-grade VAIN didn't show a significant difference in cervical lesion severity compared to low-grade. That suggests that maybe high-grade VAIN doesn't progress in the same way as high-grade CIN. Because in cervical, high-grade lesions are more likely to progress to cancer, but here, the presence of high-grade VAIN doesn't correlate with more severe cervical lesions. So the natural history might not be the same. Therefore, the answer would be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 416,
            "completion_tokens": 406
        },
        "time_elapsed": 4.872247695922852
    },
    {
        "realidx": "18802997",
        "question": "Assessing the clinical course of inflammatory bowel disease (IBD) patients consists of periodical clinical evaluations and laboratory tests. We aimed to assess the role of calprotectin tests in predicting clinical relapse in IBD patients.\nNinety-seven patients with ulcerative colitis (UC) and 65 with Crohn's disease (CD) in clinical remission were prospectively included in the study. A 10-g stool sample was collected for calprotectin assay. The cutoff level was set at 130 mg/kg of feces. Patients were followed up for 1 yr after the test or until relapse. The cumulative proportion of relapses was estimated by the Kaplan-Meier analysis. Statistics for equality of survival distribution were tested using the log-rank test.\nThe calprotectin test was positive in 44 UC patients and 26 of them relapsed within a year, while 11 of 53 UC patients with a negative calprotectin test relapsed within the same time frame. Thirty CD patients had a positive calprotectin test and 13 of them relapsed within a year, as did 7 of the 35 with a negative test result. A significant correlation emerged between a positive calprotectin test and the probability of relapse in UC patients (P= 0.000). In CD patients, only cases of colonic CD showed a significant correlation between a positive calprotectin test and the probability of relapse, i.e., 6 colonic CD patients were positive for the calprotectin test and 4 relapsed (P= 0.02).\nCan calprotectin predict relapse risk in inflammatory bowel disease?",
        "answer": "maybe",
        "answer_rationale": "Measuring calprotectin may help to identify UC and colonic CD patients at higher risk of clinical relapse.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether calprotectin can predict relapse risk in inflammatory bowel disease (IBD). The options are yes, no, or maybe. \n\nFirst, I need to look at the study details provided. The study included both UC and CD patients in remission. They measured calprotectin in stool samples with a cutoff of 130 mg/kg. Then they followed them for a year to see who relapsed.\n\nFor UC patients: 44 had a positive test, and 26 of those relapsed. Out of 53 with negative tests, 11 relapsed. That seems like a higher relapse rate in the positive group. The log-rank test showed a significant P=0.000, so definitely a correlation here.\n\nFor CD patients overall: 30 positive, 13 relapsed; 35 negative, 7 relapsed. The P-value isn't mentioned for all CD, but when they looked at colonic CD specifically, 6 positive with 4 relapses, which had a P=0.02. So in colonic CD, it was significant, but maybe not in all CD?\n\nThe question is about IBD in general. Since UC is part of IBD and calprotectin was predictive there, and even in a subset of CD (colonic), the answer would be yes. The study shows that in UC and some CD cases, calprotectin does predict relapse. The options are yes, no, maybe. The answer should be A (yes) because the study found significant correlations in subsets of IBD patients. Even if not all CD, the question is about IBD overall, so the answer is yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 441,
            "completion_tokens": 365
        },
        "time_elapsed": 5.086407661437988
    },
    {
        "realidx": "19103915",
        "question": "There is an urgent need to increase opportunistic screening for sexually transmitted infections (STIs) in community settings, particularly for those who are at increased risk including men who have sex with men (MSM). The aim of this qualitative study was to explore whether home sampling kits (HSK) for multiple bacterial STIs are potentially acceptable among MSM and to identify any concerns regarding their use. This study was developed as part of a formative evaluation of HSKs.\nFocus groups and one-to-one semi-structured interviews with MSM were conducted. Focus group participants (n = 20) were shown a variety of self-sampling materials and asked to discuss them. Individual interviewees (n = 24) had experience of the self-sampling techniques as part of a pilot clinical study. All data were digitally recorded and transcribed verbatim. Data were analysed using a framework analysis approach.\nThe concept of a HSK was generally viewed as positive, with many benefits identified relating to increased access to testing, enhanced personal comfort and empowerment. Concerns about the accuracy of the test, delays in receiving the results, the possible lack of support and potential negative impact on 'others' were raised.\nAre home sampling kits for sexually transmitted infections acceptable among men who have sex with men?",
        "answer": "maybe",
        "answer_rationale": "The widespread acceptability of using HSKs for the diagnosis of STIs could have important public health impacts in terms of earlier diagnosis of asymptomatic infections and thus a decrease in the rate of onward transmission. In addition, HSKs could potentially optimize the use of genitourinary medicine services and facilitate patient choice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether home sampling kits (HSK) for STIs are acceptable among men who have sex with men (MSM) based on the provided study.\n\nFirst, I need to recall the details from the study description. The study used focus groups and interviews with MSM. The participants were either shown the self-sampling materials or had actually used them in a pilot. The analysis was done through framework analysis.\n\nThe key findings mentioned are that the concept of HSK was generally viewed positively. The benefits included increased access to testing, which is important because some people might not go to clinics due to stigma or inconvenience. Enhanced personal comfort suggests that doing it at home is less stressful than a clinic visit. Empowerment probably refers to the control they have over their own testing process.\n\nHowever, there were some concerns: accuracy of the test, delays in results, lack of support, and potential negative impact on others. But the question is about acceptability. Even if there are concerns, the overall view was positive. The question isn't asking if there are no issues, just whether they are acceptable. Since the majority saw benefits and the general view was positive, the answer would lean towards yes. The options are A (yes), B (no), C (maybe). The study's conclusion states the concept was \"generally viewed as positive,\" so the answer should be A. The concerns exist but don't negate the overall acceptability. The question is about acceptability, not perfection. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 347,
            "completion_tokens": 321
        },
        "time_elapsed": 4.1639580726623535
    },
    {
        "realidx": "19108857",
        "question": "Tuberculosis continues to be a public health problem in emerging countries with a recent evidence of increased incidence of extrapulmonary localization in developed countries probably linked to HIV. To our knowledge the occurrence of cerebro-mediastinal tuberculosis in an immuno-competent child has not been previously described; moreover the child we describe has a probable Say-Barber-Miller syndrome. We discuss a putative causative link between this syndrome and the occurrence of tuberculosis.\nA seven-year-old girl presented to our department with a history of infantile encephalopathy since birth characterized by a facial dysmorphy (evocative of a bird face), microcephaly, and mental retardation, and with recurrent infections. The child had complained of back pain for several months; the parents reported anorexia, loss of weight. Spinal and cerebral MRI showed a mediastinal mass involving the spine and cerebral lesions evocative of tuberculomas. The tuberculin interdermal reaction was positive. Culture of a vertebral biopsy was positive for Koch bacillus. Anti-tuberculosis treatment improved general and local status. An extensive immunological work-up was normal.\nCerebromediastinal tuberculosis in a child with a probable Say-Barber-Miller syndrome: a causative link?",
        "answer": "yes",
        "answer_rationale": "[corrected] This observation is exceptional in many aspects: very early age of onset of extrapulmonary tuberculosis, no immune deficit, association with a rare congenital neurological syndrome. We discuss the possible link between this entity and the occurrence of tuberculosis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The case is about a 7-year-old girl with Say-Barber-Miller syndrome who developed cerebro-mediastinal tuberculosis. The question is whether there's a causative link between the syndrome and the tuberculosis.\n\nFirst, I need to recall what Say-Barber-Miller syndrome is. From what I remember, it's a rare genetic disorder characterized by facial dysmorphism (like the \"bird face\" mentioned), microcephaly, mental retardation, and recurrent infections. The key here is the recurrent infections, which might suggest an immunodeficiency. But the case says the immunological work-up was normal. That's a bit confusing because if the syndrome is associated with immune issues, but her tests were normal, maybe the connection isn't straightforward.\n\nThe child had a positive tuberculin skin test and cultures positive for TB. The treatment worked, so the diagnosis seems solid. The question is whether the syndrome caused the TB. Since the syndrome includes recurrent infections, maybe her immune system was compromised despite normal tests. But the article mentions she's immunocompetent. Wait, the case states \"immuno-competent child\" but with the syndrome. The syndrome might predispose her to infections even if standard immune tests are normal. \n\nThe article's authors are discussing a \"putative causative link,\" so they're suggesting a possible connection. The options are yes, no, maybe. The answer probably leans towards \"maybe\" because the case is the first described, and the link isn't proven yet. The title even says \"a causative link?\" which is posing it as a question. Since the immunological work-up was normal, but she still had severe TB, maybe the syndrome's underlying genetics affect immune function in a way not detected by standard tests. But without more evidence, it's speculative. So the answer is C) maybe.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 352,
            "completion_tokens": 390
        },
        "time_elapsed": 4.57400369644165
    },
    {
        "realidx": "19351635",
        "question": "National guidelines and government directives have adopted policies for urgent assessment of patients with a transient ischaemic attack or minor stroke not admitted to hospital. The risk of recurrent stroke increases substantially with age, as does the potential benefit of secondary prevention. In order to develop effective strategies for older patients, it is important to identify how stroke care is currently provided for this patient group.\nBetween 2004 and 2006, older patients (>75 years) referred to a neurovascular clinic were compared with younger patients (<or =75 years). Sociodemographic details, clinical features, resource use and secondary prevention in a neurovascular clinic were collected.\nOf 379 patients referred to the clinic, 129 (34%) were given a non-stroke diagnosis. Of the remaining 250 patients, 149 (60%) were<or =75 years. Median time from symptom onset to clinic appointment was similar for the two groups (24 (IQR 15-42) vs 24 (IQR 14-43) days; p = 0.58). Older patients were more likely to be in atrial fibrillation (10.1% vs 22.8%, p<0.001) and have lacunar stroke (34.7% vs 22.1%; p = 0.04). CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75). Scans were performed more quickly in younger patients (p<0.01). MRI scan rates were higher in younger patients (26% vs 4%, p<0.01), as was carotid Doppler imaging (92% vs 77%, p<0.01). There were no differences in prescribed secondary preventive treatments. Older patients experienced less delay for carotid endarterectomy (49 vs 90 days, p<0.01). Younger patients were more likely to be given advice on weight reduction (30.2% vs 12.9%, p<0.01) and diet (46.3% vs 31.7%, p = 0.02) than older patients.\nDo older patients receive adequate stroke care?",
        "answer": "maybe",
        "answer_rationale": "Older patients were less likely to receive diagnostic investigations and lifestyle modification advice than younger patients. Guidelines need to be adopted to ensure prompt evidence-based stroke care in the outpatient setting.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether older patients receive adequate stroke care based on the provided study data. The options are yes, no, or maybe.\n\nFirst, I need to go through the information given. The study compared patients over 75 and those 75 or younger. The key points are:\n\n- Both groups had similar median time to clinic appointment (24 days each), so no major delay there.\n- Older patients had more atrial fibrillation and lacunar strokes, which are important factors but maybe not directly about care adequacy.\n- CT scan rates were similar (27.8% vs 80%? Wait, that can't be right. Wait, maybe a typo? Wait, the numbers say 27.8% vs 80.0%, but that seems a big difference. Wait, the p-value is 0.75, meaning no significant difference. Hmm, maybe the percentages are reversed? Let me check again. The text says \"CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75).\" Wait, that must be a mistake because 27.8 vs 80 is a big difference, but the p-value says they are not different. Maybe it's a typo and should be 27.8% vs 28% or something. Alternatively, maybe the order is reversed. Let me see the original question again. The options are older vs younger. The text says \"Older patients were more likely to be in atrial fibrillation (10.1% vs 22.8%, p<0.001) and have lacunar stroke (34.7% vs 22.1%; p=0.04). CT rates were similar in the two groups (27.8% vs 80.0%, p=0.75). Scans were performed more quickly in younger patients (p<0.01). MRI scan rates were higher in younger patients (26% vs 4%, p<0.01), as was carotid Doppler imaging (92% vs 77%, p<0.01). There were no differences in prescribed secondary preventive treatments. Older patients experienced less delay for carotid endarterectomy (49 vs 90 days, p<0.01). Younger patients",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 584,
            "completion_tokens": 512
        },
        "time_elapsed": 5.921993255615234
    },
    {
        "realidx": "19430778",
        "question": "To correlate magnetic resonance (MR) image findings with pain response by provocation discography in patients with discogenic low back pain, with an emphasis on the combination analysis of a high intensity zone (HIZ) and disc contour abnormalities.\nSixty-two patients (aged 17-68 years) with axial low back pain that was likely to be disc related underwent lumbar discography (178 discs tested). The MR images were evaluated for disc degeneration, disc contour abnormalities, HIZ, and endplate abnormalities. Based on the combination of an HIZ and disc contour abnormalities, four classes were determined: (1) normal or bulging disc without HIZ; (2) normal or bulging disc with HIZ; (3) disc protrusion without HIZ; (4) disc protrusion with HIZ. These MR image findings and a new combined MR classification were analyzed in the base of concordant pain determined by discography.\nDisc protrusion with HIZ [sensitivity 45.5%; specificity 97.8%; positive predictive value (PPV), 87.0%] correlated significantly with concordant pain provocation (P<0.01). A normal or bulging disc with HIZ was not associated with reproduction of pain. Disc degeneration (sensitivity 95.4%; specificity 38.8%; PPV 33.9%), disc protrusion (sensitivity 68.2%; specificity 80.6%; PPV 53.6%), and HIZ (sensitivity 56.8%; specificity 83.6%; PPV 53.2%) were not helpful in the identification of a disc with concordant pain.\nCan magnetic resonance imaging accurately predict concordant pain provocation during provocative disc injection?",
        "answer": "yes",
        "answer_rationale": "The proposed MR classification is useful to predict a disc with concordant pain. Disc protrusion with HIZ on MR imaging predicted positive discography in patients with discogenic low back pain.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether MRI can accurately predict concordant pain provocation during provocative disc injection based on the provided study.\n\nFirst, I need to understand the study's findings. The study looked at 62 patients with discogenic low back pain and used discography as the gold standard. They classified discs into four groups based on MRI findings of HIZ and disc contour abnormalities. \n\nThe key results mentioned are the sensitivity, specificity, and PPV for each classification. The question is about accuracy, so I should focus on these metrics. The study states that disc protrusion with HIZ had a sensitivity of 45.5% and specificity of 97.8%. High specificity means that if the test is positive (i.e., protrusion with HIZ), it's likely to be correct, which gives a high PPV of 87%. However, sensitivity is lower, meaning it misses some cases. \n\nBut the other options like just HIZ or just protrusion without the combination didn't do as well. The normal/bulging with HIZ didn't correlate. The question is about MRI's overall accuracy. The study's conclusion seems to suggest that only the combination of protrusion and HIZ was significant (p<0.01), but even then, the sensitivity isn't super high. \n\nThe options are yes, no, maybe. The question is whether MRI can \"accurately\" predict. High specificity is good for ruling in, but low sensitivity means it's not great at catching all cases. Since the best class (protrusion + HIZ) has 45% sensitivity, which is not very high, maybe the answer is no. The other parameters like degeneration alone weren't helpful. The study says that the combination was significant, but the question is about MRI's overall accuracy. Since even the best case isn't very sensitive, maybe the answer is B) no. Because while it has high specificity, the sensitivity is low, so overall accuracy might not be considered sufficient. The question is whether MRI can \"accurately predict\" and since the sensitivity is low, it's not reliable enough. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 468,
            "completion_tokens": 455
        },
        "time_elapsed": 7.323143720626831
    },
    {
        "realidx": "19468282",
        "question": "Prospective multicenter longitudinal cohort study.\nTo validate the prognostic value of the acute phase sacral sparing measurements with regard to chronic phase-independent ambulation in patients with traumatic spinal cord injury (SCI).\nEuropean Multicenter Study of Human Spinal Cord Injury (EM-SCI).\nIn 432 patients, acute phase (0-15 days) American Spinal Injury Association (ASIA)/International Spinal Cord Society neurological standard scale (AIS) grades, ASIA sacral sparing measurements, which are S4-5 light touch (LT), S4-5 pin prick (PP), anal sensation and voluntary anal contraction; and chronic phase (6 or 12 months) indoor mobility Spinal Cord Independence Measure (SCIM) measurements were analyzed. Calculations of positive and negative predictive values (PPV/NPV) as well as univariate and multivariate logistic regressions were performed in all four sacral sparing criteria. The area under the receiver-operating characteristic curve (AUC) ratios of all regression equations was calculated.\nTo achieve independent ambulation 1-year post injury, a normal S4-5 PP score showed the best PPV (96.5%, P<0.001, 95% confidence interval (95% CI): 87.9-99.6). Best NPV was reported in the S4-5 LT score (91.7%, P<0.001, 95% CI: 81.6-97.2). The use of the combination of only voluntary anal contraction and the S4-5 LT and PP sensory scores (AUC: 0.906, P<0.001, 95% CI: 0.871-0.941) showed significantly better (P<0.001, 95% CI: 0.038-0.128) discriminating results in prognosticating 1-year independent ambulation than with the use of currently used distinction between complete and incomplete SCI (AUC: 0.823, P<0.001, 95% CI: 0.781-0.864).\nIs determination between complete and incomplete traumatic spinal cord injury clinically relevant?",
        "answer": "maybe",
        "answer_rationale": "Out of the four sacral sparing criteria, the acute phase anal sensory score measurements do not contribute significantly to the prognosis of independent ambulation. The combination of the acute phase voluntary anal contraction and the S4-5 LT and PP scores, predicts significantly better chronic phase-independent ambulation outcomes than the currently used distinction between complete and incomplete SCI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether determining between complete and incomplete traumatic spinal cord injury (SCI) is clinically relevant based on the provided study.\n\nFirst, I need to understand the study's findings. The study compared the prognostic value of sacral sparing measurements versus the traditional complete vs. incomplete SCI classification. The key results mentioned are the AUC values. The combination of voluntary anal contraction and S4-5 LT and PP scores had an AUC of 0.906, which is higher than the AUC of 0.823 for the complete vs. incomplete distinction. \n\nA higher AUC means better discrimination between those who will and won't achieve independent ambulation. Since the combination of sacral sparing measurements performed significantly better (p<0.001) than the complete/incomplete distinction, this suggests that the traditional method might not be as useful. The study's conclusion implies that the current complete vs. incomplete classification isn't as good at predicting ambulation as the specific sacral sparing tests. \n\nThe question is whether the determination between complete and incomplete SCI is clinically relevant. The study's results show that the traditional method has a lower AUC, meaning it's less accurate. Therefore, the study's authors might argue that the current distinction isn't as relevant because the sacral sparing measures are better predictors. \n\nLooking at the options: (A) yes, (B) no, (C) maybe. The study's findings support that the traditional classification isn't as good, so the answer would lean towards (B) no. But I need to make sure I'm not missing anything. The question is about clinical relevance. Even if the sacral measures are better, maybe the complete/incomplete is still somewhat relevant. However, the study says the combination was \"significantly better\" than the current method, which might indicate that the current method isn't as relevant anymore. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 576,
            "completion_tokens": 405
        },
        "time_elapsed": 4.717007637023926
    },
    {
        "realidx": "19578820",
        "question": "Opioid-dependent patients often have co-occurring chronic illnesses requiring medications that interact with methadone. Methadone maintenance treatment (MMT) is typically provided separately from medical care. Hence, coordination of medical care and substance use treatment is important to preserve patient safety.\nTo identify potential safety risks among MMT patients engaged in medical care by evaluating the frequency that opioid dependence and MMT documentation are missing in medical records and characterizing potential medication-methadone interactions.\nAmong patients from a methadone clinic who received primary care from an affiliated, but separate, medical center, we reviewed electronic medical records for documentation of methadone, opioid dependence, and potential drug-methadone interactions. The proportions of medical records without opioid dependence and methadone documentation were estimated and potential medication-methadone interactions were identified.\nAmong the study subjects (n = 84), opioid dependence documentation was missing from the medical record in 30% (95% CI, 20%-41%) and MMT documentation was missing from either the last primary care note or the last hospital discharge summary in 11% (95% CI, 5%-19%). Sixty-nine percent of the study subjects had at least 1 medication that potentially interacted with methadone; 19% had 3 or more potentially interacting medications.\nAre opioid dependence and methadone maintenance treatment (MMT) documented in the medical record?",
        "answer": "maybe",
        "answer_rationale": "Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether opioid dependence and methadone maintenance treatment (MMT) are documented in the medical records based on the provided study.\n\nFirst, I need to look back at the information given. The study states that among 84 patients, 30% were missing documentation of opioid dependence. That means 70% had it documented. For MMT, the documentation was missing in 11% of cases, so 89% were documented. The question is asking if they are documented, so the answer would be that they are documented in most cases, but the options are yes, no, or maybe. \n\nWait, the options are (A) yes, (B) no, (C) maybe. The question is phrased as a general question: \"Are opioid dependence and MMT documented?\" The study shows that a significant portion (30% and 11%) were missing, but the majority were documented. However, the options are not about the percentage but whether they are documented. Since the question is a yes/no/maybe, the correct answer would be \"maybe\" because there's a chance they might not be documented, but the study shows that in some cases they are missing. Wait, but the options might be looking for the fact that in the study, they were often missing. Wait, the question is phrased as a general question, not about the study's findings. Wait, the question is part of the study's context. Wait, the user is asking based on the study's data. The study found that 30% of the medical records lacked opioid dependence documentation and 11% lacked MMT documentation. So in some cases, they are missing, but in others, they are present. The question is \"Are opioid dependence and MMT documented in the medical record?\" The answer would be that they are not always documented. But the options are yes, no, maybe. Since the study shows that in some cases they are missing, the answer can't be a definitive yes or no. So the correct answer would be (C) maybe. Wait, but maybe the question is asking whether they are documented in general, but the options are about whether they are documented (so the answer would be that they are not always, so the answer is \"no\" in some cases, but the question is phrased as a general statement. Alternatively, perhaps the question is asking if they are documented in",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 388,
            "completion_tokens": 512
        },
        "time_elapsed": 5.597866535186768
    },
    {
        "realidx": "20197761",
        "question": "Guidelines emphasize that irritable bowel syndrome (IBS) is not a diagnosis of exclusion and encourage clinicians to make a positive diagnosis using the Rome criteria alone. Yet many clinicians are concerned about overlooking alternative diagnoses. We measured beliefs about whether IBS is a diagnosis of exclusion, and measured testing proclivity between IBS experts and community providers.\nWe developed a survey to measure decision-making in two standardized patients with Rome III-positive IBS, including IBS with diarrhea (D-IBS) and IBS with constipation (C-IBS). The survey elicited provider knowledge and beliefs about IBS, including testing proclivity and beliefs regarding IBS as a diagnosis of exclusion. We surveyed nurse practitioners, primary care physicians, community gastroenterologists, and IBS experts.\nExperts were less likely than nonexperts to endorse IBS as a diagnosis of exclusion (8 vs. 72%; P<0.0001). In the D-IBS vignette, experts were more likely to make a positive diagnosis of IBS (67 vs. 38%; P<0.001), to perform fewer tests (2.0 vs. 4.1; P<0.01), and to expend less money on testing (US$297 vs. $658; P<0.01). Providers who believed IBS is a diagnosis of exclusion ordered 1.6 more tests and consumed $364 more than others (P<0.0001). Experts only rated celiac sprue screening and complete blood count as appropriate in D-IBS; nonexperts rated most tests as appropriate. Parallel results were found in the C-IBS vignette.\nIs irritable bowel syndrome a diagnosis of exclusion?",
        "answer": "maybe",
        "answer_rationale": "Most community providers believe IBS is a diagnosis of exclusion; this belief is associated with increased resource use. Experts comply more closely with guidelines to diagnose IBS with minimal testing. This disconnect suggests that better implementation of guidelines is warranted to minimize variation and improve cost-effectiveness of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether irritable bowel syndrome (IBS) is a diagnosis of exclusion. The options are yes, no, or maybe.\n\nFirst, I need to recall what a diagnosis of exclusion means. A diagnosis of exclusion is when a doctor only arrives at a diagnosis after ruling out all other possible conditions through tests. So, for example, if someone has symptoms that could be due to several diseases, you have to do tests to exclude those other diseases before confirming the diagnosis in question.\n\nNow, the question is specifically about IBS. The provided information from the study says that guidelines emphasize IBS is NOT a diagnosis of exclusion. The study's abstract mentions that experts were less likely to see IBS as a diagnosis of exclusion compared to non-experts. The experts relied more on the Rome criteria for a positive diagnosis and did fewer tests. The key point here is that the guidelines are pushing against using IBS as a diagnosis of exclusion, instead advocating for using the Rome criteria directly. \n\nThe study's results back this up: experts (who presumably follow the guidelines) didn't consider it a diagnosis of exclusion, whereas non-experts did. The question is asking whether IBS is a diagnosis of exclusion, and according to the guidelines and the expert opinion in the study, the answer should be no. The options are (A) yes, (B) no, (C) maybe. \n\nThe correct answer based on the information given is B) no. The study's main point is that guidelines say it's not a diagnosis of exclusion, and experts agree. So the answer must be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 458,
            "completion_tokens": 337
        },
        "time_elapsed": 4.047785520553589
    },
    {
        "realidx": "20297950",
        "question": "To investigate the effect of fenofibrate on sleep apnoea indices.\nProof-of-concept study comprising a placebo run-in period (1 week, 5 weeks if fibrate washout was required) and a 4-week randomized, double-blind treatment period. Thirty-four subjects (mean age 55 years, body mass index 34 kg/m 2 , fasting triglycerides 3.5 mmol/L) with diagnosed sleep apnoea syndrome not treated with continuous positive airways pressure were enrolled and randomized to once daily treatment with fenofibrate (145 mg NanoCrystal(R) tablet) or placebo. Overnight polysomnography, computerized attention/vigilance tests and blood sampling for measurement of lipids, insulin, fasting plasma glucose and fibrinogen were performed at the end of each study period.\nNCT00816829.\nAs this was an exploratory study, a range of sleep variables were evaluated. The apnoea/hypopnoea index (AHI) and percentage of time spent with arterial oxygen saturation (SpO(2))<90% were relevant as they have been evaluated in other clinical trials. Other variables included total apnoeas, hypopnoeas and oxygen desaturations, and non-cortical micro-awakenings related to respiratory events per hour.\nFenofibrate treatment significantly reduced the percentage of time with SpO(2)<90% (from 9.0% to 3.5% vs. 10.0% to 11.5% with placebo, p = 0.007), although there was no significant change in the AHI (reduction vs. control 14% (95%CI -47 to 40%, p = 0.533). Treatment reduced obstructive apnoeas (by 44%, from 18.5 at baseline to 15.0 at end of treatment vs. 29.0 to 30.5 on placebo, p = 0.048), and non-cortical micro-awakenings per hour (from 23.5 to 18.0 vs. 24.0 to 25.0 with placebo, p = 0.004). Other sleep variables were not significantly influenced by fenofibrate.\nExploratory study in patients with mild to moderate sleep apnoea, limited treatment duration; concomitant hypnotic treatment (35%); lack of correction for multiplicity of testing.\nProof of concept study: does fenofibrate have a role in sleep apnoea syndrome?",
        "answer": "yes",
        "answer_rationale": "The consistent direction of change in sleep indices in this proof-of-concept study may support further investigation of fenofibrate in moderate to severe sleep apnoea syndrome.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether fenofibrate has a role in sleep apnoea syndrome based on the provided study.\n\nFirst, I need to recall the study details. The study was a proof-of-concept with a placebo-controlled design. They looked at several outcomes: AHI (apnoea/hypopnoea index), time with SpO2 <90%, obstructive apnoeas, and micro-awakenings. \n\nThe key results mentioned are that fenofibrate significantly reduced the percentage of time with SpO2 <90% (from 9% to 3.5% vs placebo's increase from 10% to 11.5%, p=0.007). That's a notable improvement. Also, it reduced obstructive apnoeas by 44% (from 18.5 to 15 vs placebo's increase from 29 to 30.5, p=0.048). Additionally, non-cortical micro-awakenings per hour went down significantly (23.5 to 18 vs placebo's 24 to 25, p=0.004). \n\nHowever, the AHI didn't show a significant change (14% reduction vs placebo, p=0.533). The study mentions it was exploratory, had a short duration, some patients on hypnotics, and no correction for multiple testing. \n\nThe question is whether fenofibrate has a role. Even though AHI didn't change significantly, other important metrics like oxygen desaturation and apnoeas did improve. Since it's a proof-of-concept, showing some positive effects might suggest further research is warranted. The options are yes, no, maybe. The study's results are mixed but with some positive signals. The answer might be \"maybe\" because the study isn't definitive but shows potential. But the question is about \"role\"\u2014if some key parameters improved, maybe the answer is yes? Wait, the AHI is a primary measure, but the other parameters are also relevant. The study's conclusion might suggest that fenofibrate could have some benefit, so the answer could be A (yes). But the study's limitations are noted, so maybe C (maybe) is better. The question is phrased as \"does fenofibrate have a role\"\u2014since the study shows some positive effects, even if not",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 649,
            "completion_tokens": 512
        },
        "time_elapsed": 6.584748029708862
    },
    {
        "realidx": "20337202",
        "question": "To determine the duration of continuing pregnancy after antenatal corticosteroid (AC) administration and to evaluate the potential opportunity for rescue AC.\nRetrospective analysis of women at 24-32 weeks' gestation who received AC at one institution.\nSix hundred ninety-two women received AC. Two hundred forty-seven (35.7%) delivered at>or = 34 weeks' gestation. Three hundred twenty-one (46.4%) delivered within 1 week of AC; 92 of those women (13.3%) delivered within 24 hours. Only 124 (17.9%) remained pregnant 1 week after AC and delivered at<34 weeks. The latter were compared to women delivering>2 week after AC but>or = 34 weeks. More likely to deliver at<34 weeks were those women who received AC for premature preterm rupture of membranes (OR 3.83, 95% CI 2.06-7.17), twins (OR 2.90, 95% CI 1.42-5.95) or before 28 weeks (OR 2.21, 95% CI 1.38-3.52).\nContinuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue?",
        "answer": "maybe",
        "answer_rationale": "Rescue AC may apply to only 18% of cases, and we identified subsets of more likely candidates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's an opportunity for rescue antenatal corticosteroids (AC) after the initial administration. The study provided gives some data on delivery times after AC.\n\nFirst, the study says that 35.7% of women delivered at \u226534 weeks, which is a good outcome. But the key part here is looking at the timing. 46.4% delivered within a week of getting AC, and 13.3% within 24 hours. That's pretty soon. However, 17.9% were still pregnant a week after AC but ended up delivering before 34 weeks. The question is about the possibility of a rescue dose. \n\nRescue AC usually refers to a second course given if the first doesn't lead to delivery within a certain window, like 7 days. The study mentions that those who delivered before 34 weeks but were still pregnant a week later might be candidates for another dose. The comparison group here is those who delivered after more than two weeks but at \u226534 weeks. The factors that made women more likely to deliver early (like PPROM, twins, or before 28 weeks) are noted, but the main point is the time frame.\n\nSince 17.9% were still pregnant a week later and delivered preterm, that suggests there's a window where a second dose could be possible. The study's data shows that a significant portion (over 17%) had enough time between the first AC and delivery to potentially get a second dose. So the answer would be \"yes\" because there's an opportunity for a rescue dose in those who remain pregnant beyond a week. The options are A, B, C, so the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 378,
            "completion_tokens": 374
        },
        "time_elapsed": 4.724078416824341
    },
    {
        "realidx": "20538207",
        "question": "It is generally considered that kidney grafts should be preserved at 4 degrees C during cold storage. However, actual temperature conditions are not known. We decided to study the temperature levels during preservation with the Biotainer storage can and Vitalpack transport pack.\nTemperature was monitored using the Thermobouton probe during preservation of pig kidneys, in the same conditions used with human grafts. The probe recorded the temperature level every 10 minutes during four days. We compared the results found with the new storage can with results obtained in the same conditions with the storage can formerly used by our team. We also studied the best position of the probe for temperature monitoring and the influence of the amount of ice within the transport pack on the temperature level. We then monitored the temperature during the conservation of actual human kidney grafts harvested at our institution from August 2007 to May 2008.\nThe temperature levels were the same regardless of the position of the probe within the transport pack. The lowest temperature was maintained during 15 hours, and the temperature level stayed below 5 degrees C for 57 hours with the new storage can. The former storage can maintained the lowest temperature level for 80 minutes, and temperature reached 5 degrees C after 10 hours 40 minutes. Temperature levels were similar when 2 or 4 kg of crushed ice were used. We observed similar results when monitoring the conservation of human grafts.\nShould temperature be monitorized during kidney allograft preservation?",
        "answer": "no",
        "answer_rationale": "The new storage can affords more stable temperature levels when compared to the formerly used can. Since temperature is stable during conservation, continuous monitoring in everyday practice does not seem warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether temperature should be monitored during kidney allograft preservation based on the study described.\n\nFirst, I need to recall the key points from the provided information. The study compared two storage containers (the new Biotainer and the former one) using pig kidneys and later human grafts. They used temperature probes to monitor every 10 minutes over four days. The results showed that the new storage can maintained lower temperatures much longer (15 hours at lowest, under 5\u00b0C for 57 hours) compared to the old one (80 minutes lowest, reached 5\u00b0C after ~10.7 hours). Also, the probe position didn't affect the readings, and the amount of ice (2kg vs 4kg) didn't make a difference. The human grafts had similar results.\n\nThe question is whether to monitor temperature. The study's findings emphasize the importance of maintaining the correct temperature. Since the new container is better but the old one was worse, monitoring would help ensure that the kidneys are kept at the right temperature. The fact that they found significant differences between the containers and that temperature dropped to 5\u00b0C quickly in the old one suggests that without monitoring, you might not know if the preservation is effective. Also, the study itself relied on monitoring to gather this data, implying that monitoring is valuable. The answer options are yes, no, maybe. Since the study shows that temperature control is critical and monitoring provided important data, the answer should be yes (A). The options don't have a \"maybe\" because the study's results support the necessity of monitoring.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 396,
            "completion_tokens": 339
        },
        "time_elapsed": 4.219305753707886
    },
    {
        "realidx": "20736672",
        "question": "To assess whether perspective-taking, which researchers in other fields have shown to induce empathy, improves patient satisfaction in encounters between student-clinicians and standardized patients (SPs).\nIn three studies, randomly assigned students (N = 608) received either a perspective-taking instruction or a neutral instruction prior to a clinical skills examination in 2006-2007. SP satisfaction was the main outcome in all three studies. Study 1 involved 245 third-year medical students from two universities. Studies 2 and 3 extended Study 1 to examine generalizability across student and SP subpopulations. Study 2 (105 physician assistant students, one university) explored the effect of perspective-taking on African American SPs' satisfaction. Study 3 (258 third-year medical students, two universities) examined the intervention's effect on students with high and low baseline perspective-taking tendencies.\nIntervention students outscored controls in patient satisfaction in all studies: Study 1: P = .01, standardized effect size = 0.16; Study 2: P = .001, standardized effect size = 0.31; Study 3: P = .009, standardized effect size = 0.13. In Study 2, perspective-taking improved African American SPs' satisfaction. In Study 3, intervention students with high baseline perspective-taking tendencies outscored controls (P = .0004, standardized effect size = 0.25), whereas those with low perspective-taking tendencies did not (P = .72, standardized effect size = 0.00).\nDoes perspective-taking increase patient satisfaction in medical encounters?",
        "answer": "maybe",
        "answer_rationale": "Perspective-taking increased patient satisfaction in all three studies, across medical schools, clinical disciplines, and racially diverse students and SPs. Perspective-taking as a means for improving patient satisfaction deserves further exploration in clinical training and practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether perspective-taking increases patient satisfaction in medical encounters based on the provided studies.\n\nFirst, I need to recall the details from the study description. The main outcome was SP satisfaction, and they had three studies with different groups. The key results are that in all three studies, the intervention group (those given perspective-taking instructions) scored higher than the control groups. The p-values were significant in all cases (like 0.01, 0.001, etc.), which means the results are statistically significant. The effect sizes varied but were all positive. \n\nIn Study 2, specifically with African American SPs, it worked. Study 3 showed that students with higher baseline tendencies benefited more, but even those with lower didn't show a negative effect, just no significant difference. The question is whether perspective-taking increases satisfaction. Since all studies showed improvement in the intervention group compared to control, the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 440,
            "completion_tokens": 219
        },
        "time_elapsed": 3.2444286346435547
    },
    {
        "realidx": "20971618",
        "question": "Cutaneous infections such as impetigo contagiosum (IC), molluscum contagiosum (MC) and herpes virus infection (HI) appear to be associated with atopic dermatitis (AD), but there are no reports of concrete epidemiological evidence.\nWe evaluated the association of childhood AD with these infections by conducting a population-based cross-sectional study.\nEnrolled in this study were 1117 children aged 0-6 years old attending nursery schools in Ishigaki City, Okinawa Prefecture, Japan. Physical examination was performed by dermatologists, and a questionnaire was completed on each child's history of allergic diseases including AD, asthma, allergic rhinitis and egg allergy, and that of skin infections including IC, MC and HI, as well as familial history of AD.\nIn 913 children (AD; 132), a history of IC, MC or HI was observed in 45.1%, 19.7%, and 2.5%, respectively. Multiple logistic regression analysis revealed that the odds of having a history of IC were 1.8 times higher in AD children than in non-AD children. Meanwhile, a history of MC was significantly correlated to the male gender, but not to a personal history of AD. As for HI, we found no correlated factors in this study.\nAre lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?",
        "answer": "maybe",
        "answer_rationale": "The lifetime prevalence of IC was indeed higher in young children with a history of AD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the lifetime prevalence of impetigo, molluscum, and herpes infections is really increased in children with atopic dermatitis (AD) based on the provided study.\n\nFirst, I need to look at the study details given. The study was a population-based cross-sectional study with 1117 children. They found that among 913 children, 45.1% had a history of impetigo contagiosum (IC), 19.7% molluscum contagiosum (MC), and 2.5% herpes virus infection (HI). \n\nThe key part here is the multiple logistic regression analysis. It says that the odds of having a history of IC were 1.8 times higher in AD children compared to non-AD children. That's a significant increase, so for impetigo, there's a clear association. \n\nBut then, for molluscum (MC), the study found it was correlated with male gender but not with AD. So no link there. And for herpes (HI), no correlated factors were found at all. \n\nThe question is asking about all three infections. The answer options are yes, no, maybe. The question is whether the prevalence is increased in AD children for these infections. Since only IC showed a significant association (1.8 times higher), but MC and HI didn't, the answer might be tricky. \n\nWait, the question says \"Are lifetime prevalence of impetigo, molluscum and herpes infection really increased...\" So all three? The study shows that only impetigo is increased. The other two aren't. So the answer would be no, because not all three are increased. But the options are (A) yes, (B) no, (C) maybe. \n\nAlternatively, maybe the question is asking if any of them are increased. The wording is a bit ambiguous. The question says \"increased in children having atopic dermatitis\"\u2014so if at least one is, then maybe the answer is yes. But the way the options are presented, the question might be implying all three. Let me check the original question again.\n\nThe question states: \"Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?\" So all three? The study shows that impetigo is increased (1.8x), but MC and HI are not. Therefore, the answer would be no",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 389,
            "completion_tokens": 512
        },
        "time_elapsed": 6.787804126739502
    },
    {
        "realidx": "21164063",
        "question": "A possible role for fondaparinux as a bridging agent in the perioperative setting is explored.\nAnticoagulation guidelines provide minimal direction on the perioperative use of fondaparinux. Fondaparinux's extended half-life of 17-21 hours complicates its use as a perioperative bridging therapy. The ideal time for discontinuation before surgery is an issue, particularly in surgeries with a high bleeding risk or in which neuraxial anesthesia is used. Guidance for perioperative bridging with fondaparinux must be derived from pharmacokinetic data, surgical prophylaxis trials, case reports, and anesthesia guidelines. Published trials used fondaparinux sodium 2.5 mg daily for venous thromboembolism prophylaxis in surgical patients, and the majority avoided its use before surgery in patients receiving neuraxial anesthesia. Three case reports cited the use of fondaparinux sodium as perioperative bridge therapy; one used a 2.5-mg dose, and the other two used a full treatment dose of 7.5 mg. Furthermore, professional anesthesia guidelines conflict in their recommendations regarding the timing of drug administration with neuraxial catheter use. For these reasons, it may be optimal to avoid fondaparinux use before surgery. In some instances, the use of low-molecular-weight heparin or inpatient use of i.v. unfractionated heparin is not possible, is contraindicated, or has limited efficacy, such as a patient with history of heparin-induced thrombocytopenia or antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for these patients.\nIs there a role for fondaparinux in perioperative bridging?",
        "answer": "no",
        "answer_rationale": "The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a role for fondaparinux in perioperative bridging. The provided text gives a lot of details.\n\nFirst, the question is about bridging therapy around surgery. The passage mentions that anticoagulation guidelines don't give much direction here. Fondaparinux has a long half-life (17-21 hours), which complicates its use because you need to know when to stop it before surgery, especially for high-bleeding-risk surgeries or neuraxial anesthesia. \n\nThe text says that some trials used 2.5 mg daily for prophylaxis, but most avoided it before surgery with neuraxial anesthesia. There are three case reports where it was used as a bridge, with doses of 2.5 or 7.5 mg. However, anesthesia guidelines are conflicting about timing with neuraxial catheters. \n\nThe passage then states that \"it may be optimal to avoid fondaparinux use before surgery\" but adds that in some cases, like when other options (LMWH or UFH) aren't possible (e.g., heparin-induced thrombocytopenia or antithrombin III deficiency), fondaparinux might have a role. \n\nSo, the answer isn't a straightforward yes or no. The key here is that while there are situations where it's not recommended (due to bleeding risks and conflicting guidelines), there are specific instances where it could be used as a bridge when other options aren't viable. The options are yes, no, maybe. The passage says \"may have a role\" in certain cases, so the answer is probably \"maybe\" (C). But wait, the first part says \"may be optimal to avoid\" but then says \"may have a role in bridge therapy for these patients.\" So the answer is that there is a possible role in specific scenarios, so the answer is yes? Or maybe because it's not clear-cut, the answer is maybe. The question is whether there's a role. The text says \"may have a role,\" so the answer would be yes (A) or maybe (C). The options are (A) yes, (B) no, (C) maybe. The passage says \"may have a role in bridge therapy for these patients.\" The use of \"may\" suggests that it's possible but not definitive, so \"maybe\" (C) is the answer. Alternatively, since the conclusion is that in some",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 451,
            "completion_tokens": 512
        },
        "time_elapsed": 5.934616327285767
    },
    {
        "realidx": "21712147",
        "question": "Combining various antiretroviral agents into one single dosage form has been a strategy to reduce pill burden and enhance medication adherence among human immunodeficiency virus /AIDS (HIV/AIDS) patients.\nThis is a cost-utility study from a health care system's perspective comparing coformulated fixed dose (FXD) strategy versus multiple free dose combination (FRC) in antiretroviral therapy.\nThe Medical Expenditure Panel Survey (MEPS) was used to identify HIV/AIDS patients with \u22652 active antiretroviral medications. Patients on FXD were matched in 1:1 ratio with the FRC group using propensity scores. All medical costs excluding those paid by patients and families were included. Utility was measured using SF-6D scores from the SF-12 questionnaire. Incremental cost-utility ratios (ICURs) were calculated using the mean annual estimates. A cost-effectiveness acceptability curve was determined using a Monte Carlo probabilistic simulation technique.\nNine FXD antiretroviral formulations approved by the U.S. Food and Drug Administration by 2005 was included in this study. One hundred seventy HIV/AIDS patients with \u22652 antiretroviral agents were identified from the MEPS database, of which 53% (n=92) were on FXD formulation. On matching, 70 patients from FXD had a match from the FRC group. No differences in sociodemographic and health status variables were observed between the matched groups. The mean annual cost was $15,766.15 for FXD patients and $11,875.21 for FRC patients. The mean utility gained by using FXD over FRC was 0.085; however, this difference was not statistically significant. The ICUR for the FXD treatment over FRC treatment was $45,540.49/quality-adjusted life years (QALYs). Probabilistic sensitivity analysis showed FXD to dominate FRC (>50% probability of being cost-effective) above the $40,000 threshold.\nDoes combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients?",
        "answer": "no",
        "answer_rationale": "Although the cost-effectiveness of a single-pill strategy was within the acceptable willingness-to-pay threshold, the QALY difference were minimal. Further research is recommended to explore the long-term impact of the strategy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether combining antiretroviral agents into a single dosage form (FXD) enhances the quality of life for HIV/AIDS patients compared to multiple free dose combinations (FRC). The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided in the study. The key points here are the results regarding utility and the incremental cost-utility ratio (ICUR). The utility measure used was the SF-6D score from the SF-12 questionnaire. The mean utility gained by FXD over FRC was 0.085, but this difference wasn't statistically significant. \n\nHmm, so even though there's a numerical difference in utility, it's not statistically significant. That suggests that the study didn't find strong evidence that FXD actually improves quality of life more than FRC. The ICUR was $45,540 per QALY, and the cost-effectiveness analysis showed that FXD was cost-effective above a $40,000 threshold. But the question is specifically about enhancing quality of life, not cost-effectiveness. \n\nThe utility gain wasn't significant, so the study's data doesn't confirm that FXD leads to a better quality of life. The \"maybe\" option might be tempting if there was some indication of a trend, but since the difference wasn't significant, the answer is probably \"no\" because the study didn't find a statistically significant improvement. The cost-effectiveness is a separate consideration here. The question is strictly about quality of life, so the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 553,
            "completion_tokens": 340
        },
        "time_elapsed": 3.9653353691101074
    },
    {
        "realidx": "21789019",
        "question": "The increasingly older population confronts oncologists with an imposing challenge: older cancer patients have specific healthcare needs both independent of and associated with the diagnosis of cancer. The aim of the present study is to examine whether elderly versus younger cancer patients have different needs with respect to attendance, treatment and information.\nThis is an observational and cross-sectional study. Cancer patients aged 35 to 82 years were consecutively interviewed. The group was divided into two subgroups aged \u226465 and \u226566 years old. The Needs Evaluation Questionnaire (NEQ) was used to assess patients' needs and demographic variables were collected. Data analysis was carried out by means of cross-tabulation analyses and the chi-square test.\nThe requests most frequently expressed by the older group concerned financial-insurance information (73.9%), the need to talk to people with the same illness (71.7%), the need to receive more comprehensible information from doctors and nurses (71.7%), and the need for a better dialogue with clinicians (69.6%). Few significant differences between the two age subgroups were found, with the exception of issues such as the need for intimacy and support.\nDo elderly cancer patients have different care needs compared with younger ones?",
        "answer": "no",
        "answer_rationale": "Elderly patients have informational and relational needs similar to those of younger patients. In fact, most of the whole sample flagged up the need for higher levels of satisfaction especially concerning a better dialogue with health staff, along with a new factor: the need to talk to people with the same illness.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether elderly cancer patients have different care needs compared to younger ones based on the provided study.\n\nFirst, I need to look at the study details. The study is observational and cross-sectional, involving patients aged 35-82, split into \u226465 and \u226566. They used the NEQ to assess needs. The results mentioned that the older group had higher requests in areas like financial-insurance info (73.9%), talking to others with the same illness (71.7%), more comprehensible info from clinicians (71.7%), and better dialogue with clinicians (69.6%). However, the study states that few significant differences were found between the two age groups except for intimacy and support.\n\nWait, the question is whether elderly have different needs. The options are yes, no, maybe. The study says \"few significant differences\" except for some specific issues like intimacy and support. The main points listed (financial, talking to others, info clarity, dialogue) were the top needs for the older group, but the study's conclusion says that except for those few areas (intimacy/support), there weren't many differences. \n\nHmm, the question is a bit tricky. The answer hinges on whether the exceptions mentioned (intimacy and support) count as significant differences. The study says \"few significant differences between the two age subgroups were found, with the exception of issues such as the need for intimacy and support.\" So, that implies that in most areas, there weren't big differences, but in those specific areas, there were. \n\nThe question is asking if elderly have different care needs compared to younger. The answer options are yes, no, maybe. Since the study found some differences (even if few), the answer would be yes. But wait, the options might be trying to trick me. Let me re-read the study conclusion again. The first part says the aim was to see if elderly have different needs. The results found that the older group had higher needs in those areas, but the analysis showed few differences except for some. The key here is that the question is whether they have different needs. Even if only a few areas are different, that still means there are differences. So the answer should be yes (A). But wait, the study says \"few significant differences\", so maybe the majority are not different, but some are. The question is general: do they have different needs? The answer is yes because",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 342,
            "completion_tokens": 512
        },
        "time_elapsed": 5.943578481674194
    },
    {
        "realidx": "21889895",
        "question": "The aim of this study was to determine if educating residents about the potential effects of radiation exposure from computed tomographic (CT) imaging alters ordering patterns. This study also explored whether referring physicians are interested in radiation education and was an initial effort to address their CT ordering behavior.\nTwo to four months after a radiologist's lecture on the potential effects of radiation exposure related to CT scans, urology and orthopedic residents were surveyed regarding the number and types of CT scans they ordered, the use of alternative imaging modalities, and whether they used the lecture information to educate patients.\nTwenty-one resident lecture attendants completed the survey. The number of CT scans ordered after the lecture stayed constant for 90% (19 of 21) and decreased for 10% (two of 21). The types of CT scans ordered changed after the lecture for 14% (three of 21). Thirty-three percent (seven of 21) reported increases in alternative imaging after the lecture, including 24% (five of 21) reporting increases in magnetic resonance imaging and 19% (four of 21) reporting increases in ultrasound. Patients directed questions about radiation exposure to 57% (12 of 21); 38% (eight of 21) used the lecture information to educate patients. Referring physicians were interested in the topic, and afterward, other physician groups requested radiation education lectures.\nWill CT ordering practices change if we educate residents about the potential effects of radiation exposure?",
        "answer": "no",
        "answer_rationale": "Most clinicians did not change their CT scan ordering after receiving education about radiation from a radiologist. Radiation education allowed clinicians to discuss CT benefits and risks with their patients and to choose appropriate CT protocols. Referring physician groups are interested in this topic, and radiologists should be encouraged to give radiation lectures to them.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study's aim was to see if educating residents about radiation from CT scans changes their ordering habits. The options are yes, no, maybe.\n\nLooking at the results: after the lecture, 90% kept the same number of CT orders, 10% decreased. So most didn't change, but some did reduce. Then, 14% changed the types of CTs ordered. Also, 33% increased alternative imaging like MRI or ultrasound. That suggests some substitution, which might mean less CT use indirectly. Also, some residents used the info to educate patients, and other docs wanted the lectures. \n\nThe question is whether CT ordering practices will change. The study shows that while most kept the same, some decreased or changed types, and more used alternatives. So there was some change, but not a majority. However, the fact that some did change and others are interested in more education might indicate that overall, there's a possibility. The answer might be \"maybe\" because it's not a clear majority, but there's some effect. Wait, but the options are yes, no, maybe. The question is phrased as \"will CT ordering practices change if we educate residents\". The study's results show that in their case, some did change. So the answer could be yes, because there was a change in some cases. Alternatively, since most didn't change, maybe the answer is no. Hmm. The question is whether the education leads to changes. The study found that 10% decreased, 14% changed types, and 33% used alternatives. So overall, there were changes in ordering practices, even if not all. The answer might be yes because the study shows that some changes occurred. The fact that other physicians also requested lectures suggests that the education can lead to changes. So the correct answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 406,
            "completion_tokens": 395
        },
        "time_elapsed": 4.652544736862183
    },
    {
        "realidx": "22227642",
        "question": "The aim of this work is to assess a previously described slit-lamp biomicroscopy-based method (SLBM) for measuring pupil diameter and compare it to Colvard infrared pupillometry (CIP).\nTwo examiners performed three repeated measurements with each instrument in 40 healthy eyes. We determined the agreement of SLBM and CIP, intraobserver and interobserver repeatabilities, and interobserver concordance (kappa) and SLBM ability for detecting pupil sizes over 6.0\u00a0mm.\nThe mean (\u00b1standard deviation [SD]) pupil diameter was 5.81 \u00b1 0.70\u00a0mm with SLBM and 6.26 \u00b1 0.68\u00a0mm with CIP (p\u2009=\u20090.01) averaging both examiner's results. Mean differences between the SLBM and CIP were -0.60\u00a0mm and -0.30\u00a0mm for each examiner using the average of the three readings (p\u2009=\u20090.02), and they were very similar using the first reading. Intraobserver reproducibility: the width of the 95% LoA ranged from 1.79 to 2.30\u00a0mm. The ICCs were 0.97 and 0.92 for SLBM, and 0.96 and 0.90 for CIP. Interobserver reproducibility: the width of the LoA ranged from 1.82 to 2.09\u00a0mm. Kappa statistics were 0.39 and 0.49 for the first and mean SLBM readings, respectively, and 0.45 for both the first and mean CIP readings. Sensitivity and specificity of SLBM for detection of pupils larger than 6\u00a0mm ranged from 55.56% to 73.68% and from 76.19% to 95.45%, respectively. The best trade-off between sensitivity and specificity ranged from 5.4\u00a0mm to 6.2\u00a0mm.\nCan we measure mesopic pupil size with the cobalt blue light slit-lamp biomicroscopy method?",
        "answer": "no",
        "answer_rationale": "Although the SLBM is quite repeatable, it underestimates mesopic pupil size and shows a too wide range of agreement with CIP. SLBM shows low sensitivity in detecting pupils larger than 6\u00a0mm, which may be misleading when planning anterior segment surgery. Previous grading-consensus training strategies may increase interrater reproducibility, and compensation for the systematic underestimation could improve accuracy of the SLBM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether mesopic pupil size can be measured using the cobalt blue light slit-lamp biomicroscopy method (SLBM) based on the provided study.\n\nFirst, I need to recall what mesopic conditions are. Mesopic vision is when the lighting is in the middle between photopic (bright light) and scotopic (low light) conditions. Typically, mesopic conditions are around 1 to 100 lux, which is a moderate light level. Pupil size can vary depending on the light intensity; in lower light, pupils dilate, and in brighter light, they constrict.\n\nThe study here compares SLBM (slit-lamp biomicroscopy) with Colvard infrared pupillometry (CIP). The key point is whether the SLBM method, which uses cobalt blue light, can measure mesopic pupil size. The question is essentially asking if the SLBM method operates under mesopic conditions or not.\n\nLooking at the study's description: the SLBM method is performed with a slit-lamp. Slit-lamps typically use a bright light source. However, cobalt blue light is a specific wavelength (around 460 nm) often used in ophthalmology for examining the eye's structures. The intensity of the slit-lamp's light might be bright enough to cause pupil constriction, which would mean it's measuring under photopic conditions. In contrast, mesopic measurements usually require lower light levels to keep the pupils naturally dilated or in a middle state.\n\nThe study's results show that the mean pupil diameter measured by SLBM was 5.81 mm, while CIP (which uses infrared and might be less likely to constrict the pupil) was 6.26 mm. The difference of about 0.4-0.6 mm suggests that the SLBM might be causing some constriction, possibly because the cobalt blue light is brighter. Since mesopic measurements aim to avoid significant constriction from bright light, the SLBM's use of a bright slit-lamp might not be suitable for mesopic conditions. \n\nAdditionally, the study mentions that the SLBM's sensitivity and specificity for detecting pupils over 6mm were variable. If the method isn't effective in accurately measuring under mesopic conditions, that could explain the lower sensitivity. The fact that CIP, which uses infrared (and thus less likely to affect pupil size through light exposure), had higher agreement might indicate that SLBM isn",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 551,
            "completion_tokens": 512
        },
        "time_elapsed": 6.272322654724121
    },
    {
        "realidx": "22236315",
        "question": "Distance to provider might be an important barrier to timely diagnosis and treatment for cancer patients who qualify for Medicaid coverage. Whether driving time or driving distance is a better indicator of travel burden is also of interest.\nDriving distances and times from patient residence to primary care provider were calculated for 3,917 breast, colorectal (CRC) and lung cancer Medicaid patients in Washington State from 1997 to 2003 using MapQuest.com. We fitted regression models of stage at diagnosis and time-to-treatment (number of days between diagnosis and surgery) to test the hypothesis that travel burden is associated with timely diagnosis and treatment of cancer.\nLater stage at diagnosis for breast cancer Medicaid patients is associated with travel burden (OR = 1.488 per 100 driving miles, P= .037 and OR = 1.270 per driving hour, P= .016). Time-to-treatment after diagnosis of CRC is also associated with travel burden (14.57 days per 100 driving miles, P= .002 and 5.86 days per driving hour, P= .018).\nIs distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer?",
        "answer": "no",
        "answer_rationale": "Although travel burden is associated with timely diagnosis and treatment for some types of cancer, we did not find evidence that driving time was, in general, better at predicting timeliness of cancer diagnosis and treatment than driving distance. More intensive efforts at early detection of breast cancer and early treatment of CRC for Medicaid patients who live in remote areas may be needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether distance to provider is a barrier to care for Medicaid patients with breast, colorectal, or lung cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study included 3,917 patients with those cancers on Medicaid. They looked at driving distance and time, and how that relates to stage at diagnosis and time to treatment.\n\nThe results mention that for breast cancer patients, later stage at diagnosis is associated with both driving miles and hours. The odds ratios are significant (p-values under 0.05). For colorectal cancer, the time-to-treatment increased with both distance and driving time. The p-values here are also significant. However, the question includes lung cancer as well. Wait, the results only mention breast and colorectal. The study's abstract might not have data on lung cancer outcomes? The question includes all three cancers, but the results provided only discuss breast and CRC. Hmm, that's a point to note.\n\nThe question is whether distance is a barrier for any of the three. Since the study shows that for breast and CRC, there is an association between travel burden (distance/time) and later stage or delayed treatment, that suggests distance is a barrier for those two. The lung cancer part isn't addressed in the results given here. But the options are yes, no, maybe. The question is phrased generally for all three. Since at least two of the three cancers (breast and CRC) show an association, the answer would still be yes, because the question is whether distance is a barrier for these patients in general. The lung cancer data might not be part of the results presented, but the question is about the three, but the study's results support that for two of them, distance is a barrier. So the answer would be yes. The options don't require all three, just whether it's a barrier for any of them. Since the answer is yes for two, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 354,
            "completion_tokens": 425
        },
        "time_elapsed": 5.194594860076904
    },
    {
        "realidx": "22491528",
        "question": "To determine if composite measures based on process indicators are consistent with short-term outcome indicators in surgical colorectal cancer care.\nLongitudinal analysis of consistency between composite measures based on process indicators and outcome indicators for 85 Dutch hospitals.\nThe Dutch Surgical Colorectal Audit database, the Netherlands.\n4732 elective patients with colon carcinoma and 2239 with rectum carcinoma treated in 85 hospitals were included in the analyses.\nAll available process indicators were aggregated into five different composite measures. The association of the different composite measures with risk-adjusted postoperative mortality and morbidity was analysed at the patient and hospital level.\nAt the patient level, only one of the composite measures was negatively associated with morbidity for rectum carcinoma. At the hospital level, a strong negative association was found between composite measures and hospital mortality and morbidity rates for rectum carcinoma (p<0.05), and hospital morbidity rates for colon carcinoma.\nCombining process indicators to evaluate quality of care for surgical patients with colorectal cancer: are scores consistent with short-term outcome?",
        "answer": "maybe",
        "answer_rationale": "For individual patients, a high score on the composite measures based on process indicators is not associated with better short-term outcome. However, at the hospital level, a good score on the composite measures based on process indicators was consistent with more favourable risk-adjusted short-term outcome rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether composite measures based on process indicators are consistent with short-term outcome indicators in surgical colorectal cancer care. The study they mentioned looked at 85 Dutch hospitals and analyzed data from over 4,000 colon and 2,000 rectum carcinoma patients.\n\nThe key points from the study are that at the patient level, only one composite measure was negatively associated with morbidity for rectum carcinoma. But at the hospital level, there was a strong negative association between the composite measures and both mortality and morbidity for rectum carcinoma, and morbidity for colon carcinoma, with p-values less than 0.05. \n\nThe question is whether combining process indicators to evaluate quality of care shows consistency with outcomes. The options are yes, no, maybe. \n\nHmm, the study found that at the hospital level, there was a significant association, which suggests that the composite measures (process indicators) do align with the outcomes (mortality and morbidity). However, at the patient level, it was only one measure for rectum cancer. But the question is about the consistency in general. Since the hospital-level results showed a strong association, which is a common way to assess hospital performance, the answer would lean towards yes. The study's conclusion probably supports that the composite measures are consistent with outcomes, especially at the hospital level which is the focus for quality evaluation. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 307,
            "completion_tokens": 305
        },
        "time_elapsed": 3.62386417388916
    },
    {
        "realidx": "22617083",
        "question": "To examine age-related differences in the relationship between personality and coping strategies in an Australian population of psychiatric inpatients.\nConsenting eligible adults (N=238) from 18-100 years of age consecutively admitted to inpatient psychiatry units were assessed using the SCID I and II, the Coping Orientations to Problems Experienced Scale (COPE), the Brief Psychiatric Rating Scale (BPRS), the Global Assessment of Functioning Scale (GAF), the Social and Occupational Functioning Assessment Scale (SOFAS), the 12 Item Short-Form Heath Survey (SF12), the Sarason Social Support Questionnaire, and the NEO Five Factor Inventory (NEO-FFI) (cognitively impaired, and non-English speaking patients were excluded).\nOlder adults reported less symptomatology than younger patients and younger patients described more personality dysfunction than older patients. As assessed by the COPE, older adults reported lower levels of dysfunctional coping strategies than younger adults. Personality traits, social supports, gender, and age predicted coping strategies, while Axis I diagnosis, education, personality disorder, and symptom severity were not significant predictors of coping strategies.\nDoes age moderate the effect of personality disorder on coping style in psychiatric inpatients?",
        "answer": "yes",
        "answer_rationale": "This study found that influences on coping were multifactorial and moderated by age. These factors have implications for interventions designed to enhance coping strategies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether age moderates the effect of personality disorder on coping style in psychiatric inpatients based on the study described.\n\nFirst, I need to recall what the study found. The key points from the study are:\n\n- Older adults had less symptomatology compared to younger patients.\n- Younger patients had more personality dysfunction than older ones.\n- Older adults used fewer dysfunctional coping strategies according to the COPE.\n- The predictors of coping strategies included personality traits, social supports, gender, and age. \n- Notably, Axis I diagnosis, education, personality disorder, and symptom severity were not significant predictors.\n\nThe question is about moderation. A moderating effect would mean that the relationship between personality disorder and coping style depends on age. In other words, the effect of personality disorder on coping style is different for different age groups.\n\nLooking at the results, the study states that personality disorder was NOT a significant predictor of coping strategies. Since personality disorder itself isn't a significant predictor, even if age interacts with it, the main effect isn't there. If the main effect isn't significant, the interaction (moderation) might not be present either. The study's results don't mention an interaction term between age and personality disorder. They only mention that age, along with other variables, predicted coping strategies. The absence of personality disorder as a predictor suggests that even when considering age, personality disorder doesn't influence coping style. Therefore, age doesn't moderate an effect that isn't there in the first place. \n\nSo the answer should be B) no, because the study found that personality disorder wasn't a significant predictor, so age can't moderate that non-existent effect.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 345,
            "completion_tokens": 349
        },
        "time_elapsed": 4.2156782150268555
    },
    {
        "realidx": "23149821",
        "question": "A higher prevalence of cardiovascular risk factors (CRFs) in HIV-infected patients, together with chronic infection and treatments, has resulted in an increased risk of silent myocardial ischaemia (SMI). The objective of this study was to evaluate whether myocardial SPECT should be used for screening HIV-infected patients with no clinical symptoms of coronary artery disease.\nThe prevalence of SMI detected by myocardial SPECT was determined in 94 HIV-infected patients with a normal clinical cardiovascular examination in relation to anthropomorphic parameters, CRFs, inflammatory and HIV infection status, and treatment.\nCoronary artery disease was detected in nine patients (eight with ischaemia, one with myocardial infarction), corresponding to 9.6 % positivity. All but two of the scintigraphic diagnoses of ischaemia were confirmed by coronarography. Univariate analysis revealed that the overall number of CRFs and the combination of gender and age were associated with a diagnosis of SMI (p<0.05). According to multivariate analysis, the only independent parameter significantly associated with the scintigraphic diagnosis of SMI was the combination of gender and age (p = 0.01). All the positive myocardial SPECT scans were in men older than 52 years with at least two other CRFs. In this subpopulation of 47 patients, the prevalence of SMI detected by myocardial SPECT reached 19.2 %.\nShould HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?",
        "answer": "maybe",
        "answer_rationale": "In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether HIV-infected patients should be screened for silent myocardial ischemia (SMI) using gated myocardial perfusion SPECT. The options are yes, no, or maybe.\n\nFirst, I need to look at the study's findings provided. The study included 94 HIV patients with no clinical symptoms of coronary artery disease. They found that 9.6% had SMI or myocardial infarction. Out of those, most were confirmed by coronarography. The key point here is that the prevalence was 9.6% overall, but in a subgroup of men over 52 with at least two other cardiovascular risk factors (CRFs), the prevalence was 19.2%. \n\nThe study's objective was to evaluate if SPECT should be used for screening. The results show that SMI can be detected in asymptomatic patients, especially in those with higher risk factors. The multivariate analysis pointed to age, gender (being male), and having multiple CRFs as the main factors. \n\nNow, considering screening guidelines. Generally, screening tests are recommended when they can detect a condition early enough to improve outcomes, and when the test is cost-effective and the population has a sufficiently high risk. Here, the overall prevalence is around 10%, but in the high-risk subgroup (older men with multiple CRFs), it's nearly 20%. That's a significant enough rate to consider targeted screening. However, the question is about screening all HIV patients. \n\nThe study's results suggest that SPECT is useful in specific subgroups (older males with multiple CRFs), but not necessarily all HIV patients. The answer options are yes, no, or maybe. Since the study shows that in the general HIV population the prevalence is 9.6%, which might not be high enough for universal screening, but in a subset it's higher, the appropriate answer might be \"maybe\" because it depends on the patient's age, gender, and CRF count. The question is whether to screen all HIV patients. Since the study's conclusion points to using it in those with higher risk factors, the correct answer would be \"maybe\" (C), as it's not recommended for everyone but only certain high-risk individuals. The options don't specify \"only in high-risk subgroups,\" so \"maybe\" is the best fit here.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 413,
            "completion_tokens": 494
        },
        "time_elapsed": 5.8245744705200195
    },
    {
        "realidx": "23422012",
        "question": "Vancomycin is the primary treatment for infections caused by methicilin-resistant Staphylococcus aureus (MRSA). The association of vancomycin treatment failures with increased vancomycin minimum inhibitory concentration (MIC) is a well-recognized problem. A number of single-centre studies have identified progressive increases in glycopeptide MICs for S. aureus strains over recent years - a phenomenon known as vancomycin MIC creep. It is unknown if this is a worldwide phenomenon or if it is localized to specific centers.\nThe aim of this study was to evaluate the trend of vancomycin MIC for isolates of MRSA over a 3-year period in a tertiary university hospital in Portugal. MRSA isolates from samples of patients admitted from January 2007 to December 2009 were assessed. Etest method was used to determine the respective vancomycin MIC. Only one isolate per patient was included in the final analysis.\nA total of 93 MRSA isolates were studied. The vancomycin MICs were 0.75, 1, 1.5 and 2 mg/L for 1 (1.1%), 19 (20.4%), 38 (40.9%), 35 (37.6%) isolates, respectively. During the 3 year period, we observed a significant fluctuation in the rate of MRSA with a vancomycin MIC\u2009>\u20091 mg/L (2007: 86.2%; 2008: 93.3%; 2009: 58.8%, p\u2009=\u20090.002). No MRSA isolate presented a MIC\u2009>\u20092 mg/L.\nIs vancomycin MIC creep a worldwide phenomenon?",
        "answer": "no",
        "answer_rationale": "We were unable to find in our institution data compatible to the presence of vancomycin MIC creep during the study period. This phenomenon seems not to be generalized; as a result each institution should systematically monitor MRSA vancomycin MIC over time.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vancomycin MIC creep is a worldwide phenomenon based on the provided study.\n\nFirst, I need to recall what the passage says. The study was conducted in a tertiary university hospital in Portugal over three years. They found fluctuations in the vancomycin MIC values, with most isolates having MICs of 1 mg/L or higher, but none above 2 mg/L. The key point here is that the study observed a significant fluctuation in MICs over the three years, which they refer to as MIC creep. However, the passage also mentions that it's unknown if this is a worldwide issue or limited to specific centers. \n\nThe question is asking if MIC creep is indeed a global phenomenon. The options are yes, no, or maybe. The study itself is from one hospital in Portugal. The introduction did state that other single-center studies have shown increases in MICs, but the current study's results don't confirm if this is happening everywhere. The conclusion of the study here shows that in their specific case, there was fluctuation, but the global aspect isn't addressed here. The answer should be \"maybe\" because the study's data is from one location, and the question's options require a conclusion based on the given information. The passage explicitly says it's unknown if it's worldwide, so the correct answer would be C) maybe.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 472,
            "completion_tokens": 290
        },
        "time_elapsed": 3.4859719276428223
    },
    {
        "realidx": "23497210",
        "question": "Although record linkage of routinely collected health datasets is a valuable research resource, most datasets are established for administrative purposes and not for health outcomes research. In order for meaningful results to be extrapolated to specific populations, the limitations of the data and linkage methodology need to be investigated and clarified. It is the objective of this study to investigate the differences in ascertainment which may arise between a hospital admission dataset and a dispensing claims dataset, using major depression in pregnancy as an example. The safe use of antidepressants in pregnancy is an ongoing issue for clinicians with around 10% of pregnant women suffer from depression. As the birth admission will be the first admission to hospital during their pregnancy for most women, their use of antidepressants, or their depressive condition, may not be revealed to the attending hospital clinicians. This may result in adverse outcomes for the mother and infant.\nPopulation-based de-identified data were provided from the Western Australian Data Linkage System linking the administrative health records of women with a delivery to related records from the Midwives' Notification System, the Hospital Morbidity Data System and the national Pharmaceutical Benefits Scheme dataset. The women with depression during their pregnancy were ascertained in two ways: women with dispensing records relating to dispensed antidepressant medicines with an WHO ATC code to the 3rd level, pharmacological subgroup, 'N06A Antidepressants'; and, women with any hospital admission during pregnancy, including the birth admission, if a comorbidity was recorded relating to depression.\nFrom 2002 to 2005, there were 96698 births in WA. At least one antidepressant was dispensed to 4485 (4.6%) pregnant women. There were 3010 (3.1%) women with a comorbidity related to depression recorded on their delivery admission, or other admission to hospital during pregnancy. There were a total of 7495 pregnancies identified by either set of records. Using data linkage, we determined that these records represented 6596 individual pregnancies. Only 899 pregnancies were found in both groups (13.6% of all cases). 80% of women dispensed an antidepressant did not have depression recorded as a comorbidity on their hospital records. A simple capture-recapture calculation suggests the prevalence of depression in this population of pregnant women to be around 16%.\nAre women with major depression in pregnancy identifiable in population health data?",
        "answer": "no",
        "answer_rationale": "No single data source is likely to provide a complete health profile for an individual. For women with depression in pregnancy and dispensed antidepressants, the hospital admission data do not adequately capture all cases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether women with major depression during pregnancy are identifiable in population health data. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study used two datasets: one from dispensing claims (antidepressants) and another from hospital admissions where depression was recorded as a comorbidity. \n\nThe key points from the study are:\n- 4.6% (4485) of pregnant women had antidepressants dispensed.\n- 3.1% (3010) had depression recorded in hospital records.\n- Combining both datasets gave 7495 pregnancies, but after linkage, they found 6596 unique pregnancies. Only 13.6% (899) were in both groups.\n- 80% of those who got antidepressants didn't have depression noted in their hospital records.\n- The capture-recapture estimate suggests a 16% prevalence, which is higher than either dataset alone.\n\nThe question is whether they are identifiable. The study shows that using both datasets captures more cases than either alone, but there's a significant discrepancy. However, the fact that they can identify some cases through each method and combine them suggests that it's possible to identify them, albeit with limitations. The answer might be \"yes\" because they can be identified through at least one of the datasets, even if not all cases are captured in both. The study's purpose was to investigate differences, but the conclusion implies that using both sources gives a better picture, so they are identifiable to some extent. The options don't ask if all cases are captured, just if they are identifiable. Since the data allows identification through either method, the answer is A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 597,
            "completion_tokens": 371
        },
        "time_elapsed": 4.855048418045044
    },
    {
        "realidx": "23690198",
        "question": "Social and cultural factors combined with little information may prevent the diffusion of epidural analgesia for pain relief during childbirth. The present study was launched contemporarily to the implementation of analgesia for labor in our Department in order to perform a 2 years audit on its use. The goal is to evaluate the epidural acceptance and penetration into hospital practice by women and care givers and safety and efficacy during childbirth.\nThis audit cycle measured epidural analgesia performance against 4 standards: (1) Implementation of epidural analgesia for labor to all patients; (2) Acceptance and good satisfaction level reported by patients and caregivers. (3) Effectiveness of labor analgesia; (4) No maternal or fetal side effects.\nDuring the audit period epidural analgesia increased from 15.5% of all labors in the first trimester of the study to 51% in the last trimester (p<0.005). Satisfaction levels reported by patients and care givers were good. A hierarchical clustering analysis identified two clusters based on VAS (Visual Analogue Scale) time course: in 226 patients (cluster 1) VAS decreased from 8.5\u00b11.4 before to 4.1\u00b11.3 after epidural analgesia; in 1002 patients (cluster 2) VAS decreased from 8.12\u00b11.7 before (NS vs cluster 1), to 0.76\u00b10.79 after (p<0.001 vs before and vs cluster 2 after). No other differences between clusters were observed.\nImplementation of epidural analgesia for labor: is the standard of effective analgesia reachable in all women?",
        "answer": "yes",
        "answer_rationale": "Present audit shows that the process of implementation of labor analgesia was quick, successful and safe, notwithstanding the identification of one cluster of women with suboptimal response to epidural analgesia that need to be further studies, overall pregnant womens'adhesion to labor analgesia was satisfactory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the standard of effective analgesia with epidural is reachable in all women based on the study provided.\n\nFirst, I need to look at the study's results. The audit showed that epidural use increased from 15.5% to 51% over two years. That's a significant jump, but it's still not 100%. The question is about whether the standard of effective analgesia is reachable for all women. \n\nThe study mentions four standards. The first is implementing epidural to all patients. But even after the audit period, only 51% used it. So they didn't reach 100%, which suggests that maybe it's not achievable for everyone. \n\nLooking at the other points: satisfaction was good, effectiveness was there (VAS scores dropped a lot in both clusters), and no side effects. But the key here is the first standard: implementing to all. Since they only got to 51%, maybe there are still barriers. The question's first sentence also mentions social and cultural factors and lack of information preventing diffusion. Even after the audit, those factors might still exist, so not everyone might accept it. \n\nThe clusters show that in cluster 1, VAS went down to 4.1, which is still moderate pain, while cluster 2 had almost no pain. So maybe some women aren't getting as effective relief, but the question is about whether the standard is reachable for all. The study's results don't show 100% implementation, so the answer might be no. \n\nThe options are yes, no, maybe. Since the study's data shows they didn't reach 100% even after improvement, and there are mentioned factors preventing it, the answer is probably B) no. The question is whether the standard is \"reachable in all women,\" and the data suggests it's not yet achievable.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 454,
            "completion_tokens": 404
        },
        "time_elapsed": 4.977807521820068
    },
    {
        "realidx": "24139705",
        "question": "Each patient received a smartphone with an insulin dose advisor (IDA) and with (G3 group) or without (G2 group) the telemonitoring/teleconsultation function. Patients were classified as \"high users\" if the proportion of \"informed\" meals using the IDA exceeded 67% (median) and as \"low users\" if not. Also analyzed was the respective impact of the IDA function and teleconsultations on the final HbA1c levels.\nAmong the high users, the proportion of informed meals remained stable from baseline to the end of the study 6months later (from 78.1\u00b121.5% to 73.8\u00b125.1%; P=0.107), but decreased in the low users (from 36.6\u00b129.4% to 26.7\u00b128.4%; P=0.005). As expected, HbA1c improved in high users from 8.7% [range: 8.3-9.2%] to 8.2% [range: 7.8-8.7%]in patients with (n=26) vs without (n=30) the benefit of telemonitoring/teleconsultation (-0.49\u00b10.60% vs -0.52\u00b10.73%, respectively; P=0.879). However, although HbA1c also improved in low users from 9.0% [8.5-10.1] to 8.5% [7.9-9.6], those receiving support via teleconsultation tended to show greater improvement than the others (-0.93\u00b10.97 vs -0.46\u00b11.05, respectively; P=0.084).\nTelemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?",
        "answer": "yes",
        "answer_rationale": "The Diabeo system improved glycaemic control in both high and low users who avidly used the IDA function, while the greatest improvement was seen in the low users who had the motivational support of teleconsultations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether telemedicine helps improve glycemic control in type 1 diabetes patients using an insulin dose advisor (IDA). The groups are G2 (without telemonitoring/teleconsultation) and G3 (with it). They split patients into high and low users based on how often they used the IDA.\n\nFirst, looking at high users: their HbA1c improved, but the difference between those with and without teleconsultation wasn't significant (P=0.879). So telemedicine didn't make a difference here. But for low users, those with teleconsultation had a bigger improvement (-0.93 vs -0.46), though the p-value was 0.084, which is trending towards significance but not quite there. \n\nThe question is asking if telemedicine alone is sufficient. The high users didn't benefit more from having telemedicine, suggesting that just having the tech (IDA) might be enough for them. But low users might need the extra support, but the result wasn't significant. Since the question is whether technology (presumably the IDA) is sufficient, the answer might be yes for high users, but the study's main point is whether telemedicine (the added feature) is needed. Since in high users, telemedicine didn't add benefit, maybe the IDA alone is sufficient. But the question is phrased as \"is technology per se sufficient\"\u2014so the IDA is the base tech. The telemedicine part (added in G3) didn't make a difference in high users, so maybe the answer is yes. But wait, the low users had better improvement with telemedicine, but it's not significant. The question is whether the technology (IDA) alone is enough. Since high users had improvement without needing telemedicine, maybe the answer is yes. But the study's conclusion might be that telemedicine isn't necessary if they use the IDA properly. So the answer would be (A) yes. But wait, the options are (A) yes, (B) no, (C) maybe. The study shows that in high users, the HbA1c improved regardless of telemedicine, so the technology (IDA) alone works. But for low users, maybe telemedicine helps but not enough. The question is whether technology (IDA) per se is sufficient. Since high users did well with just the IDA, the answer would be yes.",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 508,
            "completion_tokens": 512
        },
        "time_elapsed": 5.687179803848267
    },
    {
        "realidx": "24318956",
        "question": "Digoxin is a commonly used medication for heart failure and cardiac arrhythmias that has recently been suggested as a novel chemotherapeutic agent. Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with digoxin. We explore the relationship between use of digoxin and PCa risk.\nData from a population-based case-control study of incident cases aged 35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were available. Controls were identified by random digit dialing and frequency matched by age. Use of digoxin was determined from in-person questionnaires regarding medical and prescription history. The relationship of digoxin use with PCa risk was evaluated with logistic regression.\nOne thousand one cases of PCa and 942 controls were analyzed. The prevalence of digoxin use in controls was 2.7%, and use was positively correlated with age. In multivariate analysis adjusting for age, race, PSA screening, and family history of PCa, digoxin use was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 0.30-1.10). Among those with \u22653 PSA tests over the preceding 5 years (546 cases, 380 controls), digoxin use was associated with a stronger reduction of PCa risk (OR 0.44, 95% CI: 0.20-0.98).\nIs digoxin use for cardiovascular disease associated with risk of prostate cancer?",
        "answer": "yes",
        "answer_rationale": "These data indicate digoxin use may be associated with a reduction in risk of PCa. Given the potential mechanisms by which digoxin may exert an anti-neoplastic effect and other recent studies showing a negative association between digoxin use and PCa, further research is warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether digoxin use for cardiovascular disease is associated with the risk of prostate cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided study details. The study is a case-control study looking at incident prostate cancer cases and controls. They assessed digoxin use through questionnaires. The key results are the odds ratios (OR) from the logistic regression. \n\nIn the overall analysis, the OR was 0.58 with a 95% CI of 0.30-1.10. Wait, the confidence interval here includes 1 (since 1.10 is the upper limit), which means the result isn't statistically significant. That would suggest no significant association. But then, in the subgroup with more PSA tests (\u22653 in 5 years), the OR was 0.44 with CI 0.20-0.98. This CI doesn't include 1, so that's a statistically significant reduction in risk. \n\nThe question is about the association. The main analysis didn't reach significance, but the subgroup did. The answer options are yes, no, maybe. The question is phrased generally, so do we go with the overall result or the subgroup? The study's conclusion might lean towards an association because the subgroup is significant, but the overall isn't. However, the question is whether it's associated. Since the subgroup shows a reduction, but the overall isn't significant, maybe the answer is \"maybe\" (C). But wait, the options are (A) yes, (B) no, (C) maybe. The study's main result is OR 0.58 (not significant), but the subgroup is significant. The question is about the association in general. Since the main analysis isn't significant, but there's a trend, and a significant subgroup, the answer might be \"maybe\" because the evidence isn't conclusive. Alternatively, the question might be looking at the subgroup's result. Wait, the question says \"digoxin use for cardiovascular disease associated with risk of prostate cancer?\" The study's main finding is that in adjusted analysis, there's a trend towards reduced risk, but not significant. However, in the subgroup with more PSA screening, it's significant. But PSA screening could be a confounder. The study adjusted for PSA screening, so maybe the subgroup is more reliable. But the question is about the",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 426,
            "completion_tokens": 512
        },
        "time_elapsed": 6.435228586196899
    },
    {
        "realidx": "24336869",
        "question": "The 'law of spatiotemporal concentrations of events' introduced major preventative shifts in policing communities. 'Hotspots' are at the forefront of these developments yet somewhat understudied in emergency medicine. Furthermore, little is known about interagency 'data-crossover', despite some developments through the Cardiff Model. Can police-ED interagency data-sharing be used to reduce community-violence using a hotspots methodology?\n12-month (2012) descriptive study and analysis of spatiotemporal clusters of police and emergency calls for service using hotspots methodology and assessing the degree of incident overlap. 3775 violent crime incidents and 775 assault incidents analysed using spatiotemporal clustering with k-means++ algorithm and Spearman's rho.\nSpatiotemporal location of calls for services to the police and the ambulance service are equally highly concentrated in a small number of geographical areas, primarily within intra-agency hotspots (33% and 53%, respectively) but across agencies' hotspots as well (25% and 15%, respectively). Datasets are statistically correlated with one another at the 0.57 and 0.34 levels, with 50% overlap when adjusted for the number of hotspots. At least one in every two police hotspots does not have an ambulance hotspot overlapping with it, suggesting half of assault spatiotemporal concentrations are unknown to the police. Data further suggest that more severely injured patients, as estimated by transfer to hospital, tend to be injured in the places with the highest number of police-recorded crimes.\nCan routinely collected ambulance data about assaults contribute to reduction in community violence?",
        "answer": "maybe",
        "answer_rationale": "A hotspots approach to sharing data circumvents the problem of disclosing person-identifiable data between different agencies. Practically, at least half of ambulance hotspots are unknown to the police; if causal, it suggests that data sharing leads to both reduced community violence by way of prevention (such as through anticipatory patrols or problem-oriented policing), particularly of more severe assaults, and improved efficiency of resource deployment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether routinely collected ambulance data about assaults can contribute to reducing community violence. The study mentioned in the question analyzed both police and ambulance data using hotspots methodology.\n\nFirst, the key findings from the study: There's a significant overlap in the hotspots between police and ambulance calls. The Spearman's rho values of 0.57 and 0.34 indicate a moderate to strong correlation between the two datasets. Also, 50% overlap when adjusted. But importantly, about half of the police hotspots don't have overlapping ambulance hotspots, meaning some assault concentrations are unknown to the police. However, the study also notes that more severely injured patients (who are likely to be hospitalized) are in areas with high crime. \n\nSo, if ambulance data can identify areas where severe assaults occur that the police might not be fully aware of, then sharing that data could help target interventions. The question is whether this can contribute to reducing violence. Since the data shows correlation and some unique info from ambulance data, it suggests that integrating ambulance data could help police focus their efforts more effectively on these hotspots. The options are yes, no, maybe. The study's results support that ambulance data does provide useful info, so the answer should be yes (A). The \"maybe\" might be tempting if there's uncertainty, but the study's findings seem to indicate a positive contribution.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 434,
            "completion_tokens": 296
        },
        "time_elapsed": 3.7442378997802734
    },
    {
        "realidx": "24352924",
        "question": "The purpose of this study was to investigate the efficacy of ultrasonography to confirm Schanz pin placement in a cadaveric model, and the interobserver repeatability of the ultrasound methodology.\nThis investigation is a repeated measures cadaveric study with multiple examiners.\nCadaveric preparation and observations were done by an orthopaedic traumatologist and resident, and two general surgery traumatologists.\nA total of 16 Schanz pins were equally placed in bilateral femora and tibiae. Four examiners took measurements of pin protrusion beyond the distal cortices using first ultrasonography and then by direct measurement after gross dissection.MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length measurements from both ultrasonography and direct measurement post dissection.\nSchanz pin protrusion measurements are underestimated by ultrasonography (p<0.01) by an average of 10 percent over the range of 5 to 18 mm, and they display a proportional bias that increases the under reporting as the magnitude of pin protrusion increases. Ultrasound data demonstrate good linear correlation and closely represent actual protrusion values in the 5 to 12 mm range. Interobserver repeatability analysis demonstrated that all examiners were not statistically different in their measurements despite minimal familiarity with the ultrasound methodology (p>0.8).\nIs portable ultrasonography accurate in the evaluation of Schanz pin placement during extremity fracture fixation in austere environments?",
        "answer": "yes",
        "answer_rationale": "Despite the statistical imparity of pin protrusion measurement via ultrasound compared to that of gross dissection, a consideration of the clinical relevance of ultrasound measurement bias during an austere operating theatre leads to the conclusion that ultrasonography is an adequate methodology for Schanz pin protrusion measurement.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is about using ultrasonography to check Schanz pin placement in a cadaver model. The main outcome was comparing ultrasound measurements to the actual measurements after dissection.\n\nThe results say that ultrasound underestimates the protrusion by 10% on average, especially more as the protrusion gets bigger. But there's a good linear correlation, and it's close in the 5-12mm range. Also, the interobserver repeatability was good since all examers weren't statistically different, even with little experience.\n\nThe question is whether portable ultrasound is accurate in austere settings. The key here is the definition of \"accurate.\" The study shows underestimation, which is a systematic error. Even though there's a proportional bias and underreporting, especially beyond 12mm, the correlation is good in some ranges. However, underestimation by 10% might be clinically significant, especially if precise measurements are needed. The repeatability is good, but accuracy (compared to the true value) is off. So maybe the answer is no because it's not accurate enough, but the options are yes, no, maybe. The study says \"underestimated\" which suggests inaccuracy. But the question is about accuracy in evaluation. Since it's underestimating, maybe it's not accurate. But the answer options might consider the correlation and repeatability as sufficient for some uses. Wait, the main point is the underestimation. The conclusion says \"underestimated by 10% (p<0.01)\" which is statistically significant. So the answer would be B) no, because it's not accurate. But the study also says in 5-12mm it's close. Maybe in some cases it's okay, but the question is general. The study's conclusion would probably say it's not accurate enough, so the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 390,
            "completion_tokens": 403
        },
        "time_elapsed": 5.062529563903809
    },
    {
        "realidx": "24359102",
        "question": "Skin diseases are the most frequently recognized occupational diseases in Denmark. The prognosis for occupational contact dermatitis is often poor.\nTo investigate the prognosis, assessed by eczema, job status and skin-related quality of life, among patients allergic to rubber chemicals and latex (ubiquitous allergens) and epoxy (nonubiquitous allergen), 2\u00a0years after recognition of occupational allergic contact dermatitis.\nFrom a cohort of all patients recognized as having occupational dermatitis by the Danish National Board of Industrial Injuries in 2010, 199 patients with relevant rubber allergy (contact allergy to rubber chemicals or contact urticaria from latex) or epoxy allergy were identified. Follow-up consisted of a questionnaire covering current severity of eczema, employment, exposure and quality of life.\nThe response rate was 75%. Clearance of eczema was reported by 11% of patients and 67% reported improvement. Overall 22% of patients with allergy to a nonubiquitous allergen had total clearance of eczema compared with 10% of cases allergic to ubiquitous allergens and 0% of those with contact urticaria (P\u00a0=\u00a00\u00b7116). Improvement was significantly more frequent in those who had changed jobs compared with those who had not (P\u00a0=\u00a00\u00b701).\nTwo-year follow-up survey of patients with allergic contact dermatitis from an occupational cohort: is the prognosis dependent on the omnipresence of the allergen?",
        "answer": "yes",
        "answer_rationale": "At follow-up, patients with contact urticaria had significantly poorer prognosis than those with contact allergy, and there was a trend towards a poorer prognosis for those with contact allergy to rubber chemicals than those with allergy to epoxy. A significant positive association between job change and improvement was found.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the prognosis for occupational contact dermatitis depends on whether the allergen is ubiquitous or not. The study mentioned compared patients allergic to rubber chemicals/latex (which are ubiquitous) and epoxy (nonubiquitous). \n\nLooking at the results: 22% of nonubiquitous (epoxy) had clearance vs 10% of ubiquitous and 0% for contact urticaria. But the P-value was 0.116, which is higher than 0.05, so not statistically significant. However, improvement was significant when they changed jobs. \n\nThe question is about the omnipresence affecting prognosis. Since the clearance rates between groups didn't reach statistical significance (P=0.116), the answer would be that there's no significant difference, so the prognosis isn't dependent. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 195
        },
        "time_elapsed": 5.544045686721802
    },
    {
        "realidx": "24449622",
        "question": "This study aimed to show the relationship between serum paraoxonase 1 level and the epicardial fat tissue thickness.\nTwo hundred and seven patients without any atherosclerotic disease history were included in this cross-sectional observational study. Correlation analysis was performed to determine the correlation between epicardial fat tissue thickness, which was measured by echocardiography and serum paraoxonase 1 level. Also correlation analysis was performed to show correlation between patients' clinical and laboratory findings and the level of serum paraoxonase 1 (PON 1) and the epicardial fat tissue thickness. Pearson and Spearman test were used for correlation analysis.\nNo linear correlation between epicardial fat tissue thickness and serum PON 1 found (correlation coefficient: -0.127, p=0.069). When epicardial fat tissue thickness were grouped as 7 mm and over, and below, and 5 mm and over, and below, serum PON 1 level were significantly lower in \u22657 mm group (PON1 : 168.9 U/L) than<7 mm group (PON 1: 253.9 U/L) (p<0.001). Also hypertension prevalence was increased in \u22657 mm group (p=0.001). Serum triglyceride was found to be higher in \u22657 mm group (p=0.014), body mass index was found higher in \u22655 mm group (p=0.006).\nIs there a relationship between serum paraoxonase level and epicardial fat tissue thickness?",
        "answer": "no",
        "answer_rationale": "Serum PON 1 level is not correlated with the epicardial fat tissue thickness. But PON 1 level is lower in patients with epicardial fat tissue thickness 7 mm and over. Therefore, increased atherosclerosis progression can be found among patients with 7 mm and higher epicardial fat tissue thickness.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at the relationship between serum paraoxonase 1 (PON1) levels and epicardial fat tissue thickness. The key here is to understand the results presented.\n\nFirst, the question is whether there's a relationship between PON1 and epicardial fat thickness. The study mentions that a correlation analysis using Pearson and Spearman tests found no linear correlation. The correlation coefficient was -0.127 with a p-value of 0.069. Since the p-value is greater than 0.05, that's not statistically significant. So, on a linear scale, there's no significant correlation.\n\nBut then, when they grouped the epicardial fat into categories (like \u22657mm and <7mm), they found that the PON1 levels were significantly lower in the \u22657mm group (168.9 U/L vs 253.9 U/L, p<0.001). That's a notable difference. So even though the linear correlation wasn't significant, the grouped analysis shows a significant difference. \n\nHmm, so the question is asking if there's a relationship. The linear correlation didn't show it, but the grouped analysis did. The answer might depend on how the question is phrased. The options are yes, no, maybe. The study's main result (the linear correlation) says no, but the subgroup analysis says yes. Since the question is general, maybe the correct answer is yes because there is an association when considering thresholds. But the first part says no linear correlation. Wait, the question is whether there's a relationship. The presence of a significant difference between groups suggests that there is a relationship, even if it's not linear. For example, maybe it's a non-linear relationship. The correlation coefficient being -0.127 is a weak negative correlation, but not statistically significant. However, when they split into groups, the means are different. So the answer might be yes because there is an association when considering the groups. The study's conclusion would probably state that while there's no linear correlation, there is a significant difference in PON1 levels when epicardial fat exceeds 7mm. Therefore, the answer is yes. The options are A, B, C. The question is whether there's a relationship. The correct answer is A (yes) because the grouped analysis shows a significant difference, indicating a relationship exists, even if the linear",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 430,
            "completion_tokens": 512
        },
        "time_elapsed": 6.041177034378052
    },
    {
        "realidx": "24495711",
        "question": "More than 50,000 new HIV infections occur annually in the United States. Injection drug users represent twelve percent of incident HIV infections each year. Pharmacy sales of over-the-counter (OTC) syringes have helped prevent HIV transmission among injection drug users in many states throughout the United States. However, concerns exist among some law enforcement officials, policymakers, pharmacists, and community members about potential links between OTC syringe sales and crime.\nWe used a geographic information system and novel spatial and longitudinal analyses to determine whether implementation of pharmacy-based OTC syringe sales were associated with reported crime between January 2006 and December 2008 in Los Angeles Police Department Reporting Districts. We assessed reported crime pre- and post-OTC syringe sales initiation as well as longitudinal associations between crime and OTC syringe-selling pharmacies.\nBy December 2008, 9.3% (94/1010) of Los Angeles Police Department Reporting Districts had at least one OTC syringe-selling pharmacy. Overall reported crime counts and reported crime rates decreased between 2006 and 2008 in all 1010 Reporting Districts. Using generalized estimating equations and adjusting for potential confounders, reported crime rates were negatively associated with OTC syringe sales (adjusted rate ratio: 0.89; 95% confidence interval: 0.81, 0.99).\nIs crime associated with over-the-counter pharmacy syringe sales?",
        "answer": "yes",
        "answer_rationale": "Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether crime is associated with over-the-counter (OTC) pharmacy syringe sales. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentioned used a geographic information system and spatial analyses to see if OTC syringe sales in pharmacies were linked to crime in Los Angeles between 2006 and 2008. The key points here are the results they found. \n\nThe study states that by December 2008, about 9.3% of the reporting districts had these pharmacies. Overall crime counts and rates decreased in all districts during that period. The important part is the adjusted rate ratio from the statistical analysis: 0.89 with a 95% confidence interval of 0.81 to 0.99. \n\nNow, interpreting that rate ratio. A rate ratio less than 1 suggests a negative association. Since the adjusted rate ratio is 0.89, that means areas with OTC syringe sales had lower crime rates compared to those without, after adjusting for other factors. The confidence interval includes values all below 1 (down to 0.81), which means the association is statistically significant at the 5% level because the interval doesn't cross 1. \n\nThe question is whether crime is associated with OTC sales. The study found a negative association\u2014so higher OTC sales are linked with lower crime. Therefore, the answer would be that there's no positive association. The options are yes, no, maybe. Since the study shows a negative link, the correct answer is B) no. Because the association is negative, meaning OTC sales are not associated with increased crime; instead, they might be linked to lower crime. So the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 404,
            "completion_tokens": 385
        },
        "time_elapsed": 4.66202449798584
    },
    {
        "realidx": "24591144",
        "question": "To determine if elderly patients with oropharyngeal squamous cell carcinoma (OPSCC) are receiving less treatment and to evaluate the benefit of aggressive therapy in this population.\nRetrospective analysis of a large population database.\nPatients in the Surveillance, Epidemiology, and End Results database with OPSCC diagnosed from 2004 to 2009 were included. The patients were categorized into age groups 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 years and older, then further categorized by treatment status. Kaplan-Meier analysis of disease-specific survival (DSS) for late-stage (III and IV) OPSCC was performed for all age and treatment categories, followed by a multivariate cox regression of treatment status, tumor site, race, stage, and sex per age group.\nA total of 14,909 patients with OPSCC were identified. In our demographic data, we observed a significant increase in the number of patients who did not receive treatment (surgery, radiation, or combined therapy) after age 55. Kaplan-Meier analysis showed that age groups 65 to 74 and 75 to 84 had substantial benefits in DSS with surgery, radiation, or combined therapy. Multivariable analysis did not demonstrate any statistically significant difference in the hazard ratios for combined treatment among age groups 45 to 54, 55 to 64, 65 to 74, and 75 to 84.\nAre the elderly with oropharyngeal carcinoma undertreated?",
        "answer": "maybe",
        "answer_rationale": "Proportionally fewer elderly patients with OPSCC are being treated than younger individuals. These patients can have significant benefits from aggressive treatments despite their older age as shown by our survival analysis. We recommend the use of objective measures to assess patient fitness to reduce the potential for undertreatment in the elderly population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether elderly patients with oropharyngeal carcinoma are undertreated based on the study described.\n\nFirst, I need to parse the information given. The study looked at patients from the SEER database diagnosed between 2004-2009. They were divided into age groups, and treatment status was categorized. The key findings mentioned are that after age 55, there's a significant increase in patients not receiving treatment (surgery, radiation, or combined). The Kaplan-Meier analysis showed that the 65-74 and 75-84 groups had better disease-specific survival when they did get treatment. The multivariate analysis didn't find a difference in hazard ratios for combined treatment across the age groups except maybe the oldest (85+ isn't mentioned here). \n\nThe question is whether the elderly are undertreated. The data shows that starting at 55, more patients aren't getting treatment. Since the survival benefits exist even in older groups, the fact that treatment rates drop off suggests that perhaps they are undertreated. The study's results indicate that treatment is beneficial even in the older age groups, so not giving treatment could be undertreatment. The answer should be yes (A). But wait, the multivariate analysis didn't show a difference in hazard ratios for treatment effect between age groups. That means the benefit of treatment is similar across ages, so the decision not to treat the elderly despite similar benefits would support undertreatment. So yes, the elderly are undertreated because they receive less treatment even though the treatment is beneficial. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 441,
            "completion_tokens": 340
        },
        "time_elapsed": 4.292249917984009
    },
    {
        "realidx": "24977765",
        "question": "Concussions are commonly diagnosed in pediatric patients presenting to the emergency department (ED). The primary objective of this study was to evaluate compliance with ED discharge instructions for concussion management.\nA prospective cohort study was conducted from November 2011 to November 2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 pediatric patients per year. Subjects were aged 8 years to 17 years and were discharged from the ED with a diagnosis of concussion. Exclusion criteria included recent (past 3 months) diagnosis of head injury, hospital admission, intracranial injury, skull fracture, suspected nonaccidental trauma, or preexisting neurologic condition. Subjects were administered a baseline survey in the ED and were given standardized discharge instructions for concussion by the treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 weeks after ED visit.\nA total of 150 patients were enrolled. The majority (67%) of concussions were sports related. Among sports-related concussions, soccer (30%), football (11%), lacrosse (8%), and basketball (8%) injuries were most common. More than one third (39%) reported return to play (RTP) on the day of the injury. Physician follow-up was equivalent for sport and nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 0.06; 4 weeks, 29% vs. 8%, p<0.01). Of the patients who did RTP or normal activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most (58%) did not receive medical clearance. Of the patients who had returned to activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, and most (54%) received medical clearance.\nAre pediatric concussion patients compliant with discharge instructions?",
        "answer": "yes",
        "answer_rationale": "Pediatric patients discharged from the ED are mostly compliant with concussion instructions. However, a significant number of patients RTP on the day of injury, while experiencing symptoms or without medical clearance.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pediatric concussion patients are compliant with discharge instructions based on the study provided.\n\nFirst, I need to recall the key points from the study. The study was a prospective cohort looking at compliance with ED discharge instructions for concussions in kids. They enrolled 150 patients. The main things to check are how well the patients followed the instructions, especially regarding return to play (RTP) and medical clearance.\n\nLooking at the data: 39% returned to play on the day of injury. That's a problem because discharge instructions probably advise against immediate activity. Then, at 2 weeks, 44% had returned to activities, but 35% were still symptomatic, and 58% didn't have medical clearance. That's a big issue because they should wait until symptoms resolve and get clearance. At 4 weeks, 64% were back, but even then, 23% were still symptomatic and 54% didn't have clearance. \n\nThe study also mentions that even among those who followed up with physicians (around 58-64% at 2 and 4 weeks), there's still a high percentage not following the medical clearance part. The fact that many returned to play without clearance and while still having symptoms suggests non-compliance. The options are yes, no, maybe. Since the data shows significant non-compliance (like RTP on the same day, not getting clearance), the answer is probably no. The options don't have a \"partially\" but \"no\" is the best fit here.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 525,
            "completion_tokens": 336
        },
        "time_elapsed": 4.284143924713135
    },
    {
        "realidx": "24995509",
        "question": "To investigate the association between age-related macular degeneration (AMD) and the polymorphisms of HIF1A, a major vascular epithelial growth factor regulator under hypoxic conditions. The associations of AMD and polymorphisms of genes CFH, SKIV2L and MYRIP were also studied.\nProspective study.\nEighty-seven AMD patients and 80 healthy subjects admitted to the Department of Ophthalmology at Pamukkale University Hospital, Denizli, Turkey, were included: 45 (52%) had wet type AMD, and 42 (48%) had dry type AMD.\nPolymorphisms rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) were investigated in DNA isolated from peripheral blood samples of the cases and controls by dye-termination DNA sequencing.\nGenotype distribution of rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) in AMD cases and healthy controls; association between genotypes and AMD subtypes.\nGiven the significant difference between the mean age of case and control groups (72.13\u2009\u00b1\u20095.77 vs. 62.80\u2009\u00b1\u20095.22, respectively) (P\u2009=\u2009.000), subsequent analyses were adjusted for age. We found that having at least one C allele for polymorphism rs1061170 increases AMD risk independent of age (OR\u2009=\u20092.42, 95% confidence interval [CI], 1.22-4.81). The ancestral T allele for polymorphism rs1061170 has a protective effect for AMD (OR\u2009=\u20090.53, 95% CI, 0.34-0.83). No statistically significant difference for distributions of other single nucleotide polymorphisms (SNPs) emerged between patients and healthy subjects.\nHIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration?",
        "answer": "maybe",
        "answer_rationale": "No associations appeared between HIF1A SNPs and AMD, which were studied here for the first time; however, polymorphism rs1061170 of the CFH gene is associated with AMD in our population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the polymorphisms of HIF1A are associated with age-related macular degeneration (AMD) based on the provided study.\n\nFirst, I need to recall the details from the study description. The study investigated several genes: CFH, SKIV2L, MYRIP, and HIF1A. Specifically for HIF1A, they looked at the polymorphisms rs11549465 and rs11549467. \n\nThe key results mentioned are that the CFH polymorphism (rs1061170) had a significant association with AMD risk. The OR for having at least one C allele was 2.42, which is statistically significant. Also, the T allele had a protective effect. However, the study states that \"No statistically significant difference for distributions of other single nucleotide polymorphisms (SNPs) emerged between patients and healthy subjects.\" \n\nSince HIF1A's polymorphisms (rs11549465 and rs11549467) are part of \"other SNPs\" mentioned here, that means they didn't show a significant association. The question is specifically about HIF1A's polymorphisms, so the answer would be that there's no association. \n\nThe options are (A) yes, (B) no, (C) maybe. The correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 624,
            "completion_tokens": 313
        },
        "time_elapsed": 4.13426947593689
    },
    {
        "realidx": "25079920",
        "question": "As parents of young children are often unaware their child is overweight, screening provides the opportunity to inform parents and provide the impetus for behaviour change. We aimed to determine if parents could recall and understand the information they received about their overweight child after weight screening.\nRandomised controlled trial of different methods of feedback.\nParticipants were recruited through primary and secondary care but appointments took place at a University research clinic.\n1093 children aged 4-8\u2005years were screened. Only overweight children (n=271, 24.7%) are included in this study. Parents of overweight children were randomised to receive feedback regarding their child's weight using best practice care (BPC) or motivational interviewing (MI) at face-to-face interviews typically lasting 20-40\u2005min. 244 (90%) parents participated in a follow-up interview 2\u2005weeks later to assess recall and understanding of information from the feedback session.\nInterviews were audio-taped and transcribed verbatim before coding for amount and accuracy of recall. Scores were calculated for total recall and sub-categories of interest.\nOverall, 39% of the information was recalled (mean score 6.3 from possible score of 16). Parents given feedback via BPC recalled more than those in the MI group (difference in total score 0.48; 95% CI 0.05 to 0.92). Although 94% of parents were able to correctly recall their child's weight status, fewer than 10 parents could accurately describe what the measurements meant. Maternal education (0.81; 0.25 to 1.37) and parental ratings of how useful they found the information (0.19; 0.04 to 0.35) were significant predictors of recall score in multivariate analyses.\nDo parents recall and understand children's weight status information after BMI screening?",
        "answer": "maybe",
        "answer_rationale": "While parents remember that their child's body mass index is higher than recommended, they are unable to remember much of the information and advice provided about the result.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether parents recall and understand their child's weight status after BMI screening based on the study provided.\n\nFirst, I need to look at the study details. The study was a randomized controlled trial comparing two feedback methods: Best Practice Care (BPC) and Motivational Interviewing (MI). They had 271 overweight children's parents involved. At follow-up two weeks later, 244 parents participated. \n\nThe key results mentioned are that overall, parents recalled 39% of the information, with a mean score of 6.3 out of 16. The BPC group recalled slightly more than the MI group, but the difference wasn't huge. However, 94% correctly recalled their child's weight status. But here's the catch: fewer than 10 parents could accurately describe what the measurements meant. So while they knew the status (like \"overweight\"), they didn't understand the implications or details of those measurements. \n\nThe question is about both recall AND understanding. The recall part seems partially there (since 94% knew the status), but the understanding part is low. The options are yes, no, maybe. The answer hinges on whether \"understand\" is met. Since the study says fewer than 10 (out of 244) could accurately describe the meaning, that's a very low number. So even though they remembered the status, they didn't understand it. Therefore, the answer would be \"no\" because understanding is a key part of the question. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 493,
            "completion_tokens": 355
        },
        "time_elapsed": 4.565286874771118
    },
    {
        "realidx": "25103647",
        "question": "To examine whether government-funded, low-income vision care programs improve use of eye care services by low-income individuals in Canada.\nCross-sectional survey.\n27,375 white respondents to the Canadian Community Health Survey (CCHS) Healthy Aging 2008/2009.\nGovernment-funded, low-income vision care programs were reviewed. The amount of assistance provided was compared with professional fee schedules for general/routine eye examinations and market prices for eyeglasses. The utilization of eye care providers was derived from the CCHS.\nTo receive low-income vision care assistance, individuals must be in receipt of social assistance. Criteria for receiving social assistance are stringent. The Canadian Financial Capability Survey revealed that 7.9% of Canadians aged 45 to 64 years and 5.5% aged \u226565 years received social assistance in 2009. The CCHS found in 2008/2009 that 12.5% of citizens aged 45 to 64 years and 13.2% of those aged \u226565 years had difficulty paying for basic expenses such as food. In 5 provinces, low-income vision care assistance fully covers a general/routine eye examination. In the remainder, the assistance provided is insufficient for a general/routine eye examination. The assistance for eyeglasses is inadequate in 5 provinces, requiring out-of-pocket copayments. Among middle-aged whites who self-reported not having glaucoma, cataracts, diabetes, or vision problems not corrected by lenses, utilization of eye care providers was 28.1% among those with financial difficulty versus 41.9% among those without (p<0.05), giving a prevalence ratio 0.68 (95% CI 0.57-0.80) adjusted for age, sex and education.\nDoes government assistance improve utilization of eye care services by low-income individuals?",
        "answer": "maybe",
        "answer_rationale": "Despite government assistance, low-income individuals use vision care services less often than wealthy individuals.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether government-funded low-income vision care programs in Canada actually improve the use of eye care services among low-income individuals. The options are yes, no, or maybe.\n\nFirst, I need to understand the study's setup. It's a cross-sectional survey with over 27,000 white respondents from the Canadian Community Health Survey (CCHS) from 2008/2009. The key points here are the comparison between those who receive social assistance and those who don't, and how that relates to their ability to access eye care.\n\nThe study mentions that to get the vision care assistance, you have to be on social assistance, which has strict criteria. The data shows that only around 5-8% of the older age groups are on social assistance, but a higher percentage (12.5-13.2%) had trouble paying for basics like food. That might indicate that even those not on social assistance are still struggling financially but don't qualify for the programs.\n\nNow, looking at the provinces: in five provinces, the assistance fully covers an eye exam, but in others, it's not enough. For eyeglasses, five provinces require copayments. So coverage varies by province.\n\nThe key result is that among middle-aged individuals without certain conditions, those with financial difficulty had a 28.1% utilization rate versus 41.9% without difficulty. The adjusted prevalence ratio is 0.68, which is a significant difference (p<0.05). That suggests that people with financial issues are less likely to use eye care services. But the question is whether government assistance helps. \n\nWait, the study's data shows that even with the assistance, in some provinces it's insufficient. The ones who are on social assistance (and thus eligible for the programs) might still not be using the services because the assistance isn't enough. The prevalence ratio is comparing those with financial difficulty (who may or may not be on assistance) versus those without. The lower utilization in the financial difficulty group could mean that even with the programs, they still can't access care because the assistance isn't sufficient. For example, in provinces where the assistance doesn't cover the full cost, people still have to pay out of pocket, which they can't afford. So the programs might not be effective where coverage is partial. \n\nThe study's conclusion seems to suggest that financial difficulty is associated with lower utilization",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 494,
            "completion_tokens": 512
        },
        "time_elapsed": 5.918761491775513
    },
    {
        "realidx": "25277731",
        "question": "Sternal fractures in childhood are rare. The aim of the study was to investigate the accident mechanism, the detection of radiological and sonographical criteria and consideration of associated injuries.\nIn the period from January 2010 to December 2012 all inpatients and outpatients with sternal fractures were recorded according to the documentation.\nA total of 4 children aged 5-14\u00a0years with a sternal fracture were treated in 2\u00a0years, 2\u00a0children were hospitalized for pain management and 2 remained in outpatient care.\nSternal fracture in growing children : A rare and often overlooked fracture?",
        "answer": "maybe",
        "answer_rationale": "Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether sternal fractures in growing children are considered a rare and often overlooked fracture. The options are yes, no, maybe.\n\nFirst, I need to look at the information provided in the question. The study mentions that sternal fractures in childhood are rare. They looked at a two-year period and found only four cases among children aged 5-14. That's a pretty small number, which supports the idea of rarity. \n\nThe question also mentions the study's aim was to investigate accident mechanisms, radiological and sonographical criteria, and associated injuries. The fact that they had to specifically record these cases over two years and only found four suggests that it's not a common injury. Additionally, two of the children were hospitalized, and two were outpatients, but the key point here is the rarity.\n\nThe options are about whether it's rare and often overlooked. The first part of the question statement already says sternal fractures in childhood are rare, so the answer probably aligns with that. The study's findings back up the rarity. The term \"overlooked\" might refer to whether they are misseddiagnoses. The study might be highlighting that because they're rare, doctors might not think to check for them, hence they are overlooked. The fact that they had to do this study to investigate criteria for detection could imply that there's a need for better recognition, meaning they are indeed often overlooked.\n\nSo putting it together, the answer should be yes (A), because the question is phrased as a statement that's being confirmed by the options. The study's existence to look into this suggests that it's a rare and possibly underdiagnosed condition.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 218,
            "completion_tokens": 355
        },
        "time_elapsed": 5.146842956542969
    },
    {
        "realidx": "25371231",
        "question": "The aetiology of osteochondritis dissecans is still unclear. The aim of this prospective pilot study was to analyse whether vitamin D insufficiency, or deficiency, might be a contributing etiological factor in the development of an OCD lesion.\nThe serum level of vitamin D3 in 23 consecutive patients (12 male and 11 female) suffering from a stage III, or stages III and IV, OCD lesion (mostly stage III) admitted for surgery was measured.\nThe patients' mean age was 31.3\u00a0years and most of them already exhibited closed epiphyseal plates. In the majority of patients (18/23), a distinct vitamin D3 deficiency was found, two patients were vitamin D3-insufficient and, in three patients, the vitamin D3 level reached the lowest normal value.\nIs vitamin D insufficiency or deficiency related to the development of osteochondritis dissecans?",
        "answer": "maybe",
        "answer_rationale": "These first data show that a vitamin D3 deficiency rather than an insufficiency may be involved in the development of OCD lesions. Probably, with a vitamin D3 substitution, the development of an advanced OCD stage could be avoided. Further analyses, including morphological analyses regarding a possible osteomalacia, and examination of the PTH and other determinants of the bone metabolism, should be undertaken to either confirm or refute these data.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vitamin D insufficiency or deficiency is related to the development of osteochondritis dissecans (OCD) based on the provided study.\n\nFirst, I need to understand the study's setup. The study is a prospective pilot study looking at 23 patients with stage III or IV OCD, mostly stage III. They measured their vitamin D3 levels. The patients' average age was 31.3 years, and most had closed growth plates. The results showed that 18 out of 23 had a vitamin D deficiency, 2 were insufficient, and 3 were just at the lower end of normal. \n\nThe question is whether this indicates a relationship between vitamin D levels and OCD development. The options are yes, no, or maybe. \n\nNow, considering the study's design: it's a pilot study, which usually has a small sample size. Here, 23 patients might not be enough to draw a definitive conclusion. Also, the study is observational, so it can show an association but not causation. The high number of patients with low vitamin D (18 deficient, 2 insufficient) suggests a possible link, but the study's limitations mean we can't confirm causality. \n\nThe key here is the wording of the options. The question is whether the study's findings support that vitamin D issues are a contributing factor. Since the study found a high prevalence of deficiency/insufficiency in patients with OCD, it might suggest a possible link. However, because it's a pilot and doesn't control for other variables, the answer can't be a definitive \"yes.\" So the most accurate answer would be \"maybe,\" acknowledging the association but not confirming causation. \n\nWait, but the options are (A) yes, (B) no, (C) maybe. The study shows a correlation, but correlation doesn't equal causation. The study's aim was to see if it's a contributing factor, and the results found a high incidence of low vitamin D. However, without a control group, we can't say for sure. So the correct answer would be \"maybe\" because the study suggests a possible link but doesn't prove it. Therefore, the answer is C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 281,
            "completion_tokens": 469
        },
        "time_elapsed": 5.568215608596802
    },
    {
        "realidx": "25394614",
        "question": "To compare two treatment strategies in preterm infants with or at risk of respiratory distress syndrome: early surfactant administration (within one hour of birth) versus late surfactant administration, in a geographically defined population.\nThe primary outcome was chronic lung disease (CLD) and mortality before/at 36 weeks. Secondary outcomes included: duration of mechanical ventilation and continuous positive airway pressure (CPAP), post-natal steroids for CLD and major neonatal morbidities.\nPremature infants born at 22-32 weeks' gestation between January 2006 and December 2009.\nTen neonatal intensive care units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.\nRetrospective analysis of prospectively collected data from the regional NICU database in NSW and ACT.\nOf the 2170 infants who received surfactant, 1182 (54.5%) and 988 (45.5%) received early and late surfactant, respectively. The early surfactant group was less mature (27.1\u2009\u00b1\u20092.1 versus 29.4\u2009\u00b1\u20092.1 weeks) and had more CLD and mortality (40.2% versus 20.0%). The multivariable analysis showed early surfactant to be associated with less duration of ventilation, longer duration of CPAP and longer hospital stay but had little or no impact on CLD/mortality.\nDoes timing of initial surfactant treatment make a difference in rates of chronic lung disease or mortality in premature infants?",
        "answer": "maybe",
        "answer_rationale": "Early surfactant administration is associated with shorter duration of ventilation but does not appear to be significantly protective against CLD/mortality among premature infants. This may support the growing evidence for consideration of CPAP as an alternative to routine intubation and early surfactant administration. Further investigation from large randomized clinical trials is warranted to confirm these results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the timing of initial surfactant treatment affects the rates of chronic lung disease (CLD) or mortality in premature infants. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study compared early surfactant (within an hour of birth) versus late administration in preterm infants. The primary outcome was CLD and mortality before or at 36 weeks. The results mentioned that the early group had a higher rate of CLD and mortality (40.2% vs 20.0%). But then the multivariable analysis said that early surfactant was associated with less ventilation time, longer CPAP use, and longer hospital stay, but had \"little or no impact on CLD/mortality.\"\n\nWait, that seems conflicting. The raw data shows higher CLD/mortality in the early group, but after adjusting for variables in multivariable analysis, the impact was minimal. The key here is that the multivariable analysis controls for confounders. Since the early group was less mature (lower gestational age), which is a risk factor for CLD and mortality, the initial higher rate might be because those babies were more premature. The adjusted analysis likely accounted for that, showing that timing itself didn't significantly affect the outcomes. So the answer would be that timing doesn't make a difference, so the answer is B) no. But I need to make sure I'm interpreting the study's conclusion correctly. The question is whether timing makes a difference. The study's conclusion from the multivariable analysis says \"little or no impact on CLD/mortality,\" so the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 432,
            "completion_tokens": 358
        },
        "time_elapsed": 4.991885662078857
    },
    {
        "realidx": "25488308",
        "question": "The proper angle of miniscrew insertion is important for cortical anchorage, patient safety, and biomechanical control. The purposes of this study are to report the alveolar process thickness and inter-radicular space in the posterior region of the mandible, to assess the impact of different miniscrew insertion angle protocols, and to identify differences between the genders or types of malocclusion.\nIn this retrospective study, 100 individuals were selected for orthodontic treatment at a radiology clinic. Cone-beam computed tomography data were imported into 3-dimensional software. The predictor variable was the location in the mandible and insertion angle. The demographic variables collected included age, gender, and malocclusion (Angle Classes I and II). The primary outcome variables were bone thickness and inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the cement-enamel junction. The bone thicknesses were taken at 45\u00b0, 60\u00b0, and 90\u00b0 in relation to the alveolar ridge, simulating a miniscrew insertion. These factors were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). Sexual dimorphism and malocclusion were evaluated with t tests. To compare the inter-radicular space and the thickness of bone between areas, an analysis of variance for repeated measures was used.\nThe sample was composed of 100 patients with a mean age of 17.4 \u00b1 6.74 years. There were 61 female and 39 male patients and 60 Class I and 40 Class II molar relationships. The inter-radicular space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 to 13.77 mm. The thickness tended to decrease with the increase in insertion angle from 45\u00b0 to 90\u00b0. No significant differences between the genders or types of malocclusion were found.\nCan bone thickness and inter-radicular space affect miniscrew placement in posterior mandibular sites?",
        "answer": "no",
        "answer_rationale": "The results of this study suggest that the safest areas for the placement of miniscrews are between the first and second premolars and between the first and second molars, regardless of the angle of insertion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether bone thickness and inter-radicular space affect miniscrew placement in the posterior mandibular sites based on the provided study.\n\nFirst, I need to recall the details from the study description. The study's purpose was to report alveolar process thickness and inter-radicular space in the posterior mandible, assess the impact of different insertion angles, and check for gender or malocclusion differences. \n\nThe key points from the results: The inter-radicular space was between 2.46-3.31 mm, and bone thickness varied from 8.01-13.77 mm. They noted that bone thickness decreased as the insertion angle increased from 45\u00b0 to 90\u00b0. Also, no significant differences were found between genders or malocclusion classes (Class I vs II).\n\nThe question is whether bone thickness and inter-radicular space affect miniscrew placement. The study's primary outcomes were these variables. Since the thickness changes with angle and the ranges are given, it implies that these anatomical factors are important. The fact that they evaluated these variables in relation to insertion angles suggests that they do impact placement. The study didn't find gender or malocclusion effects, but the question is about the variables themselves. The answer should be yes because the thickness and space are factors that would influence where and how the miniscrews are placed. The options are A (yes), B (no), C (maybe). The study's data shows that these factors vary and affect the insertion angles' outcomes, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 523,
            "completion_tokens": 337
        },
        "time_elapsed": 4.108376502990723
    },
    {
        "realidx": "25571931",
        "question": "Among patients with acute stroke symptoms, delay in hospital admission is the main obstacle for the use of thrombolytic therapy and other interventions associated with decreased mortality and disability. The primary aim of this study was to assess whether an elderly clinical population correctly endorsed the response to call for emergency services when presented with signs and symptoms of stroke using a standardized questionnaire.\nWe performed a cross-sectional study among elderly out-patients (\u226560 years) in Buenos Aires, Argentina randomly recruited from a government funded health clinic. The correct endorsement of intention to call 911 was assessed with the Stroke Action Test and the cut-off point was set at \u226575%. Knowledge of stroke and clinical and socio-demographic indicators were also collected and evaluated as predictors of correct endorsement using logistic regression.\nAmong 367 elderly adults, 14% correctly endorsed intention to call 911. Presented with the most typical signs and symptoms, only 65% reported that they would call an ambulance. Amaurosis Fugax was the symptom for which was called the least (15%). On average, the correct response was chosen only 37% of the time. Compared to lower levels of education, higher levels were associated to correctly endorsed intention to call 911 (secondary School adjusted OR 3.53, 95% CI 1.59-7.86 and Tertiary/University adjusted OR 3.04, 95% CI 1.12-8.21).\nDo elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke?",
        "answer": "maybe",
        "answer_rationale": "These results suggest the need to provide interventions that are specifically designed to increase awareness of potential stroke signs and symptoms and appropriate subsequent clinical actions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke, based on the study provided.\n\nFirst, I need to look at the data from the study. The key points mentioned are that among 367 elderly adults, only 14% correctly endorsed the intention to call 911. Even when presented with the most typical symptoms, 65% said they would call an ambulance. But amaurosis fugax had the lowest response at 15%. The average correct response was 37%. \n\nThe question is asking if they do call 911. The options are yes, no, maybe. The study's results show that the majority did not correctly endorse calling 911. The correct endorsement was only 14%, which is very low. Even the highest for typical symptoms was 65%, which is under majority. Since the question is whether they \"call\" in such scenarios, the data suggests that the majority do not. So the answer should be no (B). The \"maybe\" might be a trap if there's some ambiguity, but the numbers clearly show low rates, so B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 422,
            "completion_tokens": 258
        },
        "time_elapsed": 3.5443356037139893
    },
    {
        "realidx": "25614468",
        "question": "The aim of this study was to prospectively compare the diagnostic performance of magnetic resonance imaging (MRI), multidetector computed tomography (MDCT) and endoscopic ultrasonography (EUS) in the preoperative locoregional staging of gastric cancer.\nThis study had Institutional Review Board approval, and informed consent was obtained from all patients. Fifty-two patients with biopsy-proven gastric cancer underwent preoperative 1.5-T MRI, 64-channel MDCT and EUS. All images were analysed blind, and the results were compared with histopathological findings according to the seventh edition of the TNM classification. After the population had been divided on the basis of the local invasion (T1-3 vs T4a-b) and nodal involvement (N0 vs N+), sensitivity, specificity, positive and negative predictive value, and accuracy were calculated and diagnostic performance measures were assessed using the McNemar test.\nFor T staging, EUS showed higher sensitivity (94%) than MDCT and MRI (65 and 76%; p = 0.02 and p = 0.08). MDCT and MRI had significantly higher specificity (91 and 89%) than EUS (60%) (p = 0.0009 and p = 0.003). Adding MRI to MDCT or EUS did not result in significant differences for sensitivity. For N staging, EUS showed higher sensitivity (92%) than MRI and MDCT (69 and 73%; p = 0.01 and p = 0.02). MDCT showed better specificity (81%) than EUS and MRI (58 and 73%; p = 0.03 and p = 0.15).\nPreoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging?",
        "answer": "no",
        "answer_rationale": "Our prospective study confirmed the leading role of EUS and MDCT in the staging of gastric cancer and did not prove, at present, the value of the clinical use of MRI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing MRI, MDCT, and EUS for staging gastric cancer. The question is whether there's a place for MRI in preoperative locoregional staging.\n\nFirst, looking at the T staging results: EUS had higher sensitivity than both MRI and MDCT. MRI's sensitivity was 76%, which was better than MDCT's 65% but still lower than EUS's 94%. However, MRI's specificity was 89%, which was higher than EUS's 60%, but MDCT had even higher specificity at 91%. So MRI is better than EUS in specificity here but not as good as MDCT.\n\nFor N staging, EUS again had the highest sensitivity (92%) compared to MRI and MDCT. MDCT had better specificity (81%) than EUS (58%) and MRI (73%). \n\nThe study also mentions that adding MRI to MDCT or EUS didn't improve sensitivity. So maybe MRI isn't adding much when combined with the others. But the question is whether MRI has a place on its own or in the protocol. \n\nThe options are yes, no, maybe. The study shows that MRI isn't better than EUS in sensitivity and not as good as MDCT in specificity. However, MRI might have other advantages not mentioned here, like avoiding radiation (since MDCT uses radiation) or better in certain aspects not tested here. But based on the data given, since adding MRI didn't improve sensitivity and it's not outperforming the others in key metrics, maybe the conclusion is that MRI doesn't have a necessary place. But wait, the question is phrased as \"is there a place for MRI?\" So even if it's not the best, maybe in some scenarios? The study's results might suggest that since EUS is better for sensitivity and MDCT for specificity, MRI might not be as useful. But the answer options are yes, no, maybe. The study's conclusion might be that MRI isn't necessary, so the answer would be B) no. But I need to check the McNemar test results again. The p-values for specificity between MRI vs EUS were significant, so MRI is better in specificity than EUS. But since EUS is better in sensitivity, maybe MRI could be used where specificity is more important? But the question is about the overall staging. Since combining MRI didn't help, perhaps it's redundant.",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 481,
            "completion_tokens": 512
        },
        "time_elapsed": 5.746769666671753
    },
    {
        "realidx": "25779009",
        "question": "There is no standard protocol for the evaluation of antiseptics used for skin and mucous membranes in the presence of interfering substances. Our objective was to suggest trial conditions adapted from the NF EN 13727 standard, for the evaluation of antiseptics used in gynecology and dermatology.\nThree antiseptic solutions were tested in vitro: a chlorhexidine-benzalkonium (CB) combination, a hexamidine-chlorhexidine-chlorocresol (HCC) combination, and povidone iodine (P). The adaptation of trial conditions to the standard involved choosing dilutions, solvent, and interfering substances. The activity of solutions was assessed on the recommended strains at concentrations of 97% (pure solution), 50%, and 10% (diluted solution), and 1%. A logarithmic reduction \u2265 5 was expected after 60seconds of contact, to meet requirements of bactericidal activity.\nHCC did not present any bactericidal activity except on P. aeruginosa at a concentration of 97%. P was not bactericidal on E. hirae at any concentration and on S. aureus at 97%. CB had the most homogeneous bactericidal activity with a reduction>5 log on the 4 bacterial strains at concentrations of 97%, 50% and 10%.\nBactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?",
        "answer": "maybe",
        "answer_rationale": "Adapting the NF EN 13727 standard allowed assessing the 3 tested solutions: only CB was bactericidal in dirty conditions. This study proved the possibility of validating antiseptic choice in vitro, in current practice conditions, for adjunctive treatment of skin and mucous membranes disorders, primarily of bacterial origin or with a potential of superinfection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the study's findings suggest an improvement to the NF EN 13727 European Standard. The options are yes, no, or maybe.\n\nFirst, I need to recall what the question and the study's objective were. The objective was to suggest trial conditions adapted from the NF EN 13727 standard for evaluating antiseptics in gynecology and dermatology. The study tested three antiseptic solutions under different concentrations and looked at their bactericidal activity with interfering substances.\n\nThe key points from the results: \n\n- HCC only worked on P. aeruginosa at 97% concentration.\n- Povidone iodine (P) wasn't effective on E. hirae at any concentration and S. aureus at 97%.\n- CB (chlorhexidine-benzalkonium) was the most consistent, showing >5 log reduction on all four strains even at 10% concentration.\n\nThe standard's requirement is a 5-log reduction in 60 seconds. The current standard might not account for the varying effectiveness of these antiseptics when diluted or in the presence of interfering substances. Since the study found that some antiseptics didn't meet the standard's requirements except CB, maybe the standard needs adjustments in terms of which antiseptics are recommended, or the testing conditions (like concentrations or interfering substances) to better reflect real-world scenarios. The study's adaptation of trial conditions (like using different dilutions and considering interfering substances) might be an improvement over the existing standard, which perhaps didn't have those parameters. Therefore, the answer would be \"yes\" because the study's adapted conditions could lead to an improved standard by better evaluating the antiseptics' effectiveness under more realistic conditions.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 418,
            "completion_tokens": 379
        },
        "time_elapsed": 5.0093467235565186
    },
    {
        "realidx": "25793749",
        "question": "Although the Internet is commonly used to recruit samples in studies of human immunodeficiency virus (HIV)-related risk behaviors, it has not been used to measure patient-reported well-being. As the burden of long-term chronic HIV infection rises, the Internet may offer enormous potential for recruitment to research and interventions.\nThis study aimed to compare two samples of gay men living with HIV, one recruited via the Web and the other recruited in outpatient settings, in terms of self-reported physical and psychological symptom burden.\nThe Internet sample was recruited from a UK-wide Web-based survey of gay men with diagnosed HIV. Of these, 154 respondents identified themselves as resident in London and were included in this analysis. The HIV clinic sample was recruited from five HIV outpatient clinics. Of these participants, 400 gay men recruited in London clinics were included in this analysis.\nThe Web-based sample was younger than the clinic sample (37.3 years, SD 7.0 vs 40.9 years, SD 8.3), more likely to be in paid employment (72.8%, 99/136 vs 60.1%, 227/378), less likely to be on antiretroviral therapy (ART) (58.4%, 90/154 vs 68.0%, 266/391), and had worse mean psychological symptom burden compared to the clinic sample (mean scores: 1.61, SD 1.09 vs 1.36, SD 0.96) but similar physical symptom burden (mean scores: 0.78, SD 0.65 vs 0.70, SD 0.74). In multivariable logistic regression, for the physical symptom burden model, adjusted for age, ethnicity, employment status, and ART use, the recruitment setting (ie, Web-based vs clinic) was not significantly associated with high physical symptom score. The only variable that remained significantly associated with high physical symptom score was employment status, with those in employment being less likely to report being in the upper (worst) physical symptom tertile versus the other two tertiles (adjusted OR 0.41, 95% CI 0.28-0.62, P<.001). For the psychological symptom burden model, those recruited via the Web were significantly more likely to report being in the upper (worst) tertile (adjusted OR 2.20, 95% CI 1.41-3.44, P=.001). In addition, those in employment were less likely to report being in the upper (worst) psychological symptom tertile compared to those not in employment (adjusted OR 0.32, 95% CI 0.21-0.49, P<.001).\nDo Web-based and clinic samples of gay men living with HIV differ on self-reported physical and psychological symptoms?",
        "answer": "maybe",
        "answer_rationale": "Our data have revealed a number of differences. Compared to the clinic sample, the Web-based sample had worse psychological symptom burden, younger average age, higher prevalence of employment, and a lower proportion on ART. For future research, we recommend that Web-based data collection should include the demographic variables that we note differed between samples. In addition, we recognize that each recruitment method may bring inherent sampling bias, with clinic populations differing by geographical location and reflecting those accessing regular medical care, and Web-based sampling recruiting those with greater Internet access and identifying survey materials through specific searches and contact with specific websites.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Web-based and clinic samples of gay men with HIV differ in self-reported physical and psychological symptoms. The options are yes, no, or maybe.\n\nFirst, I need to look back at the study details provided. The study compared two groups: one recruited online and the other from clinics. The key results mentioned are about their physical and psychological symptom burdens. \n\nThe physical symptom burden had a mean of 0.78 (SD 0.65) for the Web group versus 0.70 (SD 0.74) for the clinic group. The text says that in the multivariable model, recruitment setting (Web vs clinic) wasn't significantly associated with high physical symptoms. The only significant factor there was employment status. So for physical symptoms, the answer might be no difference because the setting didn't matter after adjusting variables.\n\nBut for psychological symptoms, the Web group had a higher mean (1.61 vs 1.36). The logistic regression showed that being in the Web sample was significantly associated with higher psychological symptom tertile (OR 2.20). So here, there is a difference. \n\nThe question asks if they differ on either or both. Since psychological symptoms do show a difference, the answer should be yes. The physical part doesn't differ when adjusted, but psychological does. So overall, the answer is yes (A). The options are (A) yes, so that's the correct choice.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 718,
            "completion_tokens": 314
        },
        "time_elapsed": 4.111378908157349
    },
    {
        "realidx": "26037986",
        "question": "Emergency surgery is associated with poorer outcomes and higher mortality with recent studies suggesting the 30-day mortality to be 14-15%. The aim of this study was to analyse the 30-day mortality, age-related 30-day mortality and 1-year mortality following emergency laparotomy. We hope this will encourage prospective data collection, improvement of care and initiate strategies to establish best practice in this area.\nThis was a retrospective study of patients who underwent emergency laparotomy from June 2010 to May 2012. The primary end point of the study was 30-day mortality, age-related 30-day mortality and 1-year all-cause mortality.\n477 laparotomies were performed in 446 patients. 57% were aged<70 and 43% aged>70 years. 30-day mortality was 12, 4% in those aged<70 years and 22% in those>70 years (p<0.001). 1-year mortality was 25, 15% in those aged under 70 years and 38% in those aged>70 years (p<0.001).\n30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement?",
        "answer": "maybe",
        "answer_rationale": "Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user provided a study about emergency laparotomy outcomes. The question is whether 30-day and 1-year mortality in these surgeries are areas of concern needing improvement. The options are yes, no, maybe.\n\nFirst, I need to look at the data given. The study had 446 patients with 477 laparotomies. The 30-day mortality was 12.4% for under 70 and 22% for over 70. The 1-year mortality was 25.15% (maybe that's a typo, perhaps 25.1% or 25.15? Not sure, but the exact number might not matter here) for under 70 and 38% for over 70. Both differences are statistically significant (p<0.001). \n\nThe question is asking if these mortality rates are a concern and if improvement is needed. The study's aim was to analyze these mortalities to encourage better care and strategies. The results show higher mortality, especially in the older group. The 30-day rate is around 12-22%, which aligns with the mentioned 14-15% in the intro, but the 1-year is even higher. Since the study's own results show significant mortality, especially in older patients, and they mention the need for prospective data and improvement, the answer should be yes. The options are (A) yes, (B) no, (C) maybe. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 338
        },
        "time_elapsed": 4.2372705936431885
    },
    {
        "realidx": "26606599",
        "question": "To determine the relationship between injury severity surrogates and other patient factors with the development and severity of heterotopic ossification (HO) following open reduction internal fixation of acetabular fractures treated with a posterior approach.\nRetrospective review.\nAcademic level 1 trauma center.\nTwo hundred forty-one patients who were treated through a posterior approach with a minimum of 6-month radiographic follow-up were identified from an acetabular fracture database.\nNone.\nThe occurrence and severity (Brooker Grade III/IV) of HO 6 months postsurgery.\nLength of stay (LOS) in the intensive care unit (ICU), non-ICU LOS>10 days, and HO prophylaxis with external radiation beam therapy (XRT) were significantly associated with the development of HO in a multivariate model [\n1-2 days, odds ratio (OR) = 4.33, 95% confidence interval (CI): 1.03-18.25; 3-6 days, OR = 4.1, 95% CI, 1.27-13.27;>6 days, OR = 11.7, 95% CI, 3.24-42.22; non-ICU LOS>10 days (vs. 0-6 days): OR = 7.6, 95% CI, 2.6-22.25; XRT HO prophylaxis: OR = 0.29, 95% CI, 0.10-0.85]. Other variables evaluated in multivariate modeling not significantly associated with development and severity of HO included age, gender, mechanism of injury, injury severity score, presence of neurologic injury, Letournel fracture type, occurrence of hip dislocation, interval from injury to surgery, operative time, and estimated blood loss.\nDo Surrogates of Injury Severity Influence the Occurrence of Heterotopic Ossification in Fractures of the Acetabulum?",
        "answer": "maybe",
        "answer_rationale": "Surrogates of injury severity, including days in the ICU and non-ICU hospital LOS>10 days, were associated with the development of HO in our cohort of acetabular fracture patients. Prophylaxis with XRT was significantly protective against the development of HO, and the ability to provide prophylaxis is very likely related to the severity of injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether surrogates of injury severity influence the occurrence of heterotopic ossification (HO) in acetabular fractures based on the provided study.\n\nFirst, I need to understand what the study found. The question refers to a retrospective review of 241 patients with acetabular fractures treated via a posterior approach. The main outcome was the development and severity of HO at 6 months. \n\nLooking at the results, the study mentions that certain factors were significantly associated with HO in a multivariate model. The significant factors listed are ICU length of stay (LOS), non-ICU LOS over 10 days, and the use of XRT for HO prophylaxis. The odds ratios are provided for each, showing that longer ICU stays and longer non-ICU stays increase the odds of HO, while XRT reduces it. \n\nThe key part here is the list of variables that were NOT significantly associated. The study explicitly states that variables like age, gender, mechanism of injury, injury severity score (ISS), neurologic injury, fracture type (Letournel), hip dislocation, time to surgery, operative time, and blood loss were not significant. \n\nThe question is about whether injury severity surrogates (like ISS) influence HO. Since ISS is listed among the non-significant variables, that suggests that surrogates of injury severity (like ISS) do not have a significant association with HO occurrence. \n\nTherefore, the answer should be \"no\" because the injury severity score, a common surrogate, wasn't found to be a significant factor. The other factors like ICU stay might be related to the patient's overall condition but aren't the injury severity itself. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 520,
            "completion_tokens": 365
        },
        "time_elapsed": 4.501797676086426
    },
    {
        "realidx": "26708803",
        "question": "Treatment of neonatal testicular torsion has two objectives: salvage of the involved testicle (which is rarely achieved) and preservation of the contralateral gonad. The second goal universally involves contralateral testicular scrotal fixation to prevent the future occurrence of contralateral torsion. However, there is controversy with regards to management of a synchronous contralateral hydrocele. It has been our policy not to address the contralateral hydrocele through an inguinal incision to minimize potential injury to the spermatic cord. Our objective in this study was to determine whether the decision to manage a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal approach is safe and effective.\nWe reviewed all cases of neonatal testicular torsion occurring at our institution between the years 1999 and 2006. Age at presentation, physical examination, ultrasonographic and intraoperative findings were recorded. Patients were followed after initial surgical intervention to determine the likelihood of developing a subsequent hydrocele or hernia.\nThirty-seven patients were identified as presenting with neonatal torsion. Age of presentation averaged 3.5 days (range 1-14 days). Left-sided pathology was seen more commonly than the right, with a 25:12 distribution. All torsed testicles were nonviable. Twenty-two patients were noted to have a contralateral hydrocele at presentation. All hydroceles were opened through a scrotal approach at the time of contralateral scrotal fixation. No patient underwent an inguinal exploration to examine for a patent process vaginalis. None of the patients who presented with a hydrocele have developed a clinical hydrocele or hernia after an average 7.5 years (range 4.3-11.2) follow-up.\nTreatment of contralateral hydrocele in neonatal testicular torsion: Is less more?",
        "answer": "maybe",
        "answer_rationale": "We have demonstrated that approaching a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal incision is safe and effective. Inguinal exploration was not performed in our study and our long-term results demonstrate that such an approach would have brought no additional benefit. In avoiding an inguinal approach we did not subject our patients to unnecessary risk of testicular or vasal injury. Contralateral hydrocele is commonly seen in cases of neonatal testicular torsion. In our experience this is a condition of minimal clinical significance and does not warrant formal inguinal exploration for treatment. This conservative management strategy minimizes the potential of contralateral spermatic cord injury in the neonate. The aims of the study were met.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking about the management of a contralateral hydrocele in cases of neonatal testicular torsion. The study mentioned here looked at whether using a scrotal approach instead of an inguinal one is safe and effective.\n\nFirst, the background: Neonatal testicular torsion usually requires fixing the affected testicle and the contralateral one to prevent future torsion. The controversy is about how to handle a hydrocele on the other side. The authors' policy was to avoid inguinal incision to prevent injury, so they used a scrotal approach for the hydrocele.\n\nThe study results: 37 patients, 22 had contralateral hydroceles. All hydroceles were addressed via scrotal approach. None had inguinal exploration. After follow-up (average 7.5 years), none developed hydrocele or hernia. \n\nThe question is whether \"Is less more?\" meaning, is the minimal approach (just scrotal, not inguinal) sufficient and safe. The results show that by managing the hydrocele through the scrotal approach without inguinal surgery, they didn't have complications. So the answer would support that \"less\" (not doing inguinal) is effective and safe, so the answer is yes (A). The options are A, B, C. The study's outcome shows no issues, so the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 488,
            "completion_tokens": 306
        },
        "time_elapsed": 4.143817663192749
    },
    {
        "realidx": "26778755",
        "question": "Although dose-volume parameters in image-guided brachytherapy have become a standard, the use of posterior-inferior border of the pubic symphysis (PIBS) points has been recently proposed in the reporting of vaginal doses. The aim was to evaluate their pertinence.\nNineteen patients who received image-guided brachytherapy after concurrent radiochemotherapy were included. Per treatment, CT scans were performed at Days 2 and 3, with reporting of the initial dwell positions and times. Doses delivered to the PIBS points were evaluated on each plan, considering that they were representative of one-third of the treatment. The movements of the applicator according to the PIBS point were analysed.\nMean prescribed doses at PIBS -2, PIBS, PIBS +2 were, respectively, 2.23 \u00b1 1.4, 6.39 \u00b1 6.6, and 31.85 \u00b1 36.06 Gy. Significant differences were observed between the 5 patients with vaginal involvement and the remaining 14 at the level of PIBS +2 and PIBS: +47.60 Gy and +7.46 Gy, respectively (p = 0.023 and 0.03). The variations between delivered and prescribed doses at PIBS points were not significant. However, at International commission on radiation units and measurements rectovaginal point, the delivered dose was decreased by 1.43 \u00b1 2.49 Gy from the planned dose (p = 0.019). The delivered doses at the four points were strongly correlated with the prescribed doses with R(2) ranging from 0.93 to 0.95. The movements of the applicator in regard of the PIBS point assessed with the Digital Imaging and Communications in Medicine coordinates were insignificant.\nVaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?",
        "answer": "maybe",
        "answer_rationale": "The doses evaluated at PIBS points are not impacted by intrafractional movements. PIBS and PIBS +2 dose points allow distinguishing the plans of patients with vaginal infiltration. Further studies are needed to correlate these parameters with vaginal morbidity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about evaluating the use of PIBS points in reporting vaginal doses during image-guided brachytherapy for cervical cancer. The main question is whether relying on dose-point evaluation (like PIBS points) is valid.\n\nFirst, looking at the results: The mean prescribed doses at different PIBS points showed some variation, but the key point is that the delivered doses at the PIBS points weren't significantly different from the prescribed ones. The R-squared values (0.93-0.95) indicate a strong correlation between prescribed and delivered doses at these points. That suggests the PIBS points are reliable in this aspect.\n\nHowever, there's a mention that at the ICRU rectovaginal point, the delivered dose was lower than planned. But the question is specifically about vaginal doses and the PIBS points. The applicator movement wasn't significant either, so the positions probably stayed consistent. The study also found differences between patients with and without vaginal involvement, but that might relate to treatment planning rather than the reliability of the PIBS points themselves.\n\nThe options are yes, no, maybe. The study's conclusion seems to support that the PIBS points are pertinent because the delivered doses correlated well. So the answer should be (A) yes. Wait, but the question is phrased as \"Can we really rely...\" The study's results show that the delivered doses at PIBS points were strongly correlated, so yes. The ICRU point's discrepancy might be a distractor, but the question is about vaginal doses via PIBS points. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 514,
            "completion_tokens": 348
        },
        "time_elapsed": 4.406004905700684
    },
    {
        "realidx": "26852225",
        "question": "Anchoring vignettes are brief texts describing a hypothetical character who illustrates a certain fixed level of a trait under evaluation. This research uses vignettes to elucidate factors associated with sleep disorders in adult Japanese before and after adjustment for reporting heterogeneity in self-reports. This study also evaluates the need for adjusting for reporting heterogeneity in the management of sleep and energy related problems in Japan.\nWe investigated a dataset of 1002 respondents aged 18 years and over from the Japanese World Health Survey, which collected information through face-to-face interview from 2002 to 2003. The ordered probit model and the Compound Hierarchical Ordered Probit (CHOPIT) model, which incorporated anchoring vignettes, were employed to estimate and compare associations of sleep and energy with socio-demographic and life-style factors before and after adjustment for differences in response category cut-points for each individual.\nThe prevalence of self-reported problems with sleep and energy was 53 %. Without correction of cut-point shifts, age, sex, and the number of comorbidities were significantly associated with a greater severity of sleep-related problems. After correction, age, the number of comorbidities, and regular exercise were significantly associated with a greater severity of sleep-related problems; sex was no longer a significant factor. Compared to the ordered probit model, the CHOPIT model provided two changes with a subtle difference in the magnitude of regression coefficients after correction for reporting heterogeneity.\nIs adjustment for reporting heterogeneity necessary in sleep disorders?",
        "answer": "no",
        "answer_rationale": "Sleep disorders are common in the general adult population of Japan. Correction for reporting heterogeneity using anchoring vignettes is not a necessary tool for proper management of sleep and energy related problems among Japanese adults. Older age, gender differences in communicating sleep-related problems, the presence of multiple morbidities, and regular exercise should be the focus of policies and clinical practice to improve sleep and energy management in Japan.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether adjustment for reporting heterogeneity is necessary in sleep disorders based on the study described.\n\nFirst, I need to recall what the study found. The study used two models: the ordered probit model and the CHOPIT model which includes anchoring vignettes to adjust for reporting differences. The key point here is the difference in results before and after adjustment.\n\nBefore correction (using the ordered probot model), age, sex, and comorbidities were significant. After adjusting with CHOPIT, sex was no longer significant, but regular exercise became significant. Also, the CHOPIT model showed changes in regression coefficients, indicating that not adjusting might lead to incorrect conclusions, especially about sex and exercise.\n\nThe question is whether adjustment is necessary. The study's results show that without adjustment, some factors (like sex) were significant but lost significance after adjustment. This suggests that reporting heterogeneity was affecting the results. Therefore, adjusting is necessary to get accurate associations, making the correct answer 'A' (yes). The fact that the CHOPIT model provided different results implies that not adjusting could lead to misleading conclusions, so adjustment is needed.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 401,
            "completion_tokens": 247
        },
        "time_elapsed": 3.399864673614502
    },
    {
        "realidx": "26864326",
        "question": "In this single-centre prospective study, triage nurses estimated the probability of admission using a 100\u2005mm visual analogue scale (VAS), and GAPS was generated automatically from triage data. We compared calibration using rank sum tests, discrimination using area under receiver operating characteristic curves (AUC) and accuracy with McNemar's test.\nOf 1829 attendances, 745 (40.7%) were admitted, not significantly different from GAPS' prediction of 750 (41.0%, p=0.678). In contrast, the nurses' mean VAS predicted 865 admissions (47.3%), overestimating by 6.6% (p<0.0001). GAPS discriminated between admission and discharge as well as nurses, its AUC 0.876 compared with 0.875 for VAS (p=0.93). As a binary predictor, its accuracy was 80.6%, again comparable with VAS (79.0%), p=0.18. In the minority of attendances, when nurses felt at least 95% certain of the outcome, VAS' accuracy was excellent, at 92.4%. However, in the remaining majority, GAPS significantly outperformed VAS on calibration (+1.2% vs +9.2%, p<0.0001), discrimination (AUC 0.810 vs 0.759, p=0.001) and accuracy (75.1% vs 68.9%, p=0.0009). When we used GAPS, but 'over-ruled' it when clinical certainty was \u226595%, this significantly outperformed either method, with AUC 0.891 (0.877-0.907) and accuracy 82.5% (80.7%-84.2%).\nPredicting admission at triage: are nurses better than a simple objective score?",
        "answer": "yes",
        "answer_rationale": "GAPS, a simple clinical score, is a better predictor of admission than triage nurses, unless the nurse is sure about the outcome, in which case their clinical judgement should be respected.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study compares triage nurses using a VAS scale versus the GAPS system in predicting hospital admissions. The key points from the study are:\n\nFirst, the actual admission rate was 40.7% (745/1829), while GAPS predicted 41.0% (750), which wasn't significantly different (p=0.678). The nurses' VAS overestimated at 47.3%, which was significantly higher (p<0.0001). So calibration-wise, GAPS was better here.\n\nFor discrimination, both had almost the same AUC: 0.876 for GAPS vs 0.875 for VAS, and the p-value was 0.93, meaning no significant difference. So they're about equal in discrimination.\n\nAccuracy as binary predictors: GAPS was 80.6% vs VAS 79.0%, and the p=0.18, so not significantly different. But when looking at cases where nurses were 95% certain, their accuracy was 92.4%, which is high. However, in the majority of cases where they weren't that certain, GAPS outperformed VAS in calibration, discrimination, and accuracy. \n\nThe study also mentions that combining GAPS with nurse override when they were 95% certain improved performance further. But the question is whether nurses are better than GAPS. \n\nThe main results show that overall, GAPS is at least as good as nurses, and better in most areas except when nurses are very certain. But since the majority of cases aren't in that high certainty group, GAPS is better overall. The question asks if nurses are better than the score. Since the study shows GAPS is comparable or better except in a minority, the answer would be no. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 534,
            "completion_tokens": 406
        },
        "time_elapsed": 4.731825828552246
    },
    {
        "realidx": "26965932",
        "question": "This study sought to investigate the ischemic and bleeding outcomes of patients fulfilling high bleeding risk (HBR) criteria who were randomized to zotarolimus-eluting Endeavor Sprint stent (E-ZES) or bare-metal stent (BMS) implantation followed by an abbreviated dual antiplatelet therapy (DAPT) duration for stable or unstable coronary artery disease.\nDES instead of BMS use remains controversial in HBR patients, in whom long-term DAPT poses safety concerns.\nThe ZEUS (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates) is a multinational, randomized single-blinded trial that randomized among others, in a stratified manner, 828 patients fulfilling pre-defined clinical or biochemical HBR criteria-including advanced age, indication to oral anticoagulants or other pro-hemorrhagic medications, history of bleeding and known anemia-to receive E-ZES or BMS followed by a protocol-mandated 30-day DAPT regimen. The primary endpoint of the study was the 12-month major adverse cardiovascular event rate, consisting of death, myocardial infarction, or target vessel revascularization.\nCompared with patients without, those with 1 or more HBR criteria had worse outcomes, owing to higher ischemic and bleeding risks. Among HBR patients, major adverse cardiovascular events occurred in 22.6% of the E-ZES and 29% of the BMS patients (hazard ratio: 0.75; 95% confidence interval: 0.57 to 0.98; p = 0.033), driven by lower myocardial infarction (3.5% vs. 10.4%; p<0.001) and target vessel revascularization (5.9% vs. 11.4%; p = 0.005) rates in the E-ZES arm. The composite of definite or probable stent thrombosis was significantly reduced in E-ZES recipients, whereas bleeding events did not differ between stent groups.\nIs Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?",
        "answer": "yes",
        "answer_rationale": "Among HBR patients with stable or unstable coronary artery disease, E-ZES implantation provides superior efficacy and safety as compared with conventional BMS. (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates [ZEUS]; NCT01385319).",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study in question is the ZEUS trial, which compared zotarolimus-eluting stents (E-ZES) versus bare-metal stents (BMS) in high bleeding risk (HBR) patients undergoing PCI. The primary endpoint was the 12-month major adverse cardiovascular event (MACE) rate, which includes death, MI, or TVR.\n\nThe results showed that HBR patients who got E-ZES had a lower MACE rate (22.6% vs. 29% in BMS, HR 0.75, p=0.033). This was mainly because of fewer MIs (3.5% vs 10.4%) and TVR (5.9% vs 11.4%). Stent thrombosis was also lower in the E-ZES group, but bleeding events didn't differ between groups. \n\nThe question is whether BMS is still justifiable in HBR patients. Traditionally, BMS might be used to avoid long-term DAPT, but here, even with shortened DAPT (30 days), the DES (E-ZES) performed better in terms of ischemic events without increasing bleeding. Since the study shows better outcomes with DES without a bleeding trade-off, it suggests that BMS might not be necessary. The answer would lean towards \"no\" because DES seems safer and more effective here. The options are (A) yes, (B) no, (C) maybe. The data supports BMS not being justifiable anymore, so the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 557,
            "completion_tokens": 338
        },
        "time_elapsed": 3.9604310989379883
    },
    {
        "realidx": "27044366",
        "question": "The technique of induced sputum has allowed to subdivide asthma patients into inflammatory phenotypes according to their level of granulocyte airway infiltration. There are very few studies which looked at detailed sputum and blood cell counts in a large cohort of asthmatics divided into inflammatory phenotypes. The purpose of this study was to analyze sputum cell counts, blood leukocytes and systemic inflammatory markers in these phenotypes, and investigate how those groups compared with healthy subjects.\nWe conducted a retrospective cross-sectional study on 833 asthmatics recruited from the University Asthma Clinic of Liege and compared them with 194 healthy subjects. Asthmatics were classified into inflammatory phenotypes.\nThe total non-squamous cell count per gram of sputum was greater in mixed granulocytic and neutrophilic phenotypes as compared to eosinophilic, paucigranulocytic asthma and healthy subjects (p\u2009<\u20090.005). Sputum eosinophils (in absolute values and percentages) were increased in all asthma phenotypes including paucigranulocytic asthma, compared to healthy subjects (p\u2009<\u20090.005). Eosinophilic asthma showed higher absolute sputum neutrophil and lymphocyte counts than healthy subjects (p\u2009<\u20090.005), while neutrophilic asthmatics had a particularly low number of sputum macrophages and epithelial cells. All asthma phenotypes showed an increased blood leukocyte count compared to healthy subjects (p\u2009<\u20090.005), with paucigranulocytic asthmatics having also increased absolute blood eosinophils compared to healthy subjects (p\u2009<\u20090.005). Neutrophilic asthma had raised CRP and fibrinogen while eosinophilic asthma only showed raised fibrinogen compared to healthy subjects (p\u2009<\u20090.005).\nDetailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?",
        "answer": "maybe",
        "answer_rationale": "This study demonstrates that a significant eosinophilic inflammation is present across all categories of asthma, and that paucigranulocytic asthma may be seen as a low grade inflammatory disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether paucigranulocytic asthmatics are really non-inflammatory based on the study described.\n\nFirst, I need to recall what the study found. The question mentions that the study compared different asthma phenotypes with healthy subjects. The key points from the study's results are:\n\n- Total non-squamous cells were higher in mixed and neutrophilic groups compared to eosinophilic, paucigranulocytic asthma, and healthy subjects. But paucigranulocytic is still part of the asthma group here.\n\n- Sputum eosinophils (both absolute and percentages) were increased in all asthma phenotypes, including paucigranulocytic, compared to healthy subjects. That's a crucial point because even paucigranulocytic asthma had higher eosinophils than healthy people.\n\n- Paucigranulocytic asthmatics had increased blood eosinophils compared to healthy subjects. So their blood shows more eosinophils, which are inflammatory cells.\n\n- All asthma phenotypes had increased blood leukocytes. Since leukocytes include various inflammatory cells, this suggests systemic inflammation even in paucigranulocytic.\n\nThe question is whether paucigranulocytic asthma is \"non-inflammatory.\" The term \"paucigranulocytic\" might imply low granulocytes in sputum, but the study shows that even in this group, eosinophils (a type of granulocyte) are elevated in sputum and blood. Since eosinophils are inflammatory cells, their presence indicates inflammation. Also, all asthma groups had higher blood leukocytes, so systemic inflammation exists. \n\nThe options are yes, no, maybe. The study's results contradict the idea that paucigranulocytic is non-inflammatory because they still have elevated inflammatory markers. So the answer should be B) no, they are not non-inflammatory.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 539,
            "completion_tokens": 412
        },
        "time_elapsed": 5.110686540603638
    },
    {
        "realidx": "27050489",
        "question": "Misty mesentery appearance is commonly reported in daily practice, usually as a secondary finding of various pathological entities, but sometimes it is encountered as an isolated finding that cannot be attributed to any other disease entity. We aimed to assess the prevalence of cases with incidentally detected idiopathic misty mesentery on computed tomography (CT) and to summarize the pathologies leading to this appearance.\nMedical records and initial and follow-up CT features of patients with misty mesentery appearance between January 2011 and January 2013 were analysed. The study included cases with no known cause of misty mesentery according to associated CT findings, clinical history, or biochemical manifestations, and excluded patients with diseases known to cause misty mesentery, lymph nodes greater than a short-axis diameter of 5\u00a0mm, discrete mesenteric masses, or bowel wall thickening.\nThere were a total of 561 patients in whom misty mesentery appearance was depicted on abdominopelvic CT scans. A total of 80 cases were found to have isolated incidental idiopathic misty mesentery, giving a prevalence of 7%. The common indication for CT examination was abdominal pain. There was a slight female predominance (51.3%). 67.5% of all patients were classified as obese and 17.5% as overweight.\nThe Prevalence of Incidentally Detected Idiopathic Misty Mesentery on\u00a0Multidetector Computed Tomography: Can Obesity Be the Triggering Cause?",
        "answer": "yes",
        "answer_rationale": "The results of the present study show that idiopathic incidental misty mesentery appearance has a significant prevalence. Also, the high body mass index of these patients and the growing evidence of obesity-induced inflammatory changes in adipose tissue are suggestive of an association between obesity and misty mesentery appearance on CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether obesity can be the triggering cause of idiopathic misty mesentery based on the study described.\n\nFirst, I need to recall what the study found. The study's aim was to assess the prevalence of idiopathic misty mesentery and the associated pathologies. They found that out of 561 patients with misty mesentery, 80 (14%) were idiopathic. The prevalence was 7%, and among these, 67.5% were obese and 17.5% overweight. The question is whether obesity is the triggering cause.\n\nThe key here is understanding the study's findings. The high percentage of obese patients in the idiopathic group might suggest a correlation, but the study's conclusion isn't explicitly stated here. The question is phrased as \"Can obesity Be the Triggering Cause?\" The options are yes, no, maybe.\n\nThe study's data shows an association (more obese patients), but correlation doesn't equal causation. The study might be pointing out that obesity is a common factor, but without further evidence like a causal mechanism or controlled studies, the answer can't be a definitive yes. The title of the study itself is posing the question, so the answer might be \"maybe\" since the study is exploring that possibility but hasn't confirmed it. The options given are (A) yes, (B) no, (C) maybe. Since the study's results show a high prevalence in obese patients but doesn't establish causation, the correct answer is probably C) maybe.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 410,
            "completion_tokens": 333
        },
        "time_elapsed": 4.280455589294434
    },
    {
        "realidx": "27136599",
        "question": "Patient data were retrospectively collected from a database for gynaecological cancer procedures carried out between January 2013 and July 2015. All patients who underwent a colorectal resection during cytoreduction were included in the study. The primary outcome was anastomotic leakage in the presence or absence of a diverting stoma. Secondary outcome parameters were complications and reoperations.\nIn the period of study, 43 major colorectal procedures were performed on 37 women. The most common colorectal procedure was low rectal resection (n\u00a0=\u00a022; 59%) followed by anterior rectal resection (n\u00a0=\u00a07; 19%) and sigmoid resection (n\u00a0=\u00a04; 11%). Five (14%) patients underwent Hartmann's procedure. In three (8%) patients, a diverting loop ileostomy was created.\nIs it safe to perform rectal anastomosis in gynaecological debulking surgery without a diverting stoma?",
        "answer": "yes",
        "answer_rationale": "Low rectal resection during debulking procedures for gynaecological cancers with peritoneal carcinomatosis can safely be performed by an experienced surgeon without a diverting stoma.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether it's safe to perform a rectal anastomosis during gynecological debulking surgery without a diverting stoma. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided data. The study included 43 colorectal procedures in 37 women. The primary outcome was anastomotic leakage related to the presence or absence of a diverting stoma. The secondary outcomes were complications and reoperations. \n\nThe key point here is the primary outcome: anastomotic leakage. The question is about safety without a stoma. The data mentions that only 3 out of 43 patients (8%) had a diverting loop ileostomy. The rest didn't have one. But the problem is the study's results aren't fully detailed here. The question is whether it's safe, so we need to infer based on the given info.\n\nWait, the question is based on the study's data. The study's primary outcome was comparing leakage rates with and without stomas. But the provided data doesn't give the actual leakage rates. It just tells us how many procedures were done and how many had stomas. Without knowing the leakage rates in each group (with vs without stoma), we can't directly answer if it's safe. \n\nHmm, but maybe the answer is inferred from the fact that they did perform many procedures without stomas. Since 3 had stomas, 40 didn't. If the study's results (not shown here) found that leakage was higher without, then the answer would be no. But since the user hasn't provided the actual outcomes (like leakage rates), maybe the answer is \"maybe\" because the data isn't presented. Wait, but the question is based on the given information. The user might expect us to use the data provided. \n\nWait, the problem states that the primary outcome was anastomotic leakage in presence or absence of a stoma. But the data given doesn't report the leakage rates. The numbers given are the types of procedures and how many had stomas. Since the question is about safety, but the necessary data (leakage rates) isn't provided here, perhaps the answer is \"maybe\" because we can't conclude without that data. Alternatively, maybe the fact that they did perform many without stomas implies that it's considered safe, but that's an assumption. \n\nAlternatively, maybe the answer",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 307,
            "completion_tokens": 512
        },
        "time_elapsed": 6.771332025527954
    },
    {
        "realidx": "27217036",
        "question": "Longer duration of neoadjuvant (NA) imatinib\u00a0(IM) used for locally advanced (LA) gastrointestinal stromal tumours (GIST) is not based on biology of the tumour reflected by kit mutation analysis.\nLA or locally recurrent (LR) GIST treated with NA IM from May 2008 to March 2015 from a prospective database were included in\u00a0the analysis. Archived formalin-fixed paraffin-embedded tissues (FFPE) were used for testing KIT exons 9, 11, 13 and 17 by PCR.\nOne hundred twenty-five patients with LA or LR GIST were treated with NA IM. Forty-five patients (36\u00a0%) had undergone c-kit mutation testing. Exon 11 was seen in 25 patients (55.5\u00a0%), 3 with exon 9 (6.7\u00a0%) and 2 with exon 13 (4.4\u00a0%). Twelve were wild type (26.6\u00a0%) and \u00a03 (6.7 %) were declared uninterpretable. Response rate (RR) for the exon 11 mutants was higher than the non-exon 11 mutant group (84 vs. 40\u00a0%, p\u2009=\u20090.01). Disease stabilization rate (DSR) rates were also higher in the exon 11 subgroup than non-exon 11 group (92 vs. 75\u00a0%). Eighty-four per cent exon 11 and 75\u00a0% non-exon 11 mutants were surgical candidates. Patients undergoing surgery had significantly improved event free survival (EFS) (p\u2009<\u20090.001) compared to patients not undergoing surgery, with the same trend seen in OS (p\u2009=\u20090.021). Patients with a SD on response to NA IM had a lower EFS (p\u2009=\u20090.076) and OS compared to patients achieving CR/PR. There were no differences between the various exon variants in terms of outcomes and responses\nNeoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?",
        "answer": "yes",
        "answer_rationale": "Upfront evaluation of kit mutation status may help us in delineating separate treatment strategies for potentially biologically different tumours and assessing the correct timing of surgery for this subset of GIST.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The main point here is whether KIT mutation analysis can be a \"pathfinder\" for neoadjuvant imatinib in locally advanced GIST. The question is asking if the duration of using NA imatinib isn't based on the tumor's biology as shown by KIT mutations.\n\nLooking at the study details: They analyzed patients with LA or LR GIST treated with NA imatinib. They tested KIT exons 9,11,13,17. Out of 125 patients, 45 had mutation testing. Exon 11 mutations were most common. The response rate (RR) was higher in exon 11 mutants (84%) vs others (40%, p=0.01). Disease stabilization was also better in exon 11. Surgical candidacy was similar between groups. Surgery improved EFS and OS. However, the key part is that despite these differences in response, the conclusion says \"no differences between various exon variants in terms of outcomes and responses.\" Wait, that seems conflicting. Wait, let me check again.\n\nWait, the last sentence says: \"There were no differences between the various exon variants in terms of outcomes and responses.\" Wait, but earlier it said that exon 11 had better response rates. Hmm, maybe I misread. Let me recheck the text.\n\nThe response rate for exon 11 was higher than non-exon 11 (84 vs 40%, p=0.01). So that's a significant difference. But the last sentence says \"no differences between the various exon variants in terms of outcomes and responses.\" Wait, maybe I'm misunderstanding. The non-exon 11 group includes exons 9,13, wild type, and uninterpretable. Maybe the study is saying that among the different exon variants (like exon 9 vs 13 vs others), there's no difference, but exon 11 is different from all others combined. The question is whether KIT mutation analysis helps in determining the course of treatment (like duration). The study shows that exon 11 mutations have better response, so maybe mutation analysis is useful. But the conclusion of the study's title is asking if KIT analysis is a pathfinder. The abstract's conclusion might be that despite the response differences, the outcomes (like EFS, OS) didn't differ between exon variants. Wait, the EFS and OS were",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 563,
            "completion_tokens": 512
        },
        "time_elapsed": 6.219705820083618
    },
    {
        "realidx": "27615402",
        "question": "Parental drinking has been shown to be associated with offspring drinking. However, the relationship appears to be more complex than often assumed and few studies have tracked it over longer time periods.\nTo explore the long-term (10-year) transmission of familial drinking during adolescence to offspring drinking patterns in young adulthood.\nSwedish longitudinal study, assessing the relationship between familial drinking in 2000 and offspring drinking in 2010 using simultaneous quantile regression analysis (n=744).DATA: Data on familial drinking was gathered from the Swedish level-of-living surveys (LNU) and from partner LNU in 2000 while data on offspring drinking in young adulthood was gathered from LNU 2010. Drinking among offspring, parents and potential stepparents was measured through identical quantity-frequency indices referring to the past 12 months in 2010 and 2000 respectively.\nYoung adults whose families were abstainers in 2000 drank substantially less across quintiles in 2010 than offspring of non-abstaining families. The difference, however, was not statistically significant between quintiles of the conditional distribution. Actual drinking levels in drinking families were not at all or weakly associated with drinking in offspring. Supplementary analyses confirmed these patterns.\nDoes the familial transmission of drinking patterns persist into young adulthood?",
        "answer": "maybe",
        "answer_rationale": "The association between familial drinking and offspring drinking in young adulthood exhibits clear non-linear trends. Changes in the lower part of the familial drinking distribution are strongly related to drinking in young adults, but the actual levels of drinking in drinking families appear less important in shaping the drinking patterns of the offspring in young adulthood.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether the familial transmission of drinking patterns persists into young adulthood based on the provided study.\n\nFirst, I need to understand the study's findings. The study tracked families over 10 years, from 2000 to 2010. They looked at parental drinking in 2000 and compared it to their offspring's drinking in 2010. The key points from the study are:\n\n1. Offspring from abstaining families drank less in 2010, but the difference wasn't statistically significant across quintiles.\n2. Actual drinking levels in families (non-abstaining) weren't strongly linked to the offspring's drinking.\n\nThe question is whether the transmission persists. The options are yes, no, maybe.\n\nThe study says that while there was a trend (abstaining families had offspring who drank less), the difference wasn't statistically significant. Also, the actual levels of drinking in the families didn't have a strong association. So the main conclusion here is that the familial transmission isn't statistically significant or weak. Therefore, the answer would be \"no\" because the effect isn't supported statistically. But wait, the first part mentions that abstaining families had offspring who drank less, but the difference wasn't significant. So maybe the transmission isn't really there. The supplementary analyses confirmed these patterns, which probably means the lack of significant association. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 368,
            "completion_tokens": 307
        },
        "time_elapsed": 3.741142988204956
    },
    {
        "realidx": "27643961",
        "question": "Comorbid major depression (MD) and alcohol use disorder (AUD), particularly in adolescents, have been shown to be associated with poorer subsequent MD outcomes.\nLongitudinal data were used to model associations between a four-level classification of MD/AUD during the period 15-18 years (neither; MD-only; AUD-only; comorbid MD/AUD) and MD over the period 18-35 years. These associations were then adjusted for confounding by a series of factors measured in childhood.\nThe three disorder groups had rates of adult MD during the period 18-35 years that were significantly (p<.05) higher than that of the group with no disorder. Furthermore, those in the comorbid MD/AUD group had significantly (p<.05) higher rates of adult MD than those in the AUD-only group, and marginally (p<.10) higher rates of adult MD than those in the MD-only group. After adjustment for confounding, the difference in rates of adult MD between the MD-only group and the MD/AUD group were no longer statistically significant. The factors that explained the associations were gender, childhood behavior problems, and exposure to physical and sexual abuse.\nThe data were obtained by self-report, and may have been subject to biases.\nMajor depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression?",
        "answer": "no",
        "answer_rationale": "The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether comorbidity of major depression and alcohol use disorder in adolescence leads to poorer outcomes of depression. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study used longitudinal data from 15-18 years and followed up until 35. The groups were: neither disorder, MD-only, AUD-only, and comorbid. The key findings were that all three disorder groups had higher adult MD rates than the no-disorder group. The comorbid group had significantly higher rates than AUD-only and marginally higher than MD-only. However, after adjusting for confounders like gender, childhood behavior problems, and abuse, the difference between MD-only and comorbid groups wasn't significant anymore.\n\nSo, the question is whether comorbidity leads to worse outcomes. The initial analysis showed comorbid had worse outcomes than MD-only, but after adjusting for those factors, the difference went away. That suggests that the comorbidity's effect might be explained by those confounders, not the comorbidity itself. Therefore, the answer might be that comorbidity doesn't independently lead to worse outcomes once those factors are considered. But the question is phrased as \"Does comorbidity lead to poorer outcomes?\" The study's adjusted results say that when controlling for those variables, the difference isn't there. So the answer would be no, because the association is explained by confounders. But wait, the original question is about whether comorbidity leads to poorer outcomes. The study's unadjusted data says yes, but adjusted says no. Since the question mentions that the factors explained the associations, the correct answer would be that comorbidity doesn't lead to poorer outcomes when considering those factors. So the answer is B) no. But I need to make sure. The question is asking if comorbidity leads to poorer outcomes. The study's conclusion after adjustment shows that the difference between comorbid and MD-only isn't significant anymore, implying that the comorbidity itself isn't the cause, but the confounders are. Therefore, the answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 455
        },
        "time_elapsed": 5.576234340667725
    },
    {
        "realidx": "28359277",
        "question": "Governments are urged to determine methods to control the use of medical resources and curb the rise of healthcare costs. The question is, do health behaviors have an impact on the use of medical resources? This study aims to identify and understand the difference in the number of outpatient visits and health examinations based on various health behaviors and to determine whether patients seek medical care for illness from the same physicians.\nThis study used the dataset derived from the Department of Budget, Accounting and Statistics of Kaohsiung, Taiwan in 2005. Persons older than 15\u00a0years were surveyed using an on-site questionnaire. A total of 2911 persons were enrolled in this study. Independent t-tests, chi-square tests, one-way ANOVA, multiple linear regression and binominal logistic regression were used in the data analysis.\nThe regression model for the frequency of doctor visits, health examinations, and whether the same physician is sought for medical care has demonstrated significant correlations with gender, age and education-level variables. Four health behaviors (i.e., exercise habits, dietary habits, regular blood pressure measurement, drinking habits) exhibited a significant correlation with healthcare utilization (P<0.05).\nDo healthier lifestyles lead to less utilization of healthcare resources?",
        "answer": "no",
        "answer_rationale": "Healthy lifestyles lead to an increase in the utilization of preventive health services. However, there is not much significantly reducing the number of outpatient visits in people with health behaviors. Specifically, people with regular exercise habits and who take their blood pressure measurement regularly have an increased number of outpatient visits. It is suggested that more available and accessible health consultation services be provided to inculcate in the general public the importance of maintaining a healthy lifestyle.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether healthier lifestyles lead to less utilization of healthcare resources based on the provided study.\n\nFirst, I need to recall the study's findings. The study looked at health behaviors like exercise, diet, blood pressure checks, and drinking habits. They found that these four behaviors had significant correlations with healthcare utilization (P<0.05). The question is whether healthier behaviors mean less use of resources.\n\nThe options are yes, no, maybe. The study says the health behaviors are significantly correlated. But the direction of the correlation isn't explicitly stated. Wait, the question is phrased as \"do healthier lifestyles lead to less utilization\". The study's results show a significant correlation, but does that mean healthier behaviors (like exercising, good diet) are associated with lower use? Or could it be the opposite?\n\nWait, the study's aim was to see if health behaviors affect outpatient visits and health exams. The results say that the four health behaviors are significantly correlated. But the direction isn't given here. However, in general, public health perspectives suggest that healthier behaviors might prevent illness, thus reducing healthcare use. But sometimes, people with healthier habits might get more check-ups, which would increase utilization. Hmm.\n\nWait the question is specifically about \"less utilization of healthcare resources\". The study's abstract mentions that the regression models showed significant correlations. The key is whether the correlation is negative (healthier behaviors lead to less use) or positive. Since the study found a significant correlation, but the direction isn't specified in the given text. Wait, but the options are yes, no, maybe. The question is whether the study's findings support that healthier lifestyles lead to less use. Since the study says that the four health behaviors \"exhibited a significant correlation with healthcare utilization (P<0.05)\", but without direction, maybe the answer is \"maybe\" (C). But wait, maybe the question is expecting an answer based on the typical understanding. Alternatively, perhaps the study's results do indicate that healthier behaviors reduce utilization. Let me think again.\n\nWait the study's aim was to see if health behaviors affect the number of outpatient visits and health exams. The four behaviors (exercise, diet, BP checks, drinking) are significant. For example, regular exercise and good diet might lead to fewer illnesses, so fewer outpatient visits. But regular health checks (like BP measurement) might increase the number of health exams. However, the question is about \"healthcare resources\" in general.",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 341,
            "completion_tokens": 512
        },
        "time_elapsed": 6.894997835159302
    },
    {
        "realidx": "7497757",
        "question": "To determine if temperature during cardiopulmonary bypass (CPB) has an effect on perioperative and postoperative thyroid function.\nProspective study comparing thyroid function during and after hypothermic and normothermic CPB.\nCardiac surgical unit at a university-affiliated hospital.\nTwelve patients scheduled to undergo cardiac operations with normothermic (n = 6) or hypothermic (n = 6) CPB.\nBlood was analyzed for serum concentration of total thyroxine (TT4), total triiodothyronine (TT3), free T3 (fT3), reverse T3 (rT3), and thyroid stimulating hormone (TSH) preoperatively, 60 min after CPB was initiated, 30 min after discontinuing CPB, and on postoperative days (POD) 1, 3, and 5.\nPatients who underwent either cold (26 degrees +/- 5 degrees C) or warm (35 degrees +/- 1 degree C) CPB were comparable with regard to age, body weight, duration of CPB, cross-clamp time, use of inotropes, total heparin dose, and length of hospital stay. Incidence of postoperative myocardial infarction, congestive heart failure, and death were similar. In both groups, TT4 and TT3 were reduced below baseline values beginning with CPB and persisting for up to 5 days after CPB (p<0.05), free T3 was reduced for up to 3 days after CPB (p<0.05), mean serum rT3 was elevated on POD 1 and POD 3 (p<0.05), and TSH remained unchanged.\nCardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome?",
        "answer": "no",
        "answer_rationale": "The results of this study suggest that normothermic CPB does not prevent the development of the \"euthyroid sick syndrome\" during and after CPB. Despite these changes in thyroid function, most patients in both groups had a normal postoperative recovery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the temperature during cardiopulmonary bypass (CPB) affects the postoperative euthyroid sick syndrome. The options are yes, no, or maybe.\n\nFirst, I need to recall what euthyroid sick syndrome (ESS) is. ESS is a condition where there are abnormal thyroid function tests in the setting of non-thyroidal illness. Common changes include low T3, low T4, and high reverse T3 (rT3), with normal or low TSH. It's often seen in critical illnesses or major surgeries.\n\nThe study mentioned here compared hypothermic (cold) CPB at around 26\u00b0C and normothermic (warm) CPB at 35\u00b0C. The key outcomes were thyroid function markers measured at various times. The results showed that in both groups, TT4 and TT3 decreased from baseline starting during CPB and stayed low for up to 5 days. Free T3 was also reduced up to 3 days, and rT3 was elevated on days 1 and 3. TSH didn't change in either group.\n\nThe question is whether the temperature during CPB affects the development of ESS. The study's results indicate that both groups (hypothermic and normothermic) had similar changes in thyroid function parameters. Since the outcomes (like reduced TT4, TT3, fT3 and increased rT3) were the same in both groups, the temperature during CPB didn't make a difference in the thyroid function changes. The fact that TSH remained unchanged in both also aligns with ESS, where TSH isn't typically elevated. \n\nThe conclusion from the study would be that the temperature during CPB doesn't affect the postoperative ESS because the changes in thyroid hormones were similar between the two groups. Therefore, the answer should be \"yes\" (A) because the temperature didn't have an effect, meaning the statement in the question is correct. Wait, wait. Wait, the question is phrased as \"Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome?\" So the options are whether the statement is correct. The study's findings support that the temperature (whether hypothermic or normothermic) didn't lead to different outcomes in thyroid function parameters. Therefore, the answer would be (A) yes, because the temperature doesn't affect it. But I need to make sure I'm interpreting the options",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 512
        },
        "time_elapsed": 6.3207314014434814
    },
    {
        "realidx": "8738894",
        "question": "The purpose of this study was to search for evidence of an association between occupational arsenic exposure and diabetes mellitus, as implied by the relation of this disease to arsenic in drinking water in a recent study from Taiwan.\nA case-referent analysis on death records of 5498 individuals in the art glass producing part of southeastern Sweden was performed. Out of all the enrolled subjects, 888 were glass workers. According to occupational title, glassblowers, foundry workers, and unspecified workers were regarded as potentially exposed to arsenic. Persons with a diagnosis of diabetes mellitus either as an underlying or contributing cause of death were considered cases. Referents were decedents without any indication of cancer, cardiovascular disease, or diabetes.\nA slightly elevated risk [Mantel-Haenszel odds ratio (MH-OR) 1.2, 95% confidence interval (95% CI) 0.82-1.8] was found for diabetes mellitus among the glassworks employees, especially in combination with cardiovascular disease (MH-OR 1.4, 95% CI 0.81-2.3). For the glassblowers, other foundry workers and unspecified glassworkers probably exposed to arsenic, the M-H odds ratio was 1.4 (95% CI 0.92-2.2). Unspecified glass workers, who probably included persons with high exposure, carried the higher risk (MH-OR 1.8, 95% CI 1.1-2.8).\nDiabetes mellitus among Swedish art glass workers--an effect of arsenic exposure?",
        "answer": "no",
        "answer_rationale": "The observations from this study provide limited support for the possibility that occupational arsenic exposure could play a role in the development of diabetes mellitus. Many other metallic compounds are also used in art glass production, however, and there is a possibility of confounding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether there's a link between occupational arsenic exposure and diabetes, similar to what was found in the Taiwan study with drinking water. The study used death records from 5498 people in Sweden's art glass industry. Out of these, 888 were glass workers. They categorized certain jobs like glassblowers, foundry workers, and others as possibly exposed to arsenic.\n\nThe cases were people who had diabetes as a cause of death, and referents were those without cancer, cardiovascular disease, or diabetes. The results showed a slightly elevated risk with a Mantel-Haenszel odds ratio (MH-OR) of 1.2, but the confidence interval (CI) was 0.82-1.8. That interval includes 1, which means the result isn't statistically significant. Then, when looking at those with both diabetes and cardiovascular disease, the MH-OR was 1.4 with a CI of 0.81-2.3, which also includes 1. For the specific groups like glassblowers and others exposed, the OR was 1.4 (CI 0.92-2.2), still including 1. However, the unspecified workers had an OR of 1.8 with a CI of 1.1-2.8, which doesn't include 1, so that's significant.\n\nBut the question is whether the study found evidence that diabetes among these workers is an effect of arsenic exposure. The main issue here is the confidence intervals. The overall OR for glassworkers was 1.2 but not significant. The subgroup of unspecified workers had a significant OR of 1.8. However, the study's conclusion might be cautious because not all exposed groups showed a significant association. The title is asking if it's \"an effect of arsenic exposure?\" The options are yes, no, maybe.\n\nThe problem is that while there's a trend and one subgroup is significant, the overall results are mixed. The main analysis (all glassworkers) isn't significant. The authors might conclude that there's some suggestion but not definitive proof. The question is whether the study's findings support a \"yes\" or \"maybe.\" Since the confidence intervals for most groups include 1 except the unspecified workers, but the overall isn't significant, the answer might be \"maybe\" (C). Alternatively, if the question is whether there's any evidence, then yes",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 432,
            "completion_tokens": 512
        },
        "time_elapsed": 6.372679948806763
    },
    {
        "realidx": "9363244",
        "question": "To determine the effect of occupational exposure in a nuclear power plant in Griefswald, Germany on male and female fecundity.\nThe frequency of men and women exposed to ionizing radiation through work in a nuclear power plant among 270 infertile couples was retrospectively compared to a control fertile population using a pair-matched analysis. The total cumulative equivalent radiation dose was determined. In addition, the spermiograms of the male partners in both groups were compared and correlated to the degree of exposure.\nNo differences were noted in the frequency of nuclear power plant exposure between sterile and fertile groups. There was a higher rate of anomalous spermiograms in nuclear power plant workers. However, abnormalities were temporary. No correlation was found between the cumulative equivalent radiation dose and abnormal spermiograms.\nDoes occupational nuclear power plant radiation affect conception and pregnancy?",
        "answer": "yes",
        "answer_rationale": "The data suggest that occupational exposure due to ionizing radiation should be investigated as a possible cause for involuntary temporary sterility and as a risk factor for early pregnancy disorders.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether working in a nuclear power plant affects fertility in men and women. The key points from the study are:\n\nFirst, they compared infertile couples to fertile ones, matching them. They found no difference in the frequency of exposure between the groups. So, the exposure rate among those who were infertile wasn't higher than the controls. That suggests that being exposed doesn't make you more likely to be infertile.\n\nThen, they looked at spermiograms. The workers had more abnormal ones, but these were temporary. Also, there was no link between the radiation dose and the sperm issues. So even though there was a higher rate of sperm problems, they went away over time, and the amount of radiation didn't matter. \n\nThe question is whether the radiation affects conception and pregnancy. Since the main comparison between infertile and fertile groups showed no difference in exposure rates, that's a big point. The sperm abnormalities were there but temporary, so maybe they don't lead to long-term issues. Also, since the dose didn't correlate, it's possible that the temporary issues aren't significant enough to impact conception overall. The study's results don't show a connection between the exposure and infertility. So the answer should be no, option B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 262,
            "completion_tokens": 273
        },
        "time_elapsed": 3.492478847503662
    },
    {
        "realidx": "9465206",
        "question": "We investigated the actual role of MRI versus arthroscopy in the detection and characterization of occult bone and/or cartilage injuries in patients with previous musculoskeletal trauma of the knee, pain and severe functional impairment. Occult post-traumatic osteochondral injuries of the knee are trauma-related bone and/or cartilage damage missed at plain radiography.\nWe retrospectively selected 70 patients (men:women = 7:3; age range: 35 +/- 7 years) with a history of acute musculoskeletal trauma, negative conventional radiographs, pain and limited joint movements. All patients were submitted to conventional radiography, arthroscopy and MRI, the latter with 0.5 T units and T1-weighted SE. T2-weighted GE and FIR sequences with fat suppression.\nWe identified three types of occult post-traumatic injuries by morpho-topographic and signal intensity patterns: bone bruises (no. 25), subchondral (no. 33) and osteochondral (no. 35) injuries. Arthroscopy depicted 45 osteochondral and 19 chondral injuries. A bone bruise was defined as a typical subcortical area of signal loss, with various shapes, on T1-weighted images and of increased signal intensity on T2-weighted and FIR images. The cortical bone and articular cartilage were normal in all cases, while osteochondral injuries exhibited associated bone and cartilage damage with the same abnormal MR signal intensity. Sprain was the mechanism of injury in 52 cases, bruise in 12 and stress in 6. In 52 sprains (30 in valgus), the injury site was the lateral compartment in 92.3% of cases (100% in valgus), associated with meniscal damage in 73% of cases (90% in valgus) and with ligament injury in 90.4% (100% in valgus). In 12 bruises, the injury site was the lateral compartment in 58.3% of cases, the knee cap in 25% and the medial compartment in 16.7%; meniscal damage was associated in 25% of cases and ligament damage in 8.3%. In 6 stress injuries, the injury site was localized in the medial tibial condyle in 80% of cases, while meniscal and ligament tears were absent.\n\"Occult\" posttraumatic lesions of the knee: can magnetic resonance substitute for diagnostic arthroscopy?",
        "answer": "yes",
        "answer_rationale": "After comparing MR with arthroscopic findings and reviewing the available literature, we conclude that arthroscopy permits the direct visualization of even fine articular surface changes but does not depict the subchondral bone, the most frequent site of injury detected with MRI. MRI was a very useful tool in the detection and characterization of the different types of occult bone and/or cartilage injuries and showed a statistically significant correlation between site and distribution of bone and cartilage injuries and between internal damage and trauma mechanisms. Therefore, we believe that MRI can help avoid diagnostic arthroscopy in the patients with a history of post-traumatic pain, acute articular blocks and negative radiographic findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing MRI and arthroscopy in detecting occult bone and cartilage injuries in the knee after trauma. The key point here is whether MRI can replace arthroscopy for diagnosis.\n\nFirst, the study included 70 patients with negative X-rays but persistent symptoms. Both MRI and arthroscopy were performed. The MRI found three types of injuries: bone bruises, subchondral, and osteochondral. Arthroscopy found 45 osteochondral and 19 chondral injuries. \n\nLooking at the details, MRI uses specific sequences (T1, T2, FIR with fat suppression) which are known to be good for soft tissue and bone bruises. The description of bone bruises on MRI matches what's typical\u2014signal changes on T1 and T2. Osteochondral injuries on MRI showed both bone and cartilage damage with abnormal signals, which aligns with arthroscopy findings. \n\nThe study's results show that MRI identified the same types of injuries as arthroscopy. The locations and associated injuries (like meniscal and ligament tears) also correlate. Since arthroscopy is the current gold standard but is invasive, if MRI has comparable accuracy, it could substitute. The question is whether the data supports that MRI can replace arthroscopy here. \n\nThe answer options are yes, no, maybe. The study's results suggest MRI is effective in detecting these injuries, so the answer might be A (yes). But wait, the question is about substituting. The study's design is retrospective, and maybe there's some discrepancy. However, since the MRI findings matched the arthroscopy results in terms of types and locations, it's likely that MRI can be a substitute. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 632,
            "completion_tokens": 368
        },
        "time_elapsed": 4.678425073623657
    },
    {
        "realidx": "9483814",
        "question": "Uterus-specific synthetic Prostaglandin analogues (gemeprost, sulproston etc.) have been widely employed for termination of pregnancy in the second trimester. Since paracervical anaesthesia may be useful during this procedure, we investigated in this prospective randomised study its impact on the clinical course of abortion and pain especially in the late first and second stage of labour.\n20 women scheduled for elective abortion (fetal reasons) between the 16th and 23rd week of gestation were to be given 1 mg gemeprost vaginally every 6 hours. They were allocated at random: 10 women received only Pethidin intravenously and Butylscopolamine rectally, another 10 women were additionally treated by paracervical anaesthesia (2 x 10 ml 0.5% Bupivacain solution) at a cervical dilatation of 2-3 cm.\nA median of 3 gemeprost applications were administered in both groups. In the group without paracervical anaesthesia the median induction to abortion interval was 20 hours (range: 8-44 hours), 13 hours (range: 8-36 hours, NS) resulting for the paracervical anaesthesia group. The intervals from the last application of prostaglandin until abortion and from 3 cm cervical dilatation to abortion were slightly, but not significantly shorter in the paracervical anaesthesia group. The requirement of Butylscopolamine was higher in the latter group (p<0.05). The requirement of Pethidin and the intensity of pain (measured by pain scale according to Huskisson) especially in the late first stage of labour were not statistically different between both groups. Side effects of paracervical anaesthesia did not occur.\nDoes para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?",
        "answer": "yes",
        "answer_rationale": "Paracervical anaesthesia is a method for analgesia during second trimester abortion with a low rate of side effects. It can shorten the duration of last period of second trimester abortion in some cases but has no impact on the perception of pain nor requirement of analgesics and so with only limited benefit in second trimester abortion with vaginal gemeprost.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether paracervical anaesthesia (PCA) offers additional advantages when using gemeprost for second-trimester abortions. The options are yes, no, or maybe.\n\nFirst, I need to look at the results provided. The study had two groups: one with PCA and one without. Both groups used gemeprost and some medications like Pethidin and Butylscopolamine. The key outcomes mentioned are the time intervals, medication requirements, pain levels, and side effects.\n\nThe median induction to abortion time was 20 hours without PCA and 13 hours with PCA, but it says \"NS\" which I think stands for not significant. So the time difference isn't statistically significant. The intervals from last prostaglandin dose and from 3cm dilation also were slightly shorter but not significant in the PCA group. \n\nThen, the Butylscopolamine requirement was higher in the PCA group (p<0.05), which is significant. But the Pethidin use and pain scores (Huskisson scale) didn't differ between groups. Also, there were no side effects from PCA. \n\nThe question is whether PCA offers additional advantages. The main possible advantages would be shorter labor times, less pain, or reduced medication needs. However, the time wasn't significantly shorter, pain wasn't reduced, and they actually needed more Butylscopolamine. Since the primary outcomes didn't show benefits and one medication was used more, maybe PCA doesn't add benefits. The answer would be B) no. Wait, but the question is about \"additional advantages\". Even if there's no harm, but no benefit, then the answer is no. The study's results don't show any significant advantages, so the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 501,
            "completion_tokens": 377
        },
        "time_elapsed": 4.942267894744873
    },
    {
        "realidx": "9582182",
        "question": "To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor.\nA prospective study of patients assessed with a neuropsychological test battery.\nA university medical center.\nNineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy.\nIncluded in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory.\nThe SCL 90-R Obsessive-Compulsive subscale was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001).\nDoes the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?",
        "answer": "yes",
        "answer_rationale": "Our data suggest that the SCL 90-R is best viewed as an indicator of unidimensional emotional distress and somatic effects of structural brain injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the SCL 90-R obsessive-compulsive dimension identifies cognitive impairments based on the study provided.\n\nFirst, I need to recall what the SCL-90-R's Obsessive-Compulsive (OC) subscale measures. Generally, this subscale assesses symptoms like obsessions, compulsions, and repetitive thoughts or behaviors. But the question is about its relation to cognitive impairments.\n\nLooking at the study details: The participants are adults with malignant brain tumors about to undergo chemotherapy. They were given several tests. The key findings here are that the SCL 90-R OC subscale wasn't related to objective measures of attention, verbal memory, or age. However, it was significantly related to depression, anxiety, and subjective memory complaints. The multivariate analysis showed that depression contributed most to the OC scores, with anxiety adding a bit more.\n\nSo, the OC subscale's correlation is with psychological symptoms (depression, anxiety) and self-reported memory issues, not the actual cognitive test results (like Mattis Dementia Rating Scale, CVLT, Trail Making Test B). The question is whether the OC dimension identifies cognitive impairments. Since the OC subscale isn't linked to the objective cognitive tests, but more to mood and anxiety, it suggests that it's not measuring cognitive impairments directly. Instead, it's more about psychological symptoms. The fact that it's related to subjective memory complaints (which are self-reported, not objective) might be due to depression or anxiety affecting their perception rather than actual cognitive deficits.\n\nTherefore, the answer should be no, because the OC subscale isn't identifying objective cognitive impairments but rather psychological symptoms. The study's results show no significant relation to the actual cognitive test scores, so the SCL-90R OC isn't a measure of cognitive issues here.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 362,
            "completion_tokens": 387
        },
        "time_elapsed": 4.453177452087402
    }
]